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ABSTRACT 
Puberty involves profound anthropometric and hormonal changes that have been 
associated with changes in mood, behaviour and other health risks that emerge in 
adolescence. However, there is little longitudinal research in the effects of puberty on 
adolescents. The overarching aim of this thesis was to demonstrate novel ways of 
studying puberty and how these improve our understanding of the longitudinal 
changes that occur over this period. 
Oestradiol is popularly associated with changes in mood and depression and 
testosterone with aggression and risk taking. Chapters 3 and 4 reviewed the effects of 
oestradiol on female, and testosterone on male adolescent mood and behaviour. In 
both reviews there were inconsistent cross-sectional data, and limited longitudinal 
data, supporting such associations. 
In Chapter 5, text messaging reminders for study compliance was studied. Specimen 
collection correlated with text message reply time. 
Liquid chromatography-tandem mass spectrometry assays on urine and serum 
specimens quantified oestradiol, testosterone and luteinising hormone levels in 97% 
of urine and 95% of serum specimens (Chapter 6). Hormone changes over one year 
were not linear, with frequent urine sampling offering a more nuanced description of 
puberty hormone change. 
Self-rated Tanner stage and other subjective measures of puberty (adolescent- and 
parent-rated) were compared with longitudinal changes in serum hormones in 
  xvi 
Chapter 7. Positive longitudinal associations were observed between these subjective 
measures and hormone changes. 
Chapter 8 identifies foot length growth as a novel marker for early puberty changes. 
Positive longitudinal relationships were observed between foot length, height, 
weight, Tanner stage and serum sex steroids. Foot length offers a practical, novel and 
cost-effective marker of early puberty. 
This thesis provides novel insights into puberty and adolescence, particularly how 
this life transition is studied. The importance of longitudinal research to determine 
the true effects of puberty hormone changes on adolescents is highlighted, and data 
are provided to show how this can be feasibly achieved. 
 
 
1. PUBERTY AND ADOLESCENCE IN CONTEXT
1.1. Introduction 
Puberty and adolescence involve profound biological and psychosocial changes. 
Despite the known importance of these changes, there are persisting gaps in our 
understanding of the impact of puberty on adolescence, and of both transitions on 
health and wellbeing across the lifespan. Many studies of pubertal hormones are 
cross-sectional, or, if longitudinal, lack sufficient sample size or adequate and 
appropriate specimen collection to capture the dynamic changes over this period. 
Additionally, limitations in hormone assay technology mean that it is only with the 
recent advent of accessible mass spectrometry that measuring low circulating 
hormone levels in early puberty with accuracy is now feasible. Puberty occurs over a 
relatively short period of time with subtle indications of its onset. Community-based 
adolescents are needed to provide sufficient samples to capture normal hormone 
changes.  
In Australia, the Adolescent Rural Cohort, Hormones and Health, Education, 
Environments and Relationships (ARCHER) study (1), was conducted to investigate 
the effects of pubertal hormone changes on the health and wellbeing in a cohort of 
342 adolescents living in rural NSW. This thesis is based on data from the ARCHER 
cohort and plans to systematically evaluate the literature for hormone effects on 
adolescent mood and behaviour, as well as describe the methodology and logistics 
necessary to complete the ARCHER study. Further, this thesis will consider how we 
might relate these novel pubertal hormone results to our established understanding of 
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puberty in terms of Tanner staging and the other anthropometric changes which 
occur.  
Puberty generally occurs during adolescence, the second decade of life (2), though 
adolescence is a life phase that extends beyond the bounds of puberty (3). 
Physiologically, puberty signifies a time of accelerated somatic growth and sexual 
development, which is promoted by the synergistic effects of rapidly increasing 
gonadal hormones and growth hormone (4). Much controversy remains as to the 
effects of these somatic and hormone changes on health and wellbeing, for example 
the effects of hormone changes on mood and behaviour. Adolescent changes include 
not just puberty’s biological transitions (which prepare the individual for 
reproductive capacity), but also a variety of other cognitive, social and psychological 
changes necessary for independent adult life (4). There are many popular ideas and 
beliefs about the effects of these life changes on the individual. This introductory 
chapter will consider the changes that occur during both puberty and adolescence, 
and how these may affect the individual, as well as identifying some of the 
unanswered questions about this crucial life transition. 
1.2. Puberty  
Puberty is the biological process by which an individual sexually matures and gains 
the physiological and psychological capacity to reproduce (3-7). This process 
involves activation of the hypothalamic-pituitary-gonadal (HPG) axis and the 
concomitant growth of the gonads, secretion of sex hormones (mainly testosterone 
for males and oestradiol for females (4)), the development of secondary sex 
characteristics, skeletal growth and finally fusion of epiphyseal growth plates to 
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achieve adult stature (3, 5). Other physical and psychological changes may occur that 
prepare the adolescent for reproductive capacity and general maturity (6, 7). 
1.2.1. The Onset of Puberty 
The mechanisms underpinning the timing of pubertal onset are still being elucidated, 
though a variety of factors are known to play a modulating role. These include 
genetics, nutrition, sex hormone levels, chronic illness and general health (4, 5, 7). 
Many of these factors will also affect the somatic growth of the individual during the 
pubertal transition (8). Body weight and adiposity have been studied extensively due 
to observations that overweight and obese children tend to commence puberty earlier 
(9). Many of these studies focus on females, while data on boys are less clear. In a 
cross-sectional Bulgarian cohort, Tomova found that heavier boys commenced 
puberty earlier, with a positive association between body mass index (BMI), body 
weight and onset of puberty (10). It is thought that leptin (see below) plays a 
significant role as well as insulin resistance, which creates compensatory increases in 
insulin levels and decreased sex hormone-binding globulin, thereby increasing the 
amount of bioavailable sex steroids (10). Similarly females with increased BMI at 
seven years of age were found to have earlier puberty in a prospective Hong Kong 
cohort (11) and in a longitudinal study of Greek girls, Pantsiotou reports earlier onset 
of puberty (Tanner breast stage 2) for girls with greater BMI, but they did not 
observe a difference in age at menarche (12). This latter finding is controversial, as 
other studies have shown earlier menarche in girls with greater BMI than age-
matched peers (13).  
1. Puberty and Adolescence in Context
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The genetic heritability of pubertal onset has also been studied. Genetic 
polymorphisms in a variety of regulatory networks have been found to influence 
pubertal timing (14-16), and genome wide association studies have identified several 
unique loci whose polymorphisms influence timing of pubertal onset. For example, 
LIN28B single nucleotide polymorphisms are associated with earlier age at menarche 
and breast development in females, earlier pubic hair development in males and 
faster height growth (17-20). Girls homozygous for the FSHR-29AA allele 
(associated with decreased follicle stimulating hormone receptor expression) enter 
puberty 7.4 months later than other common variants (FSHR-29GG or FSHR-29GA) 
(21). The overall heritability of pubertal timing has been considered in several 
studies. A mono- and dizygotic twin study by Silventoinen estimated 91% of 
variability of the pubertal growth spurt was explained by genetic heritability (9) and 
a large British cohort study found that familial timing of menarche was significantly 
associated with adolescent’s timing of menarche, with approximately 57% 
heritability and the remaining 43% of variability explained by non-shared 
environmental factors (22). Recent work by Wohlfahrt-Veje and colleagues has 
shown that pubertal timing in adolescents is influenced by the timing of their parents’ 
pubertal milestones, which suggests that at least some of the variation in pubertal 
timing is genetic (23). Parents were asked if their pubertal timing was early, average 
or late compared to peers and adolescents underwent repeated clinician examination 
for Tanner staging and girls were asked when they underwent menarche. For girls, 
the age at menarche was better associated with both maternal and paternal pubertal 
timing compared to thelarche or pubarche, indicating the role of other factors in the 
timing of the latter two milestones. The timing of menarche in girls was significantly 
earlier than their mothers’. The timing of boys’ milestones was also associated with 
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parental milestones. Early parental pubertal timing in parents was associated with 
earlier pubarche in males and menarche in girls (23).  
1.2.2. Initiation of Puberty 
We have a clearer picture of the initiation of puberty. Gonadal development and the 
increase in physical growth during puberty both begin with reactivation of the HPG 
axis by the nocturnal pulsatile secretion of gonadotrophin-releasing hormone 
(GnRH) from the hypothalamus (4-7). The neuropeptides kisspeptin (4, 24, 25), 
neurokinin B (which is encoded by TAC3) and dynorphin, leptin (26) and the 
recently described Makorin Ring Finger 3 (MKRN3) gene and its products (27-29) 
are all involved in promoter or brake roles (Figure 1.1). Inactivating neurokinin B 
(via TAC3 missense loss-of-function mutations or deletion) or its receptor is 
associated with a lack of progression into puberty (25, 29, 30) and mutations in 
MKRN3 have been associated with central precocious puberty (27, 28). These 
findings have been used to infer the contributions of these factors to normal pubertal 
initiation. A decrease in serum MKRN3 concentration precedes puberty onset in 
healthy girls, while MKRN3 concentration was negatively correlated with LH and 
FSH (31). Additionally, leptin has been implicated in the initiation of puberty 
through an indirect regulatory mechanism on GnRH neurons (26).  
1. Puberty and Adolescence in Context
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Figure 1.1. A proposed model of gonadotrophin release based upon studies in 
humans (32-38).  
In this model, kisspeptin neurons in the pre-optic area and kisspeptin-neurokinin B-
dynorphin neurons (KNDy) in the arcuate nucleus of the hypothalamus secrete 
kisspeptin to stimulate KISS1 receptors (KISS1R) gonadotrophin-releasing hormone 
(GnRH) neurons in the pre-optic area and infundibular nucleus of the hypothalamus. 
GnRH stimulates the GnRH receptor (GnRHR) on gonadotrophs in the anterior 
pituitary, leading to the secretion of LH and FSH which act on the gonads. KDNy 
neurons have complex activating and inhibiting stimuli which are not fully 
elucidated. Auto- and paracrine secretion of Neurokinin B (NKB) stimulates the 
NK3R receptor to enhance kisspeptin secretion by KNDy neurons and dynorphin 
acts on κ-opioid receptors (KOR) to inhibit kisspeptin secretion. Leptin is another 
proposed stimulator of kisspeptin secretion from KNDy neurons. MKRN3 and 
ghrelin both act as brakes on kisspeptin secretion, and sex steroids (oestradiol (E2), 
testosterone (T) and progesterone (P) are thought to act on KNDy oestrogen 
receptor-α (ERα), progesterone receptor (PR) and androgen receptor (AR) as a 
negative feedback loop. 
1. Puberty and Adolescence in Context
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The HPG axis is initially active during the foetal period, potentiating sexual 
differentiation (4-6), but is largely suppressed after birth (4), apart from in the first 
six months of life, when both sexes experience a mini-puberty. Mini-puberty refers 
to the transient activation of the HPG axis in the first months of life (39, 40). There is 
a brief surge in luteinising hormone (LH) and follicle stimulating hormone (FSH) 
from the first week of life to approximately six months of age (peaking at one 
month), which helps in gonadal development (40). In males, there is evidence that 
testosterone secreted in mini-puberty is critical for normal penile growth in infancy, 
as well as Sertoli cell proliferation and differentiation of germ cells into adult 
spermatogonia, and is thus presumed to be associated with later male fertility (40, 
41). The relationship between oestradiol and mini-puberty in females with respect to 
later fertility is less clear (40, 42, 43). In both males and females, mini-puberty is 
thought to play critical roles in childhood growth and development. The sex 
differences in growth are noted to begin around the time of mini-puberty (44) and 
have demonstrable associations with growth up to six years of age (42). In a 
longitudinal study of thirty-five infants (seventeen male) followed from one month to 
six years of age, there was a significant negative relationship between testosterone 
and LH at eight weeks of age and body weight and body mass index at three and six 
years (42). A similar negative relationship was seen for those outcomes and 
oestradiol levels at twenty weeks of age (42). Development of sex-based toy 
preferences and sex-specific behaviours in early childhood have also been 
consistently associated with changes in testosterone levels during mini-puberty (45, 
46). After the period of childhood suppression, the pubertal reactivation of the HPG 
axis has been described as part of the continuum of sexual development, beginning 
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with sexual differentiation in utero and the mini-puberty in the neonate, childhood 
quiescence, followed by puberty and then sexual maturity and reproductive capacity, 
and concluded by senescence (6, 7).  
In puberty, increased GnRH secretion causes the release of LH and FSH from the 
anterior pituitary gland. LH and FSH cause gonadal growth and sex steroid 
production through a negative feedback loop (4-7). The gonads are the most 
important site of sex steroid formation, with the ovaries producing over 90% of 
female oestradiol (and 50% of testosterone) and the testes producing over 90% of 
testosterone and 50% of oestradiol in males (4). LH acts upon gonadal interstitial 
cells (ovarian theca cells and testicular Leydig cells) to promote androgen secretion. 
In females, these androgens are precursors of oestrogens (oestrone, oestradiol, 
oestriol, the most potent and prevalent of which is oestradiol) (4). FSH stimulates 
testicular Sertoli cells in males to support the production of gametes, and ovarian 
granulosa cells in females to form oestrogens from androgenic precursors, such as 
androstenedione and testosterone. Inhibins A and B, secreted by testicular Sertoli 
cells and ovarian granulosa cells, play an important negative feedback role in 
gonadotrophin secretion. Inhibin B can serve as a marker of spermatogenesis in 
males and its increase in late pre-pubertal females suggests increasing follicular 
activity (47). 
Sex steroids also help develop secondary sexual characteristics, such as breast and 
uterine growth by oestrogens in females and penile growth, body hair and deepening 
voice in males as a result of laryngeal cartilage growth by androgens (3-5). These 
also affect changes in body composition during puberty. The increase in sex steroids 
(particularly oestrogens (48)) increases pituitary secretion of growth hormone (GH), 
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which in turn increases the levels of insulin-like growth factor 1 (IGF-1). GH and 
IGF-1 increase the rate of physical growth in a synergistic manner with sex steroids 
(especially oestradiol), and GH also optimises LH and FSH action on gonadal growth 
(4, 5, 7). The completion of physical growth in both genders is due to high-level 
oestradiol-induced fusion of epiphyseal plates (4).  
The clinical changes of puberty normally commence between 8 and 13 years in girls 
and between 9 and 14 years in males (49), with abnormally early pubertal onset 
defined as precocious and later puberty being delayed (although time differentiates 
between simple delay and pathological absence). Puberty is usually completed within 
2-4 years of onset (5, 6). Bone age is a more accurate predictor of maturation than 
chronological age, with less variation between skeletal age compared to their 
chronological age in 170 adolescents in the longitudinal Harpenden Growth Study (4, 
50). The age of menarche (as an indicator of pubertal development) has decreased 
during the mid-late 20th century (7) and similar trends have been seen using breast 
development as a marker (51-53). However, conflicting data have recently been 
found in white girls in the USA (54) and accordingly there is some controversy 
whether secular trends for earlier puberty are persistent (7). In males, recent studies 
have provided evidence for continued reduction in the timing of onset of puberty, 
using direct measurement of testicular size (55, 56) and peak height velocity (PHV), 
though PHV as a marker of pubertal progress has limitations (see Section 1.2.3). 
Tena-Sempere describes puberty as a “biological sensor”, the timing of which (and 
trends thereof) reflecting a possible change in environmental influences on 
reproductive health (26), such as intrauterine nutrition, changing dietary patterns and 
endocrine-disrupting chemicals (53).  
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Two separate endocrine processes contribute to puberty (57): the onset of adrenal 
androgen secretion (adrenarche) usually between 6-8 years, and the re-activation of 
the HPG axis and onset of sex steroid secretion from the gonads (gonadarche) 
approximately two years after this. The temporal relationship between adrenarche 
and gonadarche may suggest adrenal development might influence future gonadal 
development, however this remains unproven and there is no obvious mechanism. 
Androgens secreted by the adrenal glands, such as androstenedione and 
dehydroepiandrosterone (DHEA and its sulphate DHEAS), cause the development of 
axillary and pubic hair, as well as the development of acne, apocrine sweat glands 
and body odour (5, 58, 59). Those with primary adrenal insufficiency, however, still 
undergo gonadarche within the normal age range (6). A specific pituitary stimulating 
hormone for adrenarche has never been identified, but it is generally assumed that 
adrenocorticotropic hormone (ACTH) is responsible. Anecdotally, children with 
central pan-hypopituitarism including adrenal insufficiency frequently have little 
adrenarchal response. 
1.2.3. Physical Growth during Puberty  
One of the most striking features of puberty is the growth spurt, which transforms the 
individual to final adult height. This growth is dynamic and sexually dimorphic (60), 
and is generally independent of prior growth (61, 62). Epiphyseal fusion occurs 
during this time as well, together with increasing bone density. Between 15% and 
25% of adult height is gained during puberty – up to 25 cm in females and up to 30 
cm in males (63). Weight gain occurs too, whether by enhanced musculature (more 
marked in males; under the influence of testosterone action) or increased fat 
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deposition (more marked in females; an action of oestradiol). Male growth begins 
and concludes later than female growth.  
Bone mass doubles from the onset of puberty to young adulthood, usually peaking in 
the third decade (64), with concomitant changes in trabecular and cortical bone mass. 
This is modulated by activation of the GH-IGF-1 axis by the sex hormones (in 
particular oestrogens in both sexes), which leads to the pubertal growth spurt (64-
67). Epiphyseal chondrocyte fusion finalises bone growth and is primarily an action 
of high-level oestradiol in both sexes (65). Sex hormones also enhance calcium and 
phosphate metabolism to increase bone mass and mineral density (64), assuming 
adequate protein and calcium intake and sufficient Vitamin D.  
Peak height velocity describes the time when the height change over time is 
maximal. In males, average PHV is 10.5 cm per year (range 7-12 cm/year) and for 
females it is 9.0 cm/year (range 6-11 cm/year). From the age of two years to the 
onset of puberty, both sexes have approximately the same growth velocities: average 
5-6 cm/year height increase and average 2.5 kg/year weight increase, dependent on 
factors such as nutrition, GH and thyroid hormone levels (60). According to Marshall 
and Tanner’s studies in British children, PHV in males occurred at a mean age of 
14.1 years, at around the time that Tanner stage 4 was reached (68). Female PHV 
was approximately two years before boys, with the average PHV occurring at 12.1 
years during Tanner stage 3 (69). These are illustrated in Figure 1.7. Given the 
secular decrease in age at puberty onset, these findings are likely to have been 
altered, although the patterns of growth and development remain unchanged.  
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Recent data from German adolescents noted age ranges for PHV in females (between 
10.0 and 13.0 years), and for males PHV between 11.9 and 14.7 years (62).  A 
retrospective analysis in Swedish males born between 1946 and 1991 found that 
male PHV was reached at a mean age of 14.0 ± 1.1 years and had been decreasing by 
1.3 months for each decade of the study (56). Tanner found that adolescents of both 
sexes could still reach the same final height whether their age of pubertal onset was 2 
standard deviations earlier or later than the mean – the main difference was their 
PHV, which was more rapid and of higher magnitude in early maturing adolescents 
and more prolonged and lower magnitude for those maturing later (70). Recent work 
has also shown this in girls: those maturing earlier (as defined by age at menarche) 
had greater PHV and gained more height relative to later-maturing girls, although at 
the end of growth they were shorter and had greater adiposity (71). Measuring height 
over several visits to calculate PHV allows longitudinal trends to be observed and is 
less invasive than other measures of pubertal development. Recent work by Cole 
demonstrated that annual measurement of height generates a sufficiently accurate 
PHV as measuring more frequently (72). However, height and PHV are too indirect 
to use as standalone pubertal assessments. While sex steroids exert an effect on the 
GH-IGF-1 axis, growth is dependent on many factors, including genetics, nutrition 
and general health.  
Foot length also increases during the pubertal growth phase. The change in foot 
length is held to be among the first anthropometric changes to occur, and conclude, 
during the adolescent growth phase (73-76). Foot length is a marker of interest in 
puberty as it may offer a non-invasive and cost-effective means to assess pubertal 
development (77, 78). Indeed, measuring feet may not even be necessary as shoe 
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sizes are directly proportionate to foot length. Foot length is convenient as parents 
may recall changes in foot length (as measured by shoe size changes) more easily 
than recalling the beginnings of breast changes or body hair development. The latter 
two may be difficult to recall due to subtlety of change and to adolescent privacy 
around their body image, whereas foot length changes are memorable (74), possibly 
because these necessitate the purchase of larger shoes.  
In a large Indian cross-sectional study (973 participants, 489 male), Mitra (78) 
observed feet reached adult length at onset of puberty – that is, there was a 
significant increase in foot length between clinician-rated Tanner stage 1 and Tanner 
stage 2, but thereafter no differences were observed. Ford (77) followed 86 girls from 
six years of age with biannual follow-up (of unknown duration), comparing the age 
of foot size increase (maximum foot velocity) with the age of development of 
secondary sex characteristics (clinician assessed Tanner staging). This work found 
that foot growth peaked at a mean of 8.40 years, which was before the age of 
occurrence of secondary sex characteristics (8.79 years). Additionally, Knudtzon 
(79) retrospectively surveyed 106 female members of a Norwegian association for 
people with large feet and found that an earlier menarche was associated with larger 
adult foot size, although there is likely significant selection bias. At present, there is 
no evidence linking changes in foot length with changes in sex hormones, the direct 
measure of pubertal progress. Similarly, there are no longitudinal data in males, nor 
any large-scale longitudinal data. While there are ostensible temporal associations 
with indirect markers of puberty, one would need to demonstrate a relationship with 
longitudinal hormone changes to properly conclude this.  
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Weight gain also occurs during puberty, with the average increase for females 17.5 
kg and for males 23.7 kg. (63), with peak velocities of 9.1 kg/year in males and 8.3 
kg/year in females. The peak weight velocity for females occurs at 12.9 years, and 
14.3 years for males (80). These occur slightly after peak height gain, so some 
weight increase can be attributed to increased bone mass. Two other factors add to 
weight gain during this time: increased musculature and increased adipose tissue. 
Increased skeletal muscle is common to both sexes, though the velocity of muscle 
growth is much greater in males (61). Acquisition of skeletal muscle mass peaks at 
the time of PHV and is associated with increased physical strength, though muscle 
bulk and strength may continue to change long after PHV is reached (61). As 
children, boys have greater muscle mass than girls, though this sex difference lessens 
when girls commence puberty (generally earlier). Once male puberty commences 
however, the difference is re-established, with male musculature increasing faster 
and with greater magnitude than in females, and males having greater muscle mass 
than females (61). Growth hormone stimulates muscle mass and strength (64), as 
well as regulating fat mass (81). The androgens (especially testosterone), GH and 
IGF-1 are anabolic for protein (60). Peak GH-IGF-1 levels occur in females around 
Tanner stages 3 and 4, and in males around Tanner stage 4, with acquisition in both 
sexes declining in Tanner stage 5 (60). The peak in IGF-1 is thus, as expected, 
around the time of PHV and then it decreases (82). 
Similarly, body adiposity changes with puberty. Android fat deposition is 
predominately abdominal, and gynoid deposition is gluteo-femoral. Females have 
almost double the adipose tissue than males after puberty (60) as oestrogens enhance 
fat deposition, whereas androgens are lipolytic (60). GH is also lipolytic (83). Boys 
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also lose more limb fat than girls at puberty, though truncal fat loss is less in both 
sexes (63). Pubertal girls’ fat mass increases at a rate of 1.14 kg/year, whereas 
pubertal boys decrease by 1.15 kg/year (8).  
It must be recognised that much of the data regarding growth changes do not take 
into account recent trends of increasing overweight and obesity (84) and earlier onset 
of puberty (7, 55, 85); however, the trend of increased linear growth, musculature 
and weight changes remain. A fifty-year longitudinal study suggested that secular 
changes in body mass index (weight divided by height squared; kg/m2) may be 
independent of any trend towards earlier menarche (86). More contemporaneous 
growth velocity data are needed to accurately account for secular increases in 
overweight and obesity prevalence, especially in adolescent populations. While these 
changes have been described with respect to the timing and the tempo of the pubertal 
transition (measured through Tanner staging), the relationship between hormonal 
changes and the physical manifestations is less clear. 
1.3. Currently Used Methods of Assessment of Puberty in Research Studies 
The assessment of puberty in research studies tends to consist of clinical assessment 
or hormonal assessment (57, 87, 88). Clinical assessment may be in the form of 
pubertal staging, or measurement of anthropometry such as PHV, foot length (both 
discussed in Section 1.2.4) or voice maturation. Sampling the hormonal milieu is 
another method and assessing reproductive milestones such as menarche or 
spermarche offer alternative measures. Below, the most widely used methods of 
pubertal assessment are considered.  
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1.3.1. Clinical Assessment 
Two methods are regularly used to clinically assess pubertal development: the 
staging system developed by Tanner and Marshall (68, 69, 89) and the Pubertal 
Development Scale (PDS) (90). Tanner staging (see Figures 1.2, 1.3, 1.4, 1.5, 1.6 and 
Tables 1.1 and 1.2) is generally seen as the standard measure of pubertal status (57), 
and divides progress through puberty into five stages, with Stage 1 being pre-
pubertal and Stage 5 full adult development. These changes occur in a continuum, 
though discrete stages are used to indicate progression (91). Pubic hair development 
is categorised for both genders, while females have their breast development 
assessed and males their genitalia (68, 69). As oestradiol will stimulate breast 
development and testosterone the development of axillary and pubic hair as well as 
the male genitalia (4, 92), it is assumed that there is a direct and causative 
relationship between increase in sex hormones during puberty and changes in these 
characteristics.   
Dorn’s review of measures of pubertal status (57) notes that the original research 
used to create Marshall and Tanner’s stages was limited by a relatively small number 
of subjects (228 males and 192 females (68, 69)), all of whom were Caucasian. This 
may hinder its application in ethnically diverse settings and with increasing 
prevalence of obesity since the original stages were devised. However, it remains the 
most widely used system for assessment of pubertal status, in which the subject’s 
development is compared (ideally by a trained clinician) with standard photographs 
(such as Figures 1.2, 1.3 and 1.4) or line drawings (Figures 1.5 and 1.6) reflecting the 
development at each stage. Many studies continue to use Tanner’s black-and-white 
photographs, which may be less acceptable to adolescents than standardised line 
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drawings (87), and indeed colour drawings have shown to have higher accuracy 
when compared with self-rating (93). Figure 1.7 shows the temporal relationships 
between Tanner stages and other maturational milestones during this period.  
In research studies, there are possible ethical issues in clinician assessment of Tanner 
staging, particularly where such clinician assessment would not have been performed 
were the adolescent not enrolled in the study. Principal concerns include privacy and 
modesty for adolescents and parents regarding examination, for whom such 
assessment may be intrusive and limit involvement in the study. Whereas one can 
justify a trained examiner assessing a child’s Tanner stage in a clinical context, for 
example to assess early or delayed puberty, it may be less justifiable or indeed 
unacceptable to the adolescent enrolled in a community-based research study, who 
may not have concerns about their development, and for whom it could constitute an 
assault. Therefore, clinician examination can pose challenges for the researcher, in 
terms of ethics review board approval and gaining parental and adolescent consent. 
Additionally, the logistics of having trained examiners assess large cohorts provides 
further challenges. These mean that alternative pubertal assessment tools may be 
required. Self-rating by the adolescent therefore offers a less intrusive and safer 
means by which Tanner staging can be provided.  
Self-report of Tanner stage has been shown to be adequate when compared to 
clinician assessment (94-96), though some studies disagree (97, 98). A systematic 
review by Walker found that agreement between self- and clinician-assessed Tanner 
stage ranged from 43% to 81%, though one issue in accuracy is that some studies use 
the photographs used in Tanner’s original staging (Figures 1.2, 1.3, and 1.4) and 
others use line drawings based upon these photographs (such as the drawings in 
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Figures 1.5 and 1.6) (87). Duke’s study in 66 adolescents (43 girls) showed excellent 
agreement between self-rated and clinician-rated Tanner stage (female breast 
development 81% agreement (κ=0.81), female pubic hair 93% agreement (κ=0.91) 
and male genital stage 91% agreement (κ=0.88)) (94). Similar results in the 1980s 
and 1990s showed good correlation or agreement (κ coefficient range 0.59-0.91) 
between self-reported Tanner stage and clinician assessment in American boys and 
girls (95, 99). However, these findings have been challenged in more recent studies 
in larger and more diverse cohorts (96, 98, 100). A reason for declining accuracy in 
more contemporary studies may reflect secular trends in increasing obesity 
prevalence, with poor agreement particularly shown in studies of overweight or 
obese adolescents (93, 97, 101). Recent work by Rasmussen provides the largest 
sample size to date (n=898) to answer this question, and found that self-rated Tanner 
staging was not sufficiently accurate (κ=0.28-0.55) to be used in clinical practice, 
where accurate staging is important, for example to diagnose disorders of pubertal 
onset (102). However, despite this lack of accuracy, results are concordant enough to 
continue the use of self-rating in research studies where the emphasis on precise 
Tanner staging may not be as high, or not possible due to the reasons described. 
Recent work has shown self-rating is useful in research settings to differentiate pre-
pubertal and pubertal development as assessed by adolescents or their parents (102-
105). In Terry’s longitudinal study (104), maternal and adolescent rating of 
development was relatively sensitive and specific compared to clinician rating. 
Chavarro’s cross-sectional cohort showed that self-assessment, while inferior to 
clinician assessment, correlated to a composite index ranking of adolescent hormonal 
development derived from hormone levels measured with radioimmunoassay (105). 
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This form of hormonal assessment is not routinely used and does not have a clear 
physiological correlate.   
The PDS was developed in the 1980s and involves self- or parental report in several 
domains: body hair, growth spurt and skin changes (both genders); voice changes 
and facial hair (males only); and breast change and menarche (females only) (90). 
These all reflect the effects of hormonal changes on the body and reduce the need for 
direct visualisation. These domains are scored from one to four, with increasing 
scores reflecting more development (90). The PDS is used less commonly than 
Tanner staging in adolescent research (88). The greatest contrast between the Tanner 
scales and the PDS is that the PDS lacks pictorial standards of sexual development 
(90). While this makes it more appropriate in sensitive settings, it also may enhance 
subjectivity biases, as subjects using the PDS must perceive and rate their 
development in comparison to their peers.  
Another method of non-invasive clinical assessment of puberty is voice maturation 
assessment, characterised by changing pitch, loudness and tone due to laryngeal 
growth (87, 106, 107). This is often a late pubertal event in males (107, 108). Ong’s 
study of voice changes in a birth cohort of 2008 males found that more advanced 
voice-breaking at age 14 years was associated with higher adult body mass index and 
fat mass at 60-64 years (107). Harries’ study of 26 teenage boys (aged 13-14 years at 
recruitment) showed Cooksey stages of voice development correlated with Tanner 
stage and testis volume, though not salivary testosterone over a one-year follow up 
(106). Expert opinion in Walker’s review was that this method has promise but 
requires further research and adolescent opinion was that this non-invasive method 
would be an acceptable method of pubertal assessment (87).  
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An interesting concept is that, despite a lack of accuracy when compared to clinician 
assessment, self-rating of puberty is actually more important for adolescent 
researchers because it reflects the individual’s self-perception (109). While neuro-
endocrine changes are probably better associated with the clinician’s rating (as the 
gold standard), the adolescent’s perceived maturity is critical to understand as they 
may behave differently, seeking experiences or environments more consistent with 
their presumed development (109), which may naturally have more public health 
importance as these behavioural changes most often lead to adverse health outcomes 
in adolescence (see Sections 1.4 and 1.5). Moore and colleagues found that perceived 
pubertal timing was important in predicting engagement in sexual and romantic 
behaviour (dating, romantic sex and non-romantic sex) whereas objective pubertal 
timing (age at menarche) only predicted the onset of sexual behaviour. The 
perception of pubertal timing is therefore thought to alter the adolescent’s 
interpretations and subsequently the emotional and cognitive processing of puberty-
related cues (110). So, despite a perceived lack of accuracy with clinician-rating, 
self-rating of puberty may actually be the more important research outcome in some 
circumstances.  
1.3.2. Reproductive Milestones for Assessing Pubertal Development 
As one of puberty’s core biological functions is to mature an individual’s 
reproductive system, the use of reproductive milestones may be of use in assessing 
progress through puberty. For females, this is primarily the assessment of menarche, 
and for males the assessment of testicular volume or determination of the onset 
spermatozoa production (spermarche) or as is generally reported, semenarche (first 
ejaculation). Self-report of menarche has been shown to be relatively reliable, even 
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into later life and when reported by mothers for their daughters (111-113). It occurs 
later in puberty, at approximately Tanner breast Stage 4 (69) and is thought to be 
memorable because of its salience. Menarche itself, however, does not strictly infer 
reproductive capacity, as cycles may remain anovulatory for some time after the 
onset of menstruation (114, 115). Regardless, menarche is consistently seen as the 
best marker of female sexual development. Regarding ovulatory cycles, a rise in 
plasma progesterone in the luteal phase is the clearest indicator of ovulation, while 
changes in cervical mucus and cyclical temperature changes have been used 
clinically. Similarly, the report of dysmenorrhoea as an indication of post-ovulatory 
prostaglandin activation (116) is another means of assessing ovulation.  
For males, there is less consistency in the literature with regards to markers for the 
attainment of reproductive capacity such as spermarche, as male development does 
not have such a clearly defined event as menarche (117, 118). The transition of 
testicular volume from 3 mL to 4mL correlates to pubertal onset (119). Marshall and 
Tanner used the development of the testes, scrotum and penis to indicate androgen 
action and infer reproductive capacity (68, 89). The use of a Prader orchidometer to 
measure testicular volume has shown that the visible physical effects of testosterone 
occur around 7 mL volume and ejaculatory capacity correlates with a volume of 
approximately 10 mL (120). (119). Ultrasound measurement of testicular volume 
shows it is accurate when compared with orchidometer assessment (121-123), though 
both methods are operator-dependent, and invasive (122), with associated costs of 
ultrasound limiting widespread use in research (57). Measurement of testicular size is 
less likely to be acceptable to young people in a recent consultation paper, with 
males feeling they would prefer to self-examine to determine testicular size (87). The 
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average age of spermarche is approximately 13 years 5 months (124-126), which 
relates to Tanner pubic hair stages 2 and 3 (127, 128). Direct assessment of 
semenarche may be done through ascertaining ejaculatory capacity, whether by 
obtaining sperm samples or self-report of behaviours such as nocturnal emission, 
sexual debut or masturbation. Spermarche may be established through examining 
urine samples for retrograde ejaculation.  (118, 125). However, there have not been 
studies comparing laboratory findings of spermarche with parental or self-report (57) 
and few studies have used this as a pubertal assessment method. In fact, males are 
more willing to report non-sexual problem behaviour than they are to report 
masturbation (129), which means these measures are probably unsuitable for 
epidemiological studies, In Walker’s systematic review and consultation with young 
people on methods of assessing puberty, there was consensus among the consulted 
boys that discussion of nocturnal emissions was both embarrassing and may be 
incorrectly recalled (87).  
1.3.3. Hormonal Assessment 
The concentrations of sex steroid hormones, particularly testosterone for males and 
oestradiol for females, provides information as to the individual’s reproductive 
maturity. Accordingly, these are the most direct measure of pubertal progress, as 
these are the primary drivers of the development of secondary sexual characteristics 
measured in Tanner staging (along with adrenal androgens for hair development). 
The longitudinal changes in gonadal steroids, while rarely undertaken, would be the 
most accurate study of an individual’s puberty.  
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Other hormones commonly assayed to assess pubertal development are adrenal 
androgen hormones, gonadotropins and IGF-1, which reflect different aspects of 
development and growth. Heightened activity of the HPG axis, reactivated at the 
very start of puberty, increases levels of gonadotrophins (130). Hormone levels do 
not exactly correlate with a specific pubertal ‘stage’ (as defined by clinical staging), 
as there are overlaps between hormone levels at different stages (57, 131-133). Dorn 
outlines a variety of considerations which must be factored in to studies involving 
hormonal assays, the most important being that studies control for the diurnal 
variations in hormones by ensuring collections occur at approximately the same time 
of day, and for post-menarcheal females, the same time in their menstrual cycle (57).  
(134-136). Immunoassays were the first convenient method for measuring circulating 
hormone levels, though with commercial assay development, accuracy was traded 
for affordability and throughput efficiency (134). The poor analytic specificity of 
immunoassays for steroid hormones at low circulating levels, such as in childhood 
and early puberty, as well as significant cross-reactivity between antibody and 
epitopes from the hormone, its precursor, metabolite or conjugate, limits their 
accuracy and therefore utility for high quality research (134). Several studies have 
demonstrated such limitations. For example, Sikaris analysed testosterone levels in 
124 healthy men (21-35 years) and found that immunoassays diverged from gold-
standard mass spectrometry techniques such that diagnostic utility was impaired 
(137). Similarly, oestradiol assays with radioimmunoassay and fluoroimmunoassay 
in pre- and pubertal children by Ankarberg-Lindgren’s group demonstrated 
insufficient sensitivity for clinically useful results, unless further labour-intensive 
purification steps were undertaken (138), with attendant cost and time limitations. 
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Taieb also compared analytic methods using enzyme immunoassays and 
radioimmunoassays with gas-chromatography mass spectrometry and showed that 
none of the immunoassay techniques were sufficiently reliable for detecting 
testosterone levels in women and children compared with mass spectrometry (139). 
In response to Taieb’s paper, Herold used a random number generator and compared 
his data to Taieb’s and found that in some instances the random number generator 
produced comparable data (compared to mass spectrometry) as did Taieb’s 
immunoassay data (140), again casting doubt on the utility of immunoassays for 
high-quality analytic research, particularly at the low levels of circulating sex 
steroids seen in early puberty. With the recent development of lower cost, highly 
sensitive and specific liquid chromatography-tandem mass spectrometry (LC-
MS/MS) assays, the very low levels of sex hormones present in pre- and early 
puberty can be accurately measured. This was a limitation of previous 
radioimmunoassay and immunoassay techniques that lacked sufficient accuracy at 
such low circulating levels and thus affected estimates in hormone research at this 
life stage (134-136). 
The first step in LC-MS/MS is liquid chromatography, which separates compounds 
of interest from other analytes in the specimen (141). Following this, the eluate is 
nebulised and ionised, and specimen analysis is achieved using triple quadrupole 
mass spectrometry (142). Atmospheric pressure photo-ionisation is used to generate 
ions of steroid hormones in the ARCHER study (136), though other methods can 
also do this, such as electrospray ionisation or atmospheric pressure chemical 
ionisation (142). LC-MS/MS is able to provide the following data: retention time, 
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mass: charge ratio (m/z) of both the precursor and product ions, and these data give 
this technique its high degree of analytical specificity (142). 
A study of twenty adolescents followed every six months for five years found LC-
MS/MS could detect serum testosterone concentrations approximately 1.5 years 
earlier than detectable by immunoassay (143). This study was limited by its small 
sample size and only measuring testosterone but is promising in showing the 
analytical strength of LC-MS/MS in early puberty. Another possible improvement to 
these methodologies is to use urine samples. These are advantages in that 
venepuncture is avoided and that urine provides a more integrated measurement of 
sex steroids and LH, which are secreted diurnally and in a pulsatile fashion 
respectively and which can be collected more frequently than the 6-12 monthly 
serum samples usually used. A major drawback is that it is more time- and resource-
intensive, requiring extra steps in specimen processing that lengthen assay time by a 
day more than for serum samples (136). LC-MS/MS can also be applied to saliva 
samples but contamination by blood limits the accuracy (144). 
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Figure 1.2. Tanner staging for the development of male genitalia. 
Reproduced from Marshall WA, Tanner JM. Variations in the pattern of pubertal 
changes in boys. Arch Dis Child. 1970 Feb;45(239):13-23.  
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Figure 1.3. Tanner staging for breast development in females. 
Reproduced from Marshall WA, Tanner JM. Variations in pattern of pubertal 
changes in girls. Arch Dis Child. 1969 Jun;44(235):291-303. 
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Figure 1.4. Tanner staging for pubic hair distributions in males (top, A) and females 
(bottom, B).  
Note: Tanner stage 1 (no pubic hair) is not shown in either image. 
Reproduced from Marshall WA, Tanner JM. Variations in the pattern of pubertal 
changes in boys. Arch Dis Child. 1970 Feb;45(239):13-23 (A) and Marshall WA, 
Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child. 1969 
Jun;44(235):291-303 (B) 
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Figure 1.5. Tanner staging line drawings for female breast and pubic hair 
development. Note: Tanner stage 1 pubic hair development is not shown.  
Reproduced from Australian Paediatric Endocrine Group Growth Chart for Girls 
2-18 years: https://apeg.org.au/clinical-resources-links/growth-growth-charts/ 
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Figure 1.6. Tanner stage line drawings for male pubic hair and genitalia for (from 
left): stage 2, 3, 4 and 5. Stage 1 for pubic hair (no pubic hair) and genitalia (same 
size as in childhood) are not shown. 
Reproduced from Australian Paediatric Endocrine Group Growth Chart for Boys 
2-18 years: https://apeg.org.au/clinical-resources-links/growth-growth-charts/ 
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Figure 1.7. Sequence of events at puberty for females (top) and males (bottom). 
Reproduced from Marshall WA, Tanner JM. Variations in the pattern of pubertal 
changes in boys. Arch Dis Child. 1970 Feb;45(239):13-23. 
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Table 1.1. Descriptions of male Tanner staging (as shown in Figures 1.2 and 1.6). 
Tanner 
Stage Genitalia Pubic Hair 
1 
Pre-adolescent. Testes, scrotum, and 
penis are of about the same size and 
proportion as in early childhood. 
Pre-adolescent. The vellus over the 
pubes is no further developed than that 
over the abdominal wall, i.e. no pubic 
hair. 
2 
The scrotum and testes have enlarged 
and there is a change in the texture of 
the scrotal skin. There is also some 
reddening of the scrotal skin. 
Sparse growth of long, slightly 
pigmented, downy hair, straight or only 
slightly curled, appearing chiefly at the 
base of the penis. 
3 
Growth of the penis has occurred, at 
first mainly in length but with some 
increase in breadth. There has been 
further growth of testes and scrotum. 
Considerably darker, coarser, and more 
curled. The hair spreads sparsely over 
the junction of the pubes. 
4 
Penis further enlarged in length and 
breadth with development of glans. 
Testes and scrotum further enlarged. 
There is also further darkening of the 
scrotal skin. 
Hair is now adult in type, but the area 
covered by it is still considerably 
smaller than in most adults. There is no 
spread to the medial surface of the 
thighs. 
5 
Genitalia adult in size and shape. No 
further enlargement takes place after 
stage 5 is reached. 
Adult in quantity and type, distributed 
as an inverse triangle of the classically 
feminine pattern. Spread to the medial 
surface of the thighs, but not up the 
linea alba or elsewhere above the base 
of the inverse triangle* 
*80% of males progress to “Stage 6” with spread of pubic hair beyond this triangle 
Taken from Marshall WA, Tanner JM. Variations in the pattern of pubertal changes 
in boys. Arch Dis Child. 1970 Feb;45(239):13-23 
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Table 1.2. Descriptions of female Tanner staging (as shown in Figures 1.3, 1.4 and 
1.5). 
Tanner 
Stage Breast Pubic Hair 
1 Pre-adolescent; elevation of papilla only. 
Pre-adolescent; the vellus over the 
pubes is not further developed than that 
over the anterior abdominal wall, i.e. 
no pubic hair. 
2 
Breast bud stage; elevation of breast 
and papilla as small mound, 
enlargement of areola diameter. 
Sparse growth of long, slightly 
pigmented, downy hair, straight or only 
slightly curled, appearing chiefly along 
the labia. 
3 
Further enlargement of breast and 
areola, with no separation of their 
contours. 
Considerably darker, coarser, and more 
curled. The hair spreads sparsely over 
the junction of the pubes. 
4 
Projection of areola and papilla to form 
a secondary mound above the level of 
the breast. 
Hair is now adult in type, but the area 
covered by it is still considerably 
smaller than in most adults. There is no 
spread to the medial surface of the 
thighs. 
5 
Mature stage; projection of papilla 
only, due to recession of the areola to 
the general contour of the breast. 
Adult in quantity and type, distributed 
as an inverse triangle of the classically 
feminine pattern. Spread to the medial 
surface of the thighs, but not up the 
linea alba or elsewhere above the base 
of the inverse triangle. 
 
Taken from Marshall WA, Tanner JM. Variations in pattern of pubertal changes in 
girls. Arch Dis Child. 1969 Jun;44(235):291-30 
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1.4. Adolescence 
Adolescence is the life phase occurring in the second decade of life (10-19 years) (2). 
There are over 1.8 billion adolescents and youth (12-24 years) globally (the largest 
age demographic in the world) (2), the majority of whom live in low- and middle-
income countries (145). Adolescence has long been recognised as a defining life 
stage, with rites and rituals, both formal and informal, indicating the passage from 
childhood to adulthood. Adolescence also involves profound changes in the 
individual’s life (146), such as increasing legal and political rights and the transitions 
from schooling to higher education and employment. Other cardinal events include 
sexual debut, first consumption of alcohol and beginning to drive, each of which are 
important social steps in the adolescent’s life and identity and are associated with a 
variety of risk factors. In 1904, G. Stanley Hall described adolescence as a time of 
‘storm and stress’ for the individual (147), a perception that still persists within the 
community, though this is not necessarily true for all (49, 148). 
Several theories were posited during the 20th Century with regards to the 
development of the adolescent. Three will be considered here: Havighurst’s 
developmental task theory (an ‘educational’ theory) (149), Piaget’s ‘cognitive 
development’ theory (150, 151) and Erikson’s Stages of Psychosocial Development 
(a ‘psychoanalytic’ theory) (152). Though these theories differ in the nature of their 
focus, a common theme is the development of independence and transition to a more 
mature form.  
Havighurst’s task theory outlines a series of ‘tasks’ or ‘challenges’ that the individual 
faces during their development. Tasks specific for adolescence include developing 
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relationships with peers; accepting of sexuality and gender identities; becoming 
independent of parents and other adults; acquiring a value set and ideological and 
ethical systems; developing socially responsible behaviour and accepting the 
physique and effective use of the body (149).  
From a cognitive viewpoint, Piaget theorised the adolescent moves into the “formal 
operational” stage, in which there is a development of abstract thought, creativity and 
hypothesis formation (150). As such, “reality becomes secondary to possibility” 
(151), with the individual thinking beyond their world and belief system through the 
use of propositions (153). This reflects the final stage of cognitive development 
(153).  
Erikson’s theory reflects Hall’s postulation of adolescence being a time of crisis for 
the individual (147, 152). Through questioning themselves in a range of domains, 
Erikson argues that the adolescent develops their sense of identity (153). 
Additionally, the peer group becomes more important for the adolescent’s 
relationships than the family, including the formation of their own ideological 
perspectives independent of the family group (152).  
1.4.1. Adolescent Brain Development 
During adolescence, the brain continues to develop and mature, allowing a greater 
range of cognitive, perceptive and executive functions (154-159). This allows the 
individual to better master their behaviours and motivations (160). Neurological 
changes include neurogenesis, dendritic growth, increased myelination, synaptic 
formation and elimination, neuronal apoptosis and changes in receptor sensitivity, 
and are in regions associated with behaviour and emotional regulation (5, 161-163). 
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Rapid cognitive changes and increased abstract reasoning (163) reflect these neural 
architectural changes. Following this, different connective changes in the brain may 
potentiate the onset of such behavioural or affective alterations as depression, eating 
disorders and anxiety, all of which become more prevalent during adolescence. 
Evidence from animal studies suggests at least some of these changes are influenced 
by sex hormone changes during puberty (164). The true effect of pubertal hormones 
on human brain development is yet to be fully determined. There are, however, well 
recognised structural differences between male and female brains (165).  
1.4.1.1. Theoretical Effects of Oestradiol and Testosterone on the Brain 
Pubertal increases in testosterone and oestradiol occur over a time of important 
psychosocial change. As such, it is difficult to discern the exact contribution of each 
factor to the onset of changes in mood, behavioural and other psychological or 
psychiatric conditions.  
It is postulated that neural changes in girls commence 1-2 years before boys, 
suggesting that sex hormones influence brain structure in a way that relies upon sex 
and the predominant sex hormone for the sex of the individual (163). An analysis of 
brain imaging studies on pubertal subjects found that the sex steroids as well as LH 
are all associated with dynamic brain changes (though oestradiol and testosterone’s 
effects were specific to girls and boys, respectively). White matter increases correlate 
with LH in both sexes and testosterone in males. Grey matter changes were observed 
such that increased levels of sex-specific sex hormones were associated with 
decreases in grey matter in the pre-frontal, parietal and temporal cortices in both 
sexes (163). Issues with this review included the cross-sectional nature of the data, 
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limiting the ability to draw conclusions with regards to causality and directionality of 
the effects. Additionally, not all studies reviewed found a relationship between sex 
steroid levels and neural changes (163).  
Oestradiol and testosterone appear to induce synaptogenesis (166, 167). These are 
associated with the organisational and activational effects hypothesis, wherein 
steroids act during foetal brain development to alter neuroarchitecture (organisation), 
limiting the repertoire of the brain’s responses when acted upon by that same 
hormone later in life (activation) (162, 168). An example of such activation is the 
commencement of reproductive behaviour in adulthood, which is thought to be 
programmed earlier during the organisation phase of neural development (162).  
Various neuronal and glial populations express aromatase (169), therefore evidence 
of associations between oestradiol concentrations and behaviour or affective changes 
may be confounded by variable enzyme activity and substrate availability. A review 
of aromatase activity in human brains suggested it plays an important in role in 
modulating neural plasticity and behaviour (170). It appears that aromatisation to 
oestradiol is the predominant mechanism by which testosterone exerts its effects on 
the brain, and thus aromatisation is suggested to be important in such events as 
prenatal masculinisation of the brain (171-174).  
Oestradiol has been shown to modulate genetic expression in neural monoamine 
systems (such as the dopaminergic, serotonergic and noradrenergic systems) that are 
commonly implicated in psychiatric conditions, including depression, anxiety and 
psychoses, such as schizophrenia (175-178). The presence of the oestrogen receptor-
beta (ER-β) in areas that regulate mood (179) may also indicate an influential role of 
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oestradiol on behaviour and affect modulation. For example, a post-mortem study 
observed decreased ER-β expression in the locus coeruleus (a noradrenergic region 
of the brain) of suicide victims (176), which may indicate a role of oestradiol (and its 
receptor activity) in depression and suicidality.  
1.4.2. The Emergence of Risk Factors for Future Health and Well-Being during 
Adolescence 
Though childhood mortality has drastically decreased in the past century, adolescent 
health has not improved at rates commensurate with progress in general child health 
and mortality rates in this population have only marginally decreased (180, 181). 
Ascertaining the health risk behaviours that emerge during adolescence and the 
mechanisms which drive this increase, as well as how these behaviours can be 
mitigated, are a public health imperative.  
A large number of health risk behaviours and their associated health issues emerge 
during adolescence. Many of these have the potential to have an impact on future as 
well as current health and wellbeing. It is estimated that 70% of adult premature 
deaths are due to risk factors that emerge during adolescence (182), such as smoking, 
alcohol consumption and unsafe sexual practices, together with decreasing physical 
activity (183, 184) and increasing adiposity for many populations. One cannot 
assume pubertal changes, either in body size or hormone elevation, are the sole 
contributor to the emergence of these problems. Other factors like individual 
susceptibility, family or peer relations and environment will also contribute (49). 
However, unlike puberty, these are potentially modifiable. It would also be 
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unfortunate if puberty received excessive attribution and modifiable factors were 
ignored. 
Social, biological and emotional changes during adolescence play a major role in the 
increased burden of health risk behaviours during adolescence and into adulthood 
(185). These behaviours include increased rates of unintentional injury, suicides and 
homicides, depression, anxiety, eating disorders, and substance and alcohol abuse, as 
well as sexually transmitted infections and unwanted pregnancies. Many of these can 
be viewed, in part, as the result of the adolescent’s difficulty in controlling emotions 
and behaviour (179, 185-189). General trends show that females are more 
predisposed to problems such as depression and eating disorders than males, and 
these differences first emerge during the adolescent life phase (187). For males, 
conduct disorders increase during puberty in a similar fashion, with a lesser 
preponderance in females (190). However, emotional and behavioural lability is 
sometimes considered typical of the life phase and as such may not be recognised as 
a clinical disorder (191). These changes may be due to reorganisation of the 
adolescent brain, which could alter judgement and behavioural patterns, as discussed 
previously (185, 192, 193).  
Despite these observations, the cross-sectional nature of many studies in puberty and 
adolescence means that the aetiology and duration of these mood and behavioural 
changes are unclear (194). It has also been asserted that while affective expression 
does change during adolescence, extremes of moodiness and emotionality are 
relatively uncommon (195). Though the adolescent is faced with a variety of 
potential health risks and challenges, each of which may contribute to future health 
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and wellbeing, the contribution of puberty’s biological changes in this regard 
remains contentious.  
1.5. The Effects of Pubertal Changes on Adolescent Well-Being 
1.5.1. Pubertal Timing 
There are numerous endogenous and exogenous influences on the timing of the onset 
of puberty. There are also known associations between the timing of puberty and 
adolescent psychosocial factors, including emotional and behavioural problems (166, 
196). Pubertal timing generally refers to the time of onset (such as reaching Tanner 
stage 2), but it can also be used in to indicate the congruency of an individual’s 
pubertal stage relative to their age-matched peers (91).  
For both sexes, it has been observed that off-timed, especially early, puberty may 
potentiate depression (197). Other potential associations between early but normal 
puberty and adolescent health and wellbeing have been observed. For girls, there 
exists well-documented evidence of a link between timing of puberty and problem 
behaviours, including earlier sexual debut, although a variety of cofactors are 
implicit (198). Pubertal timing also has implications for future health, with early-
maturing girls at higher risk of obesity, cardiovascular disease and breast cancer in 
later life (199-202). Early puberty for girls is associated with greater popularity, 
though it also increases their risk of emotional problems, impairs self-image and 
increases susceptibility to depression, anxiety, delinquency (disorders of conduct), 
substance use and eating disorders (49, 188, 197, 198, 203-205). Recent work in a 
large Hong Kong Chinese cohort (n=5795) found that earlier breast development (as 
assessed by a trained clinician) was associated with a higher risk of the presence of 
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depression in girls, though no associations were identified for boys (11). While this 
risk is highest for early maturing girls, on-time puberty is also associated with 
increasing rates of delinquency (206). 
There is evidence for earlier puberty being both beneficial (associated with greater 
career success and marital satisfaction (205, 207) and detrimental (associated with 
substance misuse and aggressive or anti-social conduct (49, 205)) in boys (49, 205). 
Conversely, late maturation has also been shown to predispose males to anxiety and 
higher rates of excess alcohol consumption, with one investigator proposing these 
behaviours as a coping strategy for diminished social dominance due to later 
maturation and achievement of adult stature (208). The lack of consistency indicates 
a need for further research to better clarify any associations or causative factors.  
Early maturing adolescents are often more popular, possibly due to achieving adult 
bodies (and the effect of popular media on perceptions of this as being superior). 
However, females face challenges to their wellbeing and health from early puberty. 
These may result from associating with chronologically older peers of similar 
physical development, or personal dissatisfaction with the rate of changes to their 
body, in particular changes in adiposity. For males, the earlier achievement of adult 
stature and enhanced musculature may promote physical prowess, with attendant 
benefits to self-esteem. However in one North American study, it was found that 
regardless of early or late timing (as measured by two standard deviations from the 
mean) of peak height velocity, adolescent males and females both reached similar 
final heights – the main difference between the groups was the pace and timing at 
which they achieved these heights, indicating physical status is not necessarily  
determined solely by timing of pubertal onset (70).  
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1.5.2. Pubertal Tempo 
While the degree of hormonal change during the course of puberty is well 
documented, the effects of pubertal tempo (time from onset to completion of puberty 
(91)) have been less well studied. Further, the effects of different pubertal tempos on 
adolescent health and wellbeing outcomes have not been studied in as much detail as 
have the effects of variations in timing of pubertal onset. The duration of puberty is 
thought to be typically four years (range one to seven years) (55, 109).  
Longitudinal studies in healthy female European adolescents have shown that the 
tempo of pubertal change (time from Tanner breast stage 2 to menarche) was 
inversely related to age at Tanner breast stage 2, with longer duration of puberty (and 
thus slower maturational tempo of change) in girls who entered Tanner breast stage 2 
at an earlier age (12, 209, 210). In contrast, girls entering Tanner stage 2 at a later 
age underwent menarche at a similar age to their counterparts, therefore having a 
greater tempo of change. The girls with earlier onset (Tanner stage 2 at 10 years) 
were initially shorter than the later maturing girls (Tanner stage 2 at 13 years), 
though their final heights were not significantly different, indicating different growth 
patterns (210). In an American study of white and African-American females, 
earlier-maturing girls had greater height velocity and absolute height increase than 
those who matured later, and early-maturing girls were more likely to be shorter at 
the conclusion of their pubertal growth spurt (71). One study that looked at boys 
showed that the age of puberty commencement does not significantly affect the final 
height; rather the period of growth changes to compensate, meaning that height 
growth tempo increases with later onset to reach an adult height similar to early-
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maturing boys (211), even though early-maturing adolescents started growth from a 
shorter height, meaning their absolute height gain was greater.  
There is no universally accepted definition of puberty, or for its measurement, which 
may account for some of the differences in findings. Further, none of the above 
studies performed any direct assessment of hormonal levels, or their change over the 
course of maturation. Hormonal assessment may offer a better explanation to these 
observed phenomena and provide a concrete biological explanation as to why growth 
rates change. Work by Marceau showed that males with increasing levels of 
testosterone and dihydrotestosterone at a younger age had a slower pubertal tempo 
(212).  
The relationship between pubertal tempo and psychological outcomes has been 
described in terms of a “maturational compression” hypothesis (109, 213), in which a 
faster development is thought to exacerbate the challenges that accompany puberty 
as the adolescent must adapt more rapidly to changes. However, Beltz found that 
tempo was not clearly correlated with psychological outcomes, whereas timing was 
(213). Marceau notes that there is a dearth of evidence regarding the effects of 
pubertal tempo (using Tanner staging, not hormone levels) on adolescents’ 
psychological wellbeing (91). For those undergoing a rapid pubertal transition, 
arising psychological issues may be due to the inability to meet the new challenges 
arising from faster biological and social changes than their peers, whereas a normal 
maturational tempo may allow one to accustom themselves with such changes in a 
constructive way and at a manageable pace (91). More rapid tempo has been 
associated with depressive symptoms, social difficulties and substance use in males 
(193, 214, 215) and psychological problems in females (91). However, this 
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hypothesis is yet to be confirmed: as an example, separate studies on pubertal tempo 
and depression showed opposite effects: while one found a rapid tempo (as measured 
by rate of change in PDS score) was linked to greater risk of depression (216), 
another two found tempo (as measured by rate of change in Tanner stage) protective 
(217), including at ten years post-puberty (218). Additionally, Marceau and 
colleagues found tempo (time rate of change in Tanner stage between Tanner stages 
1 and 5) was positively associated with male externalising behaviours (aggressive 
and delinquent) and female internalising (anxious or depressive) and externalising 
behaviours (91). 
1.5.3. Hormone Changes 
The contributions of sex hormones to physical growth were described previously in 
this review (section 1.2.3). Studying the associations between pubertal sex steroid 
changes and mood and behaviour in normal adolescents only began in the 1980s, 
with the advent of radioimmunoassay (219), though these measurements have now 
been superseded by the modern, highly accurate LC-MS/MS.   
Evidence for the contributions of the primary sex steroids testosterone and oestradiol 
to adolescent affect and behaviour is limited. The majority of the literature 
addressing this question involves cross-sectional analyses, which limits the ability to 
form conclusions. Causality cannot be inferred from cross-sectional studies, as the 
data may simply show an association that could be a persistent or short-term change 
or even coincidence (208). Likewise, the direction and progression of the effect can 
only be postulated, and moreover the lack of a statistically significant association 
may be due to confounding factors not otherwise accounted for. A longitudinal 
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cohort study with sufficient power to draw conclusions would offer the best 
confirmation of any effect of gonadal hormone changes on adolescent mood and 
behaviour. The contributions of hormones to sexual behaviours will not be examined 
in this literature review, as pubertal development is implicitly necessary universally 
for sexual behaviour. Further, the long-term implications of off-timed puberty 
hormone changes are outside the scope of this discussion.   
1.5.3.1. Testosterone 
Owing to evidence that testosterone levels correlate with aggressive behaviours in 
animals (220, 221) and the recognised effects of excessive anabolic steroids in 
humans (222), there has been much study into the effects of endogenous testosterone 
in male humans. Higher testosterone has been found to correlate with greater 
aggression in several cross-sectional studies in adolescent males (221, 223, 224) and 
more recently in cross-sectional investigations of both sexes (225). However, there 
are numerous studies that contradict such findings (189, 204, 226, 227). Added to 
this is evidence of testosterone’s relationship with social dominance. Vermeersch 
found females with higher testosterone levels were more likely to have dominant 
personality traits (as scored by the California Personality Inventory – Dominance 
Scale). This result was not observed in the males in their cohort. (228). Since there is 
at least a tenfold difference between testosterone levels in males and females by the 
end of puberty, there is difficulty interpreting the effects of the one hormone without 
accounting for changes in other hormones, including oestradiol for females.  
Aggression can also be manifested in behavioural problems. Some cross-sectional 
male studies (229, 230) observed positive correlations between testosterone and anti-
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social and problem behaviours, while other such studies did not (223, 231). A 
significant association has also been demonstrated between testosterone levels and 
assaultive behaviour in boys who live in “adverse” neighbourhoods (232). However, 
there exist numerous confounding factors, including the nature of the neighbourhood 
– Tarter states that in such socioeconomically depressed settings, notions of male 
honour are often demonstrated physically (232), which may prompt violent and 
assaultive behaviour, regardless of hormone levels. 
In two cross-sectional studies of Belgian youth, one male and the other female, 
Vermeersch and colleagues found boys had significant positive associations between 
free testosterone and non-aggressive risk taking (sensation seeking and novel 
behaviour that is not aggressive or violent in nature). No association in this study was 
observed between free testosterone and aggressive risk taking (233). In contrast, no 
relationships were observed for either free or total testosterone and either aggressive 
or non-aggressive risk taking in females (234).  
Not all risk taking involves physicality. Substance use is a common risk behaviour in 
adolescents, and a study by Foshee has observed that testosterone levels negatively 
correlate with cigarette and alcohol consumption for both sexes, with peer context 
playing an important role in mediating this association (235). In contrast to Foshee, 
Udry found that higher testosterone levels were related to alcohol abuse in adolescent 
boys (236). The conflicting results observed between studies may be due to the 
communities in which they are set, sample sizes and participant ages. Additionally, 
there are few large-scale longitudinal studies considering causative relationships 
between hormone levels and any of these behaviours. Furthermore, none of these 
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studies used mass spectrometry to measure hormone levels and accuracy of the data 
may have played a part. 
Depressive affect and anxiety disorders increase in prevalence during adolescence. 
Angold’s longitudinal Great Smoky Mountains Study found higher testosterone was 
associated with an increased odds ratio for depression for girls (237). Associations 
between testosterone and depression were not found in cross-sectional studies (189, 
204, 238), nor did these observe any significant relationships between testosterone 
and measures of anxiety.  Booth has noted that there was an important modifying 
effect of family interactions with testosterone in its association with depression: 
positive family relations led to non-significant associations with depression, whereas 
negative family relations interacted with testosterone to positively correlate with 
depressive symptomatology (239). This latter finding suggests the complexity of the 
interactions between hormonal changes and environmental factors in the onset of 
adolescent depression, amongst a variety of other conditions that emerge during this 
life phase.  
1.5.3.2. Oestradiol 
Studies involving oestradiol tend to focus on female adolescents, though some also 
involve males. In adult males, oestradiol levels are similar to females in their 
menstrual/early follicular phase. For the remainder of the menstrual cycle, oestradiol 
levels in females are up to ten times higher than in males. Additionally, studies do 
not account for the potential confounding effects of testosterone, which in adult 
males is consistently at least ten times higher than in females.  
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Oestradiol was associated with depression most strongly during the transition from 
pre-pubertal to adult hormone levels in two cross-sectional analyses from Brooks-
Gunn and Susman (191, 240). However, more recent work from Angold and Graber 
in this field has found linear associations between oestradiol and female depressive 
affect (237, 241). Angold’s study is the largest longitudinal study to date (339 
adolescents followed for three years) to consider whether there is a relationship 
between hormone changes and depression (237), though there is a limitation to the 
applicability of their findings as specimen collection time was not strictly controlled. 
As for anxiety, Rapkin observed a negative correlation between this mood state and 
oestradiol in females (242).  
Adolescent behavioural changes have also been associated with oestradiol levels. 
These studies are all cross-sectional in their analyses and therefore only provide 
preliminary associations of interest, which require longitudinal studies to confirm 
whether the hormone-outcome association is of a causative nature. For example, 
analyses observed that lower oestradiol correlated with delinquent behaviours (204, 
243) and another showed that higher oestradiol correlated with positive behaviour 
(238). Risk taking behaviours in both adolescent males and females positively 
correlate with oestradiol levels, though peer associations affected this outcome (233, 
234). Additionally, alcohol consumption was associated with a higher mean 
oestradiol level in one study on females (244).  
In summary, there is insufficient evidence to suggest a clear role for either 
testosterone or oestradiol in adolescent behavioural, mood or affect changes, 
although it remains likely that there will be some role demonstrated in appropriately 
devised longitudinal studies. The longitudinal studies discussed have had either small 
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sample sizes or insufficient time points that limit the power from which their 
conclusions can be drawn. The cross-sectional evidence that has been discussed 
suggests that a relationship might exist between hormonal changes and 
behaviour/affect. However, it is likely that this would be heavily modified by a 
variety of other factors which interact during this phase of the adolescent’s life, 
including changing peer and family relations, education and their general social 
environment. Any future study on hormonal changes and behaviour or affect changes 
should be longitudinal in its design, with sufficient participants for adequate power. 
A variety of behavioural and affect measures should be considered to better typify 
these states during adolescence and how these change with the changing hormonal 
milieu, and to account for all possible confounders which may interact and influence 
any changes.  
1.6. Concluding Remarks  
Puberty and adolescence represent universal transitions for the individual, though 
numerous gaps in the evidence remain regarding their implications for health and 
wellbeing. Adolescence, while allowing the development of peak physical and 
reproductive capacity for the individual, involves and introduces health risks that 
may affect the individual both during and after this life phase.  
Using clinical staging or cross-sectional hormone analyses offer some insights into 
the effects of the pubertal transition upon the adolescent. However, the evidence is 
often inconsistent and does not adequately account for the full effect of the hormonal 
transition as would a longitudinal cohort study. It is clear that profound physical and 
neurological changes occur during the second decade. The physical changes create 
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an adult body and allow the individual reproductive capability. Neurological changes 
improve cognitive ability and executive function, although may predispose to 
increased risk taking and sensation seeking, both causes for concern given their 
associations with increased adolescent morbidity and mortality. The contribution of 
pubertal hormone changes to these are not entirely elucidated, although given the 
contemporaneous nature of hormone and physical/neurological changes, 
consideration must be given to how differing hormonal milieu and the interaction 
with an adolescent’s environment may alter physical, mood or behavioural systems. 
1.6.1. The ARCHER Study 
The Adolescent Rural Cohort, Hormones and Health, Education, Environments and 
Relationships (ARCHER) study (1) is a three-year longitudinal study of 342 
adolescents  342 adolescents (153 females; ages 9-14 at baseline) and their parents 
(n=272; 239 female), living in rural New South Wales, Australia, centred on the 
towns of Dubbo and Orange. It was designed to be the most intensive biological 
study of puberty hormones ever undertaken, with three-monthly urine collection and 
annual blood collection for hormone analysis (and other biological variables of 
interest). Novel assay methodologies have been developed, using liquid 
chromatography-tandem mass spectrometry (LC-MS/MS) on urine and serum 
specimens, which will allow the detection of sex steroids at much lower and accurate 
levels than previously achieved (135, 136, 245). As well as collection of biological 
samples (serum and urine), participants undergo anthropometric assessment and 
complete a lengthy psychosocial survey annually. Their parents also complete a 
similar survey about their child as well as proving data about family, home and 
community context. The principal aim of the ARCHER study is to determine how 
1. Puberty and Adolescence in Context
50
  
the timing and tempo of hormone changes affect adolescent behavior, health and 
wellbeing. In so doing, many of the questions raised in this literature review should 
be answered.  
As regular biological sample collection is intrinsic to achieving the aims of the 
ARCHER study, it is important for adolescents (and their parents) to comply with 
study protocols, particularly the three-monthly home-based urine sample collection. 
Given the large study catchment area, participants need to be easily contacted for 
specimen collection. Text messaging is being used in the ARCHER study, however 
the utility of this as a research tool is unclear (246, 247). Potential benefits of text 
messaging include its relatively low costs and the ubiquity of mobile telephones 
(248-250) and adolescents’ familiarity with text messaging as a communication tool 
(251, 252). Indeed, the utility of text messaging in healthcare settings has been 
demonstrated previously (249) and also in child and adolescent populations in 
research as a data collection tool (253, 254). However, its role in enhancing 
compliance to protocols in adolescent research has not yet been established. 
The published methodology of the ARCHER study is provided for reference in 
Appendix A. 
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2. GENERAL METHODS
The detailed protocol for the Adolescent Rural Cohort, Hormones and Health, 
Education, Environments and Relationships (ARCHER) study, upon which this 
thesis is based, is provided in Appendix A. Note that non-published chapters use 
British spelling while the published chapters (Chapters 3-8) use the requisite spelling 
for the journal’s requirements. 
2.1. Aims and Hypotheses of this Thesis 
The overall purpose of this thesis is to examine relevant research methodologies that 
are needed to answer important questions regarding puberty hormone changes and 
the relationship between these and other changes during adolescence. This thesis has 
five aims, each of which will be addressed in chapters 3-8. The research conducted 
to meet these aims will provide a multi-dimensional demonstration of novel 
techniques in adolescent research, through which the ARCHER study can provide a 
deeper understanding of the longitudinal effects of puberty on adolescent health and 
wellbeing.  
The aims of this thesis are: 
1) Summarise, in greater depth, the present body of knowledge regarding the effect
of oestradiol levels on female adolescent mood and behaviour and the effects of 
testosterone on male adolescent mood and behaviour, so as to identify gaps in the 
evidence. This is a way to provide context to the ARCHER study going forward and 
indicate ways that a longitudinal study of adolescence and pubertal hormones can 
add to our understanding of the complexities of this life phase (see Section 1.5.3). 
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2) Demonstrate the feasibility of the ARCHER study methodology with respect to 
specimen collection. Investigating the role of text messaging as a novel research tool 
to enhance compliance with the study protocol will supplement this, as regular 
repeated sample collection is crucial to the success of the ARCHER study, and 
indeed to future studies involving adolescents where frequent biological specimen 
collection is required.  
3) Demonstrate the feasibility of the ARCHER study methodology to analyse 
collected specimens and describe preliminary outcomes on relationships between 
urine puberty hormones measured by liquid chromatography-tandem mass 
spectrometry and more traditional research descriptors of puberty. 
4) Investigate the longitudinal relationship between serum hormone levels and 
adolescent and parental subjective reports of pubertal progress in the ARCHER study 
cohort to determine the applicability of these assessments in longitudinal studies 
where direct physical examination of pubertal status is not possible. This would also 
determine how subjective assessments are related to hormone levels and whether 
these have sufficient accuracy to identify the onset and progress of puberty, a finding 
of utility to both clinical and research settings. 
5) Investigate the use of foot length change as a possible marker of early puberty. 
Some data exist regarding foot length in puberty (see Section 1.2.4) but no studies 
have considered the relationship between this possible anthropometric marker and 
hormone levels.  
For each of the above aims, and based upon the literature review presented in 
Chapter 1, it is hypothesised that: 
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1) There are insufficient longitudinal studies of high-quality design to support 
popular assertions of a causative link between oestradiol or testosterone changes and 
alterations in mood and behaviour for female or male adolescents, respectively. 
2) Text messaging will be a useful reminder tool for adolescents participating in the 
ARCHER study, which would be indicated by a significant positive correlation 
between message response time and specimen collection time. This in turn is 
hypothesised to lead to an increased specimen collection rate and compliance with 
study protocol.   
3) The more frequent sampling and LC-MS/MS methodology for urine hormone 
analyses will provide novel insights into hormone changes over one year of the 
ARCHER study.  
4) The changes in urine and serum hormones will be associated with longitudinal 
changes in traditional markers of puberty, specifically anthropometry (height, 
weight, BMI) and self-rated Tanner stage. 
5) Adolescents will be able to self-rate their Tanner staging with some accuracy (1-6) 
and this will be significantly and positively associated with hormone levels. 
However, parental assessment of puberty is hypothesised to be less accurate, 
possibly due to increased adolescent privacy as their bodies change. Both ratings will 
be sufficiently acceptable, when compared to the true markers of pubertal progress 
(hormone levels) to be used in research settings where direct clinician examination is 
not possible.  
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6) Foot length is a novel marker of early puberty and foot growth and is related to the 
hormonal drivers of pubertal changes. It could provide a useful, cost-effective and 
novel way to assess early puberty. Studies looking at Tanner stage change and peak 
height velocity have shown foot growth is an earlier event in puberty, occurring 
between Tanner stage 1 and 2 and prior to peak height velocity (7, 8). Therefore, it is 
hypothesised that foot growth will be greatest in adolescents whose hormone levels 
are relatively lower than their peers.  
As this thesis is being completed by publication, the specific methodologies for each 
chapter are included in each publication. The rest of this chapter provides details of 
broader methods employed across the thesis, such as study setting, hormone assay 
techniques and statistical analysis methodology.  
2.2. Subjects and Setting 
The ARCHER study enrolled 342 adolescents (153 females; ages 9-14 at baseline) 
and their parents (n=272; 239 female), with some sibling recruitment, and followed 
them over three consecutive years. The study was set in Central Western New South 
Wales (NSW), specifically around the towns of Dubbo and Orange where research 
offices were established for annual participant visits. These are large regional towns 
whose local hospitals are affiliated with the University of Sydney, the overseeing 
institution for the ARCHER study (9). As demonstrated in Table 2.1, there were no 
significant differences in gender proportions in the recruited cohort of ARCHER 
study compared to either the local government area (LGA) or the state of NSW for 
the age range included in the study (10). There was no significant difference in the 
proportion of adolescents identifying as Indigenous recruited as compared to living 
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in the LGA, though the proportion of Indigenous participants in the ARCHER study 
is over double the percentage of Indigenous adolescents in NSW (10). Recruited 
parents were more likely to be employed full time, speak English as a first language 
and have a tertiary or post-graduate qualification than those in the LGA or the rest of 
NSW (10). Lack of parental competence English was an exclusion criterion for the 
ARCHER study (9). A detailed description of the ARCHER study cohort is provided 
in Appendix B.  
By focusing on adolescents in regional and rural Australia, the ARCHER study will 
give added insights into growing up and transitioning through puberty in a relatively 
under-researched geographic population. Rural adolescents, both in Australia and 
abroad, have their own unique health risk profile (11, 12). Feasibility studies were 
conducted before the rolling recruitment of the ARCHER study proper commenced 
in 2012. Given the number of participants, timeframe of the study and enormity of 
the data collected and its complex longitudinal analysis (discussed further in this 
chapter), this thesis addresses a subset of data from within the longitudinal study. 
Recruitment occurred through schools, local community groups and both traditional 
(newsletters and advertisements) and social (Facebook page) media (for parents) (9, 
13). Adolescents provided informed assent and their parents informed consent. The 
ARCHER study has full ethics approval through the University of Sydney (HREC 
13094) and within the Australian National Health and Medical Research Council 
Guidelines for Human Experimentation, which are consistent with the Declaration of 
Helsinki.
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Table 2.1. ARCHER baseline demographics compared with the comparison local 
government areas (LGAs) and New South Wales (NSW). 
 ARCHER1  LGA2 NSW Statistics 
 
% (n) % (n) 
 
% (n) 
ARCHER vs 
Region 
ARCHER 
vs NSW 
Adolescents (N = 342) (N = 5,754) (N = 350,321) p value p value 
Gender      
Males  55.3 (189) 51.2 (2,947) 51.3 (179,821) 
0.147 0.158 Females 44.7 (153) 48.8 (2,807) 48.7 (170,500) 
Indigenous status      
Indigenous 11.3 (38) 16.6 (907) 5.0 (16,546) 0.011 < 0.001 Non-Indigenous 88.7 (299) 83.4 (4,571) 95.0 (316,951) 
      
1 Some Adolescent data are missing so not all categories total to N = 342.   
2 The regional comparison area includes LGAs of Cabonne and Wellington areas and the cities of 
Dubbo and Orange.   
Data generated from ABS 2011 Census of Population and Housing.
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2.3. Surveys, Anthropometry and Specimen Collection 
Adolescents responded to a survey and underwent anthropometric assessment 
annually. Parents answered survey questions at the same time as the adolescent. 
Adolescent and parent surveys focused on adolescent health and well-being, mood 
and behaviour, as well as questions regarding living situation, family relations, 
education, risk taking behaviours and sexuality, among others. Adolescents provided 
self-rated Tanner stage based on line drawings, and both parent and adolescent were 
asked simple subjective questions about the adolescent’s pubertal development. 
Close to the time of the annual survey, adolescents provided fasted, first-morning 
blood collections for analysis and a first morning urine sample. Every three months 
between annual visits, a collection kit was sent to the adolescent for further first-
morning urine samples. A text message was sent to the adolescent (or their parent) 
on the morning of collection to prompt their collection. The message also asked the 
adolescent to provide a rating of their mood on a linear scale from 0 (worst) to 9 
(best ever). See Section 5.3 for further details. 
At the time of the annual clinic visit, adolescents underwent anthropometry 
assessment. Height (to 0.1 cm) was measured using a portable stadiometer (Seca 
GmBH, Hamburg, Germany). Weight (to 0.1 kg) was measured in light clothing 
using a Tanita TBF-300 Pro Body Composition Analyzer (Tanita, Tokyo, Japan). 
Foot length (to 0.1 cm) was measured using a Ritz stick foot measure (Footer, 
Wisconsin, USA), modified with a millimetre-graduated measuring tape (to 0.1 cm). 
The foot measure was placed under the sole of the foot and length measured from the 
heel to the end of the distal phalanx of the hallux. The right foot was measured 
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unless this was inaccessible, in which case the left foot was used (3 of 1316 
measurements, in three separate adolescents). As anthropometric assessment 
occurred annually, there was concern growth curves and peak height velocity could 
not be adequately determined given the relative infrequency of anthropometry. 
Additionally, over three years’ follow-up, the full extent of pubertal growth may be 
missed. Recent work by Cole, using superimposition by translation and rotation 
(SITAR) modelling, compared longitudinal height data (128679 measurements of 
3172 boys) with intervals of two, three, four, six, twelve and twenty-four months, 
and found that measuring at intervals between two to twelve months provided 
essentially identical growth curve models for generating peak growth data and 
therefore concluded that annual anthropometric assessment is just as informative as 
more frequent measurement (14). This was reassuring for the ARCHER study, as the 
sheer geography of the study catchment area and the human resources available 
would not facilitate more frequent clinic visits, particularly outside school holiday 
periods.  
Serum and urine specimens were frozen and transported to Sydney for storage in 
alarmed -80 °C freezers. Urine samples underwent hormone assay using liquid 
chromatography-tandem mass spectrometry (LC-MS/MS) for sex steroids: oestrone, 
oestradiol, testosterone, dihydrotestosterone, androstenedione, and 
dihydroepiandrosterone (DHEA). The ARCHER study has ethics approval for future 
analysis of other analytes of interest related to pubertal development and metabolic 
health. This thesis will principally look at the oestradiol and testosterone data. A 
subset of urine samples was analysed with immunoassay for both luteinising 
hormone (LH) and follicle stimulating hormone (FSH) using an Immulite analyser. 
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Only LH satisfied the requirements for specificity and FSH analysis in urine was 
therefore abandoned. Collection date was controlled for post-menarcheal females to 
be in the early-mid-follicular phase (menstrual cycle days 7-10). While this may not 
control for pre-menarcheal ovarian activity, it ensured standard collection time in 
girls who were post-menarcheal.  
2.4. Liquid Chromatography-Tandem Mass Spectrometry 
As described in Section 1.3.3, LC-MS/MS involves liquid chromatography, which 
separates compounds of interest from other analytes in the specimen (15) and then 
mass spectrometry, which nebulises and ionises the chromatographic eluate (16). In 
the ARCHER study, atmospheric pressure photo-ionisation is used to generate ions 
of steroid hormones (17). The composition of a mixture (such as urine or serum) is 
determined by analysis of both the precursor and product ions, with minimal cross-
reactivity (compared to immunoassay), which gives LC-MS/MS a high level of 
sensitivity and specificity. This is useful in early puberty, as testosterone and 
oestradiol levels are too low for other assay methodologies to accurately determine 
(such as radioimmunoassay and enzyme-linked immunosorbent assay, unless the 
laboratory uses in-house assays specifically developed for lower range levels; see 
Section 1.3.3) (16). It should be noted that many peer reviewed journals will now 
only accept gonadal hormone results obtained by mass spectrometry (18). 
Urine and serum specimens were separated by liquid chromatography using a 
Shimadzu Nexera UHPLC system (Shimadzu Scientific Instruments, Columbia, 
USA). Following this, tandem-mass spectrometry analysis was performed on 
samples using an API-5000 triple-quadrupole mass spectrometer (Applied 
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Biosystem/MDS SCIEX, Ontario, Canada) (17). Both urine and serum analyses 
followed previously described methodologies (17, 19). A thorough validation was 
carried out for the LC-MS/MS method to measure oestradiol and testosterone 
according to standard analytical validity criteria (20). Urine analysis requires an extra 
extraction step that lengthens the procedure by a day longer than for serum extraction 
for LC-MS/MS analysis, making urine analysis currently more expensive and 
resource intensive (17). Urine specimens were adjusted for urine creatinine or urine 
specific gravity to correct for the influence of hydration status on urine analysis, but 
such an adjustment did not appear to be necessary, at least in adolescents, in a 
preliminary methodological paper by our group (Appendix C). Deming regression 
and Bland-Altman comparison of the unadjusted and adjusted measured 
concentrations both showed a lack of bias, whether uncorrected or corrected for 
specific gravity or urine creatinine (17). This possibly reflects the standardisation of 
urine collection as a first morning specimen which ensures a more controlled 
hydration state (17). For further detail, refer to Section 6.3.3. 
2.5. Statistical Analyses  
This thesis required multiple techniques to be used for the analysis of our 
longitudinal dataset, with multiple time-based variables. The repeated measures 
allowed the use of longitudinal regression techniques such as mixed-models linear 
regression. These will aid our understanding of puberty in general by providing 
results using longitudinal sets of data that provide more robust analysis than that 
possible with cross-sectional data. For this thesis specifically, using the collected 
data will provide novel findings to demonstrate the feasibility of longitudinal 
research in adolescents, both through determining the compliance to an intensive 
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specimen collection regimen (Aim 2) and that using such intensive sampling can be 
associated with anthropometric changes (Aim 3) and parental and adolescent rating 
of pubertal progress (Aim 4) as well as foot length change providing a novel marker 
of early puberty (Aim 5). This will provide a platform from which further 
longitudinal analytical models can be developed. The data and their analysis will 
ultimately allow translation of these findings to answer questions about the effects of 
puberty on adolescent health and well-being (as demonstrated through Aim 1). These 
are findings which we hypothesise will be related to onset of hormone change in 
part, as well as to tempo of change and stability of that hormone change. 
Collected data were divided into binary, ordinal and continuous variables. Binary 
variables included gender and the achievement of menarche for females. Ordinal data 
were self-rated Tanner stage and text message mood scores. Continuous variables 
were age, height (in m), weight (in kg), body mass index (BMI; kg/m2), foot length 
(cm), serum and urine testosterone (nmol/L), oestradiol (pmol/L) and luteinising 
hormone (IU/L) concentrations, time to reply to text message and time to provide 
urine sample. Differences in continuous variables were compared using Student’s t-
test (significance p<0.05).  
In Chapter 5, Pearson’s correlation coefficient was used to test the relationship 
between time until specimen collection and time to reply to text message. In Chapter 
6, linear regression was used to determine relationships between changes in 
anthropometry (height, weight, BMI) and self-rated Tanner stage with changes in 
urine and serum hormones between baseline and one-year follow-up. For these, the 
models were adjusted for the baseline anthropometric measurement and baseline 
hormone concentration. Mixed-models linear regression was used to assess 
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longitudinal changes in serial measures of hormones with gender and collection time 
from baseline as covariates, with models including a random effect for each child.  
In Chapter 7, the relationship between serum hormone concentration and survey 
response questions (self-rated Tanner stage, parent and adolescent questions 
regarding pubertal development) were assessed using mixed-models linear regression 
(hormone levels as outcome) or mixed-models logistic regression (dichotomous 
survey responses as outcome) with models including a random effect for each child. 
Cohen’s kappa (κ) was used to assess agreement between adolescent and parent 
questionnaire results. Hormone data were logarithmically transformed as these were 
skewed, so regression results were presented as odds ratios. Chapter 8 uses mixed-
models linear regression to determine the relationship between hormone level 
changes and changes in anthropometry (foot length, height and weight) and Tanner 
stage with random slopes for each individual. In Chapters 7 and 8, adolescents were 
classified as pre-pubertal if serum testosterone was < 0.5 nmol/L (males) or serum 
oestradiol < 40 pmol/L (females). These definitions were based upon a large cross-
sectional clinical research study defining hormone confidence intervals using LC-
MS/MS in adolescents and adults (21, 22) and conservative cut-offs were set.  
Mixed-models linear regression allows for time-dependent covariates, which enables 
its use in longitudinal research that involves the repeated measurement of the same 
variables over time. In general, it estimates longitudinal changes in an outcome (23) 
and allows for missing data points which are to be expected in studies of free living 
humans, which gives an advantage over analysis of variance methods that do not 
provide individual-specific analysis and are less suited to missing data points (24). 
Longitudinal models allow for a clearer interpretation of changes in outcomes over 
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time. In contrast, cross-sectional studies allow less time-intensive (and thus cheaper) 
data collection as only one collection point is required, which may simplify research 
with adolescent populations, an age group that is under-researched, and which offers 
both unique research challenges and opportunities (25). The cost of cross-sectional 
approaches is that analyses only offer a “snapshot” which may mean associations are 
under- or overestimated, or even caused by chance, with longitudinal analyses 
allowing a truer estimation of the relationship between exposure and outcome over 
time, and thus indicating any causative relationships. The implications of this are 
explained further in Chapters 3 and 4. 
This analytical strategy will offer a better understanding of the changes that occur in 
puberty by providing, for the first time, frequent repeated samples collected from a 
large cohort of community adolescents who are commencing or in early puberty. 
These data can be used to demonstrate the nature of hormone changes during this 
time, in addition to changes in anthropometric and psychosocial outcomes to give a 
holistic perspective of this transition. Using the aforementioned statistical methods, 
longitudinal regression models can be developed to demonstrate how pubertal 
hormone changes may truly affect the adolescent over the study duration. These 
could then be translated to provide population-based curves that may be used to 
predict those at risk of adverse outcomes during puberty, such as risk-taking, mood 
or behavioural changes, so that targeted interventions can be developed. If such 
identification of at-risk youth occurred, the approach would clearly not be aimed at 
altering the hormonal trajectory of physiological puberty, rather it would provide 
other interventions and support that may ameliorate adverse risks. For the 
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preliminary data in this thesis, we aim to show how the full study data could be used 
for such longitudinal analysis at the completion of the ARCHER study.  
2.6. Concluding Remarks 
In undertaking this thesis, I have learnt about many of the challenges of research in 
adolescents, and why they remain an under-researched population with respect to 
longitudinal studies with biological data collection. The attribution of pubertal 
hormone effects on adolescent mood, behaviour and wellbeing are yet to be 
determined. The ARCHER study is adequately powered to determine that attribution 
(9). The findings of this thesis are novel and represent the first of many exciting and 
explanatory findings which go some way to elucidate, for the first time, the true 
effects of puberty hormones. 
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3.1. Abstract 
Mood disorders and health risk behaviours increase in adolescence. Puberty is 
considered to contribute to these events. However, the precise impact of pubertal 
hormone changes to the emergence of mood disorders and risk behaviours is 
relatively unclear. It is important that inappropriate attribution is not made. Our aim 
was to determine what is known about the effect of endogenous oestradiol on human 
adolescent girls’ mood and behaviour. The databases searched were MEDLINE, 
Embase, PsycINFO, ERIC, Pre-MEDLINE, Web of Science and Scopus for all dates 
to October 2014. For inclusion, contemporaneous hormone and mood or behavioural 
assessment was required. Data were extracted following a template created by the 
authors. Fourteen studies met our inclusion criteria. There was some consistency in 
findings for mood and oestradiol levels, with associations between oestradiol and 
depression, and emotional tone and risk taking. Results were less consistent for 
studies assessing other mood and behavioural outcomes. Most studies were cross-
sectional in design; assay methodologies used in older studies may lack the precision 
to detect early-pubertal hormone levels. 
Conclusion: Three longitudinal and several cross-sectional studies indicate potential 
associations between oestradiol and certain mood or affective states, especially 
depression and mood variability though there are insufficient data to confirm that the 
rise in oestradiol during puberty is causative. We believe that it is important for 
health professionals to take care when attributing adolescent psychopathology to 
puberty hormones, as the current data supporting these assertions are limited. 
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3.2. List of Abbreviations: 
AQ Aggression Questionnaire; BESAA Body Esteem Scale for Adolescents and 
Adults; CAPA = Child and Adolescent Psychiatric Assessment; CBC Child 
Behaviour Checklist; CDI Children’s Depression Inventory; CPA Children’s 
Physical Activity Scale; CPI California Psychological Inventory; CSI Children’s 
Somatization Inventory; DISC Diagnostic interview Schedule; DSM-IV Diagnostic 
and Statistical Manual of Mental Disorders, 4th Edition; ERIC Education Resources 
Information Centre (ERIC); MAACL Multiple Affect Adjective Checklist; MASC 
Multi-dimensional Anxiety Scale for Children; MEBS Minnesota Eating Behaviours 
Survey; MTFS Monitoring the Future Survey; OSIQ Offer Self-Image 
Questionnaire; PACES Physical Activity Enjoyment Scale; PDS Pubertal 
Development Scale; PRISMA Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses; SIQYA Self-Image Questionnaire for Young Adolescents; SPP Self 
Perception Profile for Children; SSAS Sensation Seeking and Anxiety States Test; 
YBP Youth Behaviour Profile; YSR Youth Self Report 
3.3. Introduction 
Adolescence is a formative time for an individual’s identity, development and 
functioning (1). During this time, long term behavioural and affective patterns 
emerge, as well as psychopathologies (2). Puberty is the universal biological event of 
adolescence, the primary purpose of which is to achieve adult reproductive capacity 
(3, 4). Puberty involves dramatic and well-remembered physical changes (5) and it is 
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perhaps unsurprising that intuitively these changes are allocated importance in both 
physical and psychosocial contexts.  
The popular assertions of adolescence as a time of “puberty blues”, “storm and 
stress” or other behavioural changes (6, 7) are palpably not correct (8) for all 
adolescents. Certain problem behaviours and mental health issues do emerge during 
adolescence (1, 9), and deterioration in health may be linked to such behavioural 
changes (10). These include the appearance of sex differences in the prevalence of 
depression (the prevalence of depression in females is twice that of males) (11), 
increased sensation seeking (2, 12), substance use (13) and disordered eating (14). 
For girls, depressive illnesses, self-image and eating disorders are of particular 
concern. Gender differences and the coincidental increase in pubertal hormones at 
this time of increased risk implicate some role for sex hormones. However there 
exists no systematic analysis of the literature.  
Given the importance of non-biological factors such as social, family and peer 
relations in the development of adolescent behaviours and affect (15), it could be 
postulated that hormones influence adolescent behaviour indirectly, either by 
modulating internal status reactivity to modify affect, and/or by the effect on others 
of phenotypic development (6). While the hormone levels remain high after puberty, 
behavioural and mood disorders often ameliorate, giving rise to popular notions of 
“puberty blues” being confined to this period alone. Why some of these mood and 
behavioural changes fail to abate in certain individuals is unclear. It is important to 
understand the true effect and duration of that effect of sex hormones on adolescent 
mood and behaviour, so that clinicians can target established, evidence-based 
interventions to those most at risk (5). Additionally, while diagnosable psychiatric 
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conditions increase in prevalence, many parents will describe mood and behaviour 
changes despite absence of an identifiable mental illness. While these changes fall 
within a normal spectrum of mood or behaviour, these can still be confronting and 
challenging to the parent and adolescent alike.  
The age of onset of puberty in many Western countries has declined over the recent 
decades, (3, 16), with earlier exposure to rising levels of oestradiol, the primary 
puberty hormone in females. This is an additional reason to better understand how 
oestradiol affects the mood and behaviour in the pubertal transition, and which girls 
might be especially at risk for any negative impacts of their puberty hormones.  
One specific mechanism for any effect of oestradiol might be through central neural 
monoamine systems, which have been implicated in a wide range of mood and 
behavioural disorders (17, 18). Oestradiol may also induce the formation of new 
synapses (19). Such a neuroarchitectural effect is part of the organizational and 
activational effects hypothesis, wherein steroids act during brain development to alter 
neuroarchitecture, which limits the repertoire of the brain’s responses when acted 
upon by that hormone later in life (activation) (17, 20). An example of such 
activation is the commencement of reproductive behaviour in adulthood, which is 
programmed earlier during the organization phase of neural development (20).  
Animal studies, especially those in rodents (21, 22), have informed the role of 
oestradiol in adolescent behaviour. For example, the importance of oestradiol in 
sexually differentiated behaviour patterns in rodents (23) and other animals (24) may 
provide hypotheses as to sex-based behavioural differences in humans. While these 
studies proffer putative roles for oestradiol in human mood and behaviour, we know 
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that variation between different animal species is significant (25) and it is difficult to 
adequately model the complexities of human behaviour and mood in animal settings. 
The aim of this systematic review was to determine what evidence exists for the true 
effect of the endogenous puberty hormone, oestradiol, on adolescent girls’ mood and 
behaviour. 
3.4. Methods 
3.4.1. Search Strategy 
A systematic search was conducted to identify publications on the effect of 
endogenous oestradiol on mood and behaviour in healthy adolescent girls (10-19 
years) using the terms as laid out in Appendix D. The following databases were 
searched: MEDLINE, Embase, PsycINFO, Education Resources Information Centre 
(ERIC), Pre-MEDLINE, Web of Science and Scopus from the date of database 
inception to October 2014. No language limits were set. The search strategy for 
MEDLINE is included in Appendix D, with search terms for the other databases 
modified to their requirements. Where relevant, reference lists were hand searched 
for further records. No initial restrictions were placed upon publication type.  
3.4.2. Inclusion Criteria 
To be considered for this review, study participants were female adolescents (10-19 
years) from community samples, with no specified diseases. Institutionalized or 
incarcerated populations were excluded, unless a control group was reported 
separately, due to potential confounders for behavioural outcomes. Study participants 
must have undergone, or be undergoing spontaneous puberty. Thus studies involving 
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exogenous oestradiol or other oestrogens were excluded. Oral contraceptive pill use 
was also a criterion for exclusion, as these preparations contain synthetic and 
biologically potent oestrogens that suppress endogenous oestradiol production. In the 
event that a study did not explicitly define oral contraceptive use, authors were 
contacted for further information.  
Oestradiol measurement in blood, saliva or urine was required, with the laboratory 
methodology provided. Though assay methodology and quality has improved 
markedly over the past decades, we did not limit studies by assay type. It should be 
noted that even now assays might not be able to detect very low (i.e. pre-and early 
pubertal) oestradiol levels with adequate sensitivity (26). We considered whether to 
include only studies that used a standardized time of biological data collection, in 
order to control for known diurnal physiological variation in oestradiol in early 
puberty (3). If we had adhered to this criterion the only study to be excluded would 
have been a large, longitudinal study in which the collection time for the majority of 
samples was relatively constant (27). Only one study in females controlled for cycle 
time (28). In the others there was no stratification for pre- or post-menarchal status, 
and hence no explicit control for menstrual cycle.  We decided to retain these (all 
cross-sectional) studies, but also to address the inherent limitations of this approach 
in the discussion. Studies were included if outcomes were mood and/or behaviour 
measured by a recognized, validated tool and with the mood/behavioural 
measurement concurrent with hormone measurements.  
Studies on the effects of oestradiol generally do not account for the potential 
confounding effects of testosterone, and thus testosterone was not addressed in the 
review. The mood or behavioural effects of progesterone were considered beyond the 
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scope of the review, as we were interested in the pubertal transition, rather than the 
mature adult ovulatory cycle where progesterone induced mood variation is possible. 
(29).  
Specific moods and behaviours sought included depression, anxiety, eating disorders 
and self-image disturbance, social interactions, aggressive, disruptive or conduct-
disordered behaviour; risk taking including substance abuse. Studies were excluded 
if these addressed primarily sexual behaviours, as such behaviours are essential for 
reproduction which is the key biological function of puberty (3). 
3.4.3. Data Collection and Analysis 
3.4.3.1. Selection of Studies 
Once irrelevant studies and duplicates were removed, one reviewer (BB) scanned the 
title, abstract and keywords of the remaining articles. Where a reference seemed 
suitable for the review, the full text was retrieved for further analysis by two 
reviewers (BB, KS) and was either included or excluded on the above criteria.  
3.4.3.2. Data Extraction 
Information was extracted from each study into a template developed by the authors.  
The following information was recorded: participants (sample size, sex and age 
range), affect or behaviour measured (type, measurement tool and its validity), 
oestradiol measurement (assay type, time of day and time of cycle where available), 
assessment of pubertal status (method used; examination, self-report or parental 
report), study outcomes and discussion of limitations. These data are described in 
Tables 3.1 and 3.2.  
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3.4.3.3. Quality Assessment 
A general methodology for quality assessment was followed, based upon checklists 
for the evaluation of studies (30, 31) and is reported in Table 3.3 in the Results 
section.  
3.4.3.4. Statistical Analyses 
Given the heterogeneity of the outcomes and outcome measures in this systematic 
review, no further analyses (such as meta-analysis) could be performed and the 
results are presented as descriptive data.  
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) Statement (32) was followed in the writing of this review. 
3.5. Results 
3.5.1. Search Results 
The result of the searches is displayed in Figure 3.1. Of the initial 9904 results 
obtained from database searches, 9574 were removed. Three additional studies were 
identified from manual reference list searching. After exclusion based upon abstracts, 
the remaining 76 citations were inspected in full text. Fourteen of these met the 
inclusion criteria. The reviewers had full consensus in their findings. All included 
publications were written in English. 
The 62 full text articles which were excluded, as well as the reasons for their 
exclusion, are detailed in Appendix D. Participant age, lack of oestradiol 
measurement and oral contraceptive use were the main reasons for exclusion.  
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Figure 3.1. PRISMA Diagram for Study Selection. 
 
3. Oestradiol and Female Adolescent Mood and Behaviour
87
3.5.2. Included Studies 
Fourteen studies met the inclusion criteria. These studies are summarized in Tables 
3.1 and 3.2. Thirteen studies used standard radioimmunoassay measurement of 
oestradiol for blood samples.  One used an enzyme-linked immunoassay in saliva 
(33). Three studies (27, 34, 35) were longitudinal and the remainder was cross-
sectional, whether by study design or analysis. Four of the studies were based upon 
the same participant sample (35-38). Nine of 14 studies examined mood and affect 
alone, and 11 of 14 of the studies examined aggression, delinquency and behavioural 
or conduct disorders. Six of the nine studies on aggression also included an 
assessment of mood and affect.  
For clarity of interpretation, the variables of interest were grouped under four 
categories: A: mood and affect; B: self-image and social competency and related 
behaviours; C: risk taking, sensation seeking and substance use; and D: aggression, 
behaviour/conduct disorder and delinquency as shown in Table 3.1. The groupings 
describe similar outcomes so that a degree of inter study comparison can be made in 
the absence of formal meta-analysis. Most of the included studies considered more 
than one categorical outcome, and in order to reduce repetition we have not looked at 
the four outcome categories separately. In addition most studies were unable to 
demonstrate an association, so repetition of negative findings is also reduced. As 
previously stated, it was not possible, due to heterogeneous outcomes, to perform 
meta-analysis.
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Table 3.1. Study Characteristics (males are excluded from further analysis). 
Author Year N Sex# Setting 
Age (mean 
(SD) or 
range) 
Behaviour 
or affect 
Susman et al. †* 1991 108 56 Male, 52 Female 
USA, community 
based 
10-14 (M);
9-14 (F) A, D 
Slap et al.† 1994 54 Female USA, community based, high schools 10-14 A, B 
Angold et al. † 1999 339 Female USA, community based 9-15 A 
Susman et al.* 1985 108 56 Male
#, 
52 Female 
USA, community 
based 
10-14 (M);
9-14 (F) A, D 
Nottelmann et al.* 1987 108 56 Male, 52 Female 
USA, community 
based 
10-14 (M);
9-14 (F) B, D 
Susman et al.* 1987 108 56 Male, 52 Female 
USA, community 
based 
10-14 (M);
9-14 (F) A, D 
Brooks-Gunn et al. 1989 103 Female USA, community based, private schools 12.1 (0.8) A, D 
Warren et al. 1989 100 Female USA, community based 10.6-13.3 A, B, D 
Martin et al. 1999 94 Female USA, community based, high schools 16.6 (1.0) C 
Graber et al. 2006 100 Female 
USA, community 
based, urban high 
schools 
12.1 (0.8) A, D 
Rapkin et al. 2006 106 Female USA, community based 13.0 (3.0) A 
Davison et al. 2007 178 Female USA, community based 11.3 (0.28) B, D 
Vermeersch et al. 2008 298 Female Belgium, community based, high schools 14.3 (0.59) C, D 
Klump et al. 2010 258 Female USA, twin study, community based 12.0 (1.40) B 
† Longitudinal analysis 
* These studies are based upon the same data set
# In studies which included males, only the female data are reported
A = mood and affect; B = self-image and related behaviours; C = risk taking, sensation seeking and
substance use; D = aggression, behaviour/conduct disorder and delinquency
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3.5.3. Study Data 
The studies characterized in Table 3.1 are further detailed in Table 3.2. To briefly 
summarize the most important findings:  
3.5.3.1. Mood and affect (Category A) 
Most of the studies considered mood and affect. The studies can be summarized as 
follows: female sample size varied from 52 to 339, with a mean of 122 and median 
100. The age ranges of these subjects are listed in Table 3.1. In the nine publications
considering this domain, 13 different measures were used for participant assessment. 
All of these studies were based on community samples from the United States of 
America. Mood was investigated in different ways, such as DSM-IV depression (27), 
emotional tone (variability in mood) (34, 35, 38, 39), depressive affect (10, 40), and 
anxiety (41). While these studies do not all  examine the same aspects of mood or 
affect, all do consider what can be identified as pathological or maladaptive states.  
Susman’s longitudinal study in 52 girls over one year considered the roles played by 
several hormones (luteinizing hormone, follicle stimulating hormone, testosterone, 
oestradiol dehydroepiandrosterone and its sulfate, androstenedione and cortisol) in a 
variety of negative affective states: emotional tone, internalizing behaviour problems, 
symptoms of depression and anxiety. Longitudinal data were given for emotional 
tone and internalizing behaviour problems, though only cross-sectional data were 
provided for depression and anxiety symptoms. For girls, no significant cross-
sectional relationships were observed between oestradiol and any of the study 
outcomes, though longitudinal analyses showed a significant positive relationship 
between oestradiol and increased emotional tone (35). Slap et al. found no 
3. Oestradiol and Female Adolescent Mood and Behaviour
92
longitudinal association between oestradiol and mood (34). This study followed girls 
for one year, focusing on changes in self-image throughout puberty. Emotional tone 
was one scale of interest for their questionnaire. Regression analyses did not find a 
relationship between changes in oestradiol and changes in emotional tone over one 
year. It should be noted that there was a significant decline in emotional tone scoring 
(indicating a more variable mood) though changes in oestradiol were not significant 
between baseline and follow-up. In contrast, Angold’s larger (n=339) three-year 
longitudinal study found an approximately linear relationship between oestradiol and 
depression, which was diagnosed by interview using DSM-IV criteria (27). This 
study found that the odds ratio of oestradiol changes being related to depression was 
significant (odds ratio 2.5, 95% confidence interval 1.5 to 4.3). Additionally, 
Angold’s study found that oestradiol was more strongly related to depression than 
Tanner stage, supporting, not unexpectedly, the primacy of hormone change over 
morphological change in providing an etiological basis for depression in their cohort. 
When oestradiol levels were divided into quintiles, the percentage of girls with 
DSM-IV depression was approximately linear as hormone levels increased. 
Two cross-sectional studies observed that oestradiol had a non-linear relationship 
with depressive affect. When oestradiol concentration was reported as quartiles, 
depression was lowest in the pre- and post-pubertal quarters (bottom 25% and 
uppermost 25% respectively), and highest in the transition between these two (10, 
40). For Brooks-Gunn’s data, there were significant interactions between negative 
life events and hormonal levels in depression rating (40). In Rapkin’s study, anxiety 
was inversely correlated with oestradiol when hormone levels were tertiled. Without 
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categorization, oestradiol was not significantly correlated with anxiety, however the 
authors note a trend to this correlation (p=0.051) between the two variables. 
Of the seven cross-sectional analyses, emotional tone was considered in three (35, 
38, 39). Susman’s results from 1991 are reported above, as both longitudinal and 
cross-sectional analyses were provided.  An earlier paper in the same data set did not 
find any significant cross-sectional relationship with emotional tone and oestradiol 
(38). Both of these studies used different mood assessment tools. In contrast to 
Susman’s studies, more recent work in a larger study population (n=100) observed a 
correlation between oestradiol and emotional tone (39). 
3.5.3.2. Self-image and related behaviours (Category B) 
Slap et al. (34) found no longitudinal association between changes in oestradiol and 
self-image. In contrast, cross-sectional studies observed correlations between 
oestradiol and body esteem (42) and with the appearance of genetically influenced 
disordered eating attitudes and behaviours (43).  In Davison et al a negative 
correlation between oestradiol and body esteem was observed at 11 years in girls, 
though not at any other time point (42). Nottelmann et al. found no association 
between oestradiol and body image (36).  
3.5.3.3. Risk taking, sensation seeking and substance use (Category C) 
A significant correlation was found between the level of oestradiol and alcohol use in 
Martin et al. (28). No relationship between oestradiol and other substance use was 
identified. In a large Belgian population-based study, Vermeersch et al. found 
positive relationships between total and free oestradiol in girls and risk taking (44). 
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Aggressive risk taking was most evident at mid-cycle (defined by the investigators as 
an oestradiol of greater than 60 pg/mL (220 pmol/L) (28)), with non-aggressive risk 
taking showing no such cycle effect.  
3.5.3.4. Aggression, behaviour/conduct disorder and delinquency (Category D) 
There were limited data in this Category. Brooks-Gunn et al. and Nottelmann et al. 
both observed no correlation between oestradiol and aggression in their studies (36, 
40). Graber et al. found that aggression only correlated with oestradiol in females 
when negative life events were included as a mediating effect (39).  
3.5.4. Quality Assessment 
Table 3.3 provides a detailed description of quality assessment. No study included a 
power analysis, nor were there adequate descriptions of sampling methods. Four 
studies specified exclusion criteria. Of the fourteen studies, only Martin et al. 
controlled for menstrual cycle (28). Though Angold’s study did not use exact timing 
of sample collection, approximately three-quarters of samples were collected at 
consistent times which the authors report as minimizing diurnal variation effect (27). 
With respect to confounding factors, four studies accounted for or controlled for 
factors such as age and socio-economic status. 
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3.6. Discussion 
This systematic review is the first to examine the effect of oestradiol levels on mood 
and behaviour in adolescent girls. It is timely because long-standing assumptions and 
the evidence regarding sex hormone effects on adolescent mood and behaviour have 
never been comprehensively explored. With the growing awareness of mood and 
behavioural changes in adolescents, confirming or challenging these assumptions is 
important to develop or refine new paradigms in the diagnosis and management. 
Given the earlier onset of female puberty (3, 16) it is important to be aware of when 
any oestradiol effects might be expected to occur, especially as there are established 
links between early onset and later female mood and behavioural problems (14, 36, 
45, 46).  
The review demonstrated reasonably consistent findings on mood and affect, with 
depression and increased mood variability being positively correlated with oestradiol 
for at least some stages of puberty. Associations were most consistently observed 
between oestradiol concentrations and depressive states during the transition from 
pre-pubertal to adult oestradiol levels (10, 27, 39, 40), suggesting that tempo or 
rapidity of hormone change might play a part. A positive correlation was generally 
observed between oestradiol and affective variability (35, 38, 39). While mood 
variability more likely reflects “puberty blues” than does DSM-IV diagnosed 
depression (27), both benign and pathological changes in mood and affect are 
important causes of parental and adolescent concern during puberty. We have shown 
both of these have some association with oestradiol levels. There was no clear 
consistency of oestradiol effect for behaviours such as aggression, behaviour/conduct 
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disorder and delinquency (see 3.3.4). These behaviours are more often (falsely) 
associated with testosterone, as another review by our group has shown (47). 
The cross-sectional nature of all but three studies limits the conclusions of this 
review. Thus, reported outcomes can only show associations between oestradiol 
concentrations and the affect or behaviour of interest.  Causality cannot be inferred, 
as an association could be a persistent relationship, short-term change or mere 
coincidence (48); likewise the direction of the effect can only be postulated. 
Additionally, four of the studies were from the same cohort (35-38), and three of 
these described similar outcomes (all assessed with different scales), which risks 
over-representation of their data. Only four of the twelve cross-sectional studies 
controlled for potential confounders such as socio-economic status.  
Brooks-Gunn et al. estimated only 1% of variance in negative emotional expression 
was due to oestradiol (40) in their study. Environmental and social factors or 
determinants in an individual may mediate or amplify susceptibility to behavioural or 
affective changes as a result of pubertal hormone change (48). Angold et al. 
postulated that hormonal influences on mood and behaviour are less causative than 
sensitizing – that is, pubertal increases in sex hormones surpass a threshold that 
would render one more likely to alter affect or behaviour (27). That one-fifth of 
samples had hormone levels that fell below assay limits of detection and timing of 
sample collection was not as rigorous as other studies should be viewed as specific 
study limitations. 
The studies appraised in this systematic review are both observational and primarily 
cross-sectional. Longitudinal cohort studies would provide the best evidence for an 
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effect, if any, of oestradiol on adolescent mood and behaviour and this was the 
finding in the large longitudinal study from Angold et al (27). 
None of the studies in the systematic review addressed mechanisms for a putative 
relationship between oestradiol and behaviour and/or mood. Such mechanisms are 
likely primarily central. Oestrogens, especially oestradiol, have been shown to 
modulate genetic expression in neural monoamine systems (such as the 
dopaminergic, serotonergic and noradrenergic systems) (17, 18). These systems are 
commonly targeted by psychotropic drugs such as monoamine oxidase inhibitors and 
selective serotonin re-uptake inhibitors, which support at least a role for oestradiol in 
the onset or progression of mood or behavioural disorders. Pubertal hormone 
changes are often thought to modulate mood and behaviour by activating previously 
organized neuroarchitecture (see Introduction). It would be anticipated that these 
changes persist into adulthood, but given the limited follow-up in the studies 
reviewed, we cannot postulate as to whether oestradiol’s effects in this regard are 
persistent. Regardless, it is important to consider how sex hormone changes might 
affect adolescent mood and behaviour, especially given the salient increase in 
psychopathology during and after adolescence and the importance of earlier 
intervention.  
This systematic review has several strengths. Our methodology included 
comprehensive searches of many databases of potential relevance to this review, as 
well as detailed data extraction and quality analysis. Of the fourteen included studies, 
seven included over 100 girls.  
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There are a number of limitations. The studies included in the systematic review used 
a range of measurement tools to assess behaviour and affect, and meta-analysis or 
quantitative analysis of the collected study data was not possible. There may be a 
bias in that only published manuscripts were included in our final analysis, but as a 
counter to this argument, published studies had mainly negative findings. 
Information about the quality of the environment and early-life stresses experienced 
by the participants were not offered in the majority of the studies. These factors 
might well contribute to any aberrant moods or behaviours, and are thus important 
confounders. 
The irregular nature of menstrual cycles for some time after menarche makes control 
for menstrual cycle difficult in any study, and was only done in one of the retained 
studies. Failing to control for menstrual cycle may be a limitation of the review. 
Alternatively selecting a specific phase of the cycle (follicular, mid or luteal) may 
also skew the findings – if samples were not collected in the mid-follicular phase, 
progesterone may be a confounding factor. The most important methodological 
limitation of every study is the method of oestradiol measurement. The American 
Endocrine Society’s consensus statement on oestradiol measurement (26) concludes 
that even current assays are inadequate for pre-pubertal oestradiol measurement, 
indicating that the methodologies of the reviewed studies may lack sufficient 
sensitivity to detect oestradiol, especially at low levels or indeed to measure with 
enough specificity mid puberty levels.  In older, less sensitive assays especially 
oestradiol-mediated effects will be underestimated if too many oestradiol levels are 
below limits of quantification.   
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In conclusion, this systematic review has found that there are insufficient 
longitudinal data of high methodological quality to confirm that the rise in oestradiol 
during puberty plays a causative role in adolescent mood and behavioural changes, 
though the current evidence clearly suggests such a relationship exists. Future studies 
would require sufficient duration and frequency of sampling of biological markers, 
adequate statistical power and the use of mass spectrometry techniques to clarify the 
role of oestradiol. However, given the intra- and inter- individual variability of 
oestradiol levels from the beginning of puberty onwards, and the variation in timing 
and tempo of puberty it is possible that even with careful longitudinal studies, the 
assignation of a causal role may prove elusive.   
We believe that it is important for health professionals to take care when attributing 
adolescent psychopathology to puberty hormones, as the current data supporting 
these assertions are limited. Both timing and tempo of puberty may contribute to 
vulnerability in certain adolescents, particularly if other adverse psychosocial 
circumstances exist. Such adolescents may require supportive intervention during 
their adolescence in order to ensure that health trajectories are optimized. To this 
end, further understanding on how the dramatic rise in oestradiol during puberty 
affects adolescent girls’ mood and behaviour has important public health 
repercussions. 
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4.1. Abstract 
Purpose: During human puberty, there is an approximate 30-fold increase in 
testosterone production in boys. This increase is often linked to changes in mood and 
behaviour in adolescence such as aggression, an increase in risk taking, and 
depression. The aim of this systematic review was to determine what evidence exists 
on the effects of endogenous testosterone on behaviour and mood in males during 
adolescence. 
Methods: The following databases were searched: MEDLINE, Pre-MEDLINE, 
Education Resources Information Centre, PsycINFO, EMBASE, Scopus, and Web of 
Science. Only human studies were included. The study is community based, and the 
participants were healthy male adolescents within the age range of 9-18 years. 
Studies were required to have a validated mood and/or behaviour assessment 
contemporaneous with a timed testosterone measurement.  
Results: A total of 27 studies met the inclusion criteria of which only one was a 
longitudinal study. The remaining 26 studies were cross sectional in their analysis. 
As a variety of measurement tools were used, no meta-analysis was possible. Most 
studies focused on aggression. The one longitudinal study looking at testosterone and 
aggression showed little relationship with concurrent changes in aggression. Most of 
the cross-sectional studies of adolescent males observed relationships between 
aggression and testosterone levels. With respect to other behaviours and moods 
and/or affect, no consistent relationships with testosterone were observed in cross-
sectional studies.  
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Conclusions: This systematic review concludes that there are insufficient 
longitudinal data of high methodological quality to currently confirm that changing 
testosterone levels during puberty are significantly associated with mood and 
behaviour in adolescent males. To discount these findings is to risk apportioning 
blame inappropriately and missing other important diagnoses in adolescent males.  
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4.2. Introduction 
During human puberty, there is a 20- to 30-fold increase in endogenous testosterone 
production in males (1). Many assumptions are made about the nonphysical effects 
of this dramatic rise in testosterone; in particular that testosterone is responsible for 
changes in mood and behaviour. These changes are often considered to be 
undesirable or concerning and include aggression, an increase in risk taking, and 
depression (2, 3).  
Aggression is the most commonly cited behaviour associated with testosterone. 
Aggression is defined as a range of behaviours that can result in either physical or 
psychological harm to oneself, others, or objects in the environment. The common 
measurement for aggression in children is within the Youth Self-Report, and its 
parent-report equivalent, the Child Behavioural Check List (CBCL). The Youth Self-
Report and CBCL assess several types of aggressive behaviours, including bragging, 
arguing, screaming, showing off, attention seeking, teasing, being demanding, 
threatening behaviour, and displaying a temper.  
The implied association of testosterone with these behaviours is based on related but 
indirect evidenced normal developmental events, conditions of abnormal androgen 
excess and exogenous testosterone use. The second trimester surge in testosterone 
production in utero in males (4) is presumed to play a role in neural modifications 
that allow expression of behaviours more consistently seen in boys, such as 
physically rough-and- tumble play. This play pattern is also observed in females with 
congenital adrenal hyperplasia who are exposed to high levels of their own adrenal 
androgens, including testosterone, in utero (4). In males who fail to progress through 
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puberty because of abnormalities in the hypothalamic-pituitary-gonadal axis, the 
initiation of puberty by exogenous androgen therapy has demonstrated increases in 
physically aggressive behaviour (5). The behavioural changes induced by the abuse 
of exogenous androgens in testosterone-replete individuals (6) have been used to 
support assertions that testosterone has an important role in the etiology of mood and 
conduct disorders. However, there is no certainty that these latter data can be 
extrapolated to include the normal physiological rise in testosterone observed in 
puberty. For example, at normal physiological levels of testosterone, androgen 
receptors are saturated and therefore some of the effects of androgenic anabolic 
steroids are likely to be through different mechanisms such as high oestrogen levels 
or effects on the GH-IGF1 axis (7).  
There is indeed a concern that behaviour and mood change may be falsely attributed 
to puberty hormones, which are unalterable, and the true diagnosis ignored or not 
excluded. Although adolescence is often viewed as a period of storm and stress, most 
adolescents negotiate the period without short- or long-term detrimental behavioural 
outcomes, and the changes in mood and behaviours often ameliorate with time, 
despite the testosterone levels remaining largely unchanged relative to the changes 
during puberty.  
There have been a large number of animal studies (including rat, mice, hamster, and 
monkey) that have informed the role of testosterone in adolescent behaviour. This 
includes the activational and organizational effects of testosterone on neural circuitry 
and neurohormones (8), the effects of androgenic anabolic steroids (8), and the 
influence of prenatal testosterone on behaviour (9, 10). Although these models can 
inform human studies, we know that variation between strains and species is 
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significant (11) and may or may not translate to the complexities of human 
behaviour.  
The aim of this systematic review, therefore, was to determine what evidence exists 
on the effects of endogenous testosterone on behaviour and mood in human males 
during adolescence.  
4.3. Methods  
4.3.1. Search strategy 
A systematic search was conducted to determine the effect of endogenous 
testosterone on behaviour, affect, and mood in healthy male adolescents. Only 
human studies were sought. There is a large body of animal, primarily rodent, data 
using non- physiological testosterone manipulation. These are well beyond the scope 
of this review, even in discussion. The following data- bases were searched from the 
data on which records began up until the first week of March 2013: MEDLINE, Pre-
MEDLINE, Education Resources Information Centre, PsycINFO, EMBASE, 
Scopus, and Web of Science. Studies published in any language were included. The 
MEDLINE search strategy can be viewed in Appendix E. The other databases were 
searched with a similar strategy adjusted for the particular database.  
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4.3.2. Inclusion criteria 
4.3.2.1. Study type.  
The study can be a published prospective or cross- sectional study in any language, 
despite the inability to draw conclusions on causality from onetime point data 
(addressed in the Discussion section).  
4.3.2.2. Participants.  
Study participants are male adolescents. Most participants are within the age range of 
9-18 years as this age range captures the extremes of early (non-precocious) puberty
and of constitutional delay. Participants are not to have a specified disorder or 
disability, or if a specified disorder or disability is present, there is a control group 
with results reported separately. The study is community based and not from an 
institutionalized or incarcerated population (unless community-based controls are 
reported for comparison) as these may confound behavioural outcomes. Participants 
are not to be taking exogenous testosterone, which implies nonspontaneous puberty. 
4.3.2.3. Hormone studies. 
All studies must have a measure of testosterone from serum or saliva, by a validated 
immunoassay or mass spectrometry (MS). The Endocrine Society position statement 
on testosterone measurement supports the use of MS as a more accurate way of 
measuring sex steroids especially at low levels (12). However, MS was not 
commonly available when most of these studies were performed, and therefore, 
studies that used a validated serum and/or plasma or saliva immunoassay are 
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included. It is not possible to comment on how comparable or otherwise the various 
assays are.  
The time of the testosterone collection must be standardized to account for diurnal 
variation in testosterone production. Testosterone levels fall approximately 40% 
from peak to nadir (13). In this review, studies must include a documented time of 
collection or adjustments for timing.  
4.3.2.4. Outcome measure. 
The outcomes are those behaviours and affect disorders that are known to have a 
clear increased incidence and prevalence in the second decade of life and the 
behaviours commonly inferred to be the result of puberty hormones: 
aggressive/disruptive/conduct disordered behaviour, substance abuse, social 
competency and social interactions, depression and anxiety, and self-image concerns. 
Contextual moderators such as family or peer relationships and social context were 
sought because of their known influence on behaviour and mood.  
Because most published studies address a single behaviour or mood, the extracted 
manuscripts were grouped together based for clarity on common themes: (1) 
externalizing behaviours, including aggression; (2) alcohol and other drug use; (3) 
self-image and social behaviours; and (4) mood and affect. The behaviours or affect 
disturbance needed to have been measured using recognized and validated tools. 
Those studies that focused primarily on sexual behaviours were excluded. This was 
because testosterone’s role in the development of male secondary sexual 
development and sexual behaviour is universally acknowledged, and the focus of this 
review is on behaviours that may indicate psychopathology or at the least troubling 
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behaviours. The assessment of the specified outcome needed to be contemporaneous 
with testosterone measure. A physical examination for puberty status was not 
required but was extracted if included.  
4.3.3. Data collection and analysis 
4.3.3.1. Selection of studies.  
After the removal of obviously irrelevant studies or duplicates, a single reviewer 
(S.A.D.) scanned the title, abstract, and keywords of every record and retrieved the 
full text for further assessment when the reference suggested that the study might fit 
the inclusion criteria. The full text of these studies was analyzed by two reviewers 
(S.A.D. and K.S.S.) and identified as included or excluded based on the previously 
mentioned criteria.  
4.3.3.2. Data extraction. 
Information was extracted from each study into a specific template developed by the 
authors. The following in- formation was extracted: study design, description of 
participants which included sample size, age range, the outcome measured and the 
tool used, testosterone level(s) including sample type, time collected and laboratory 
assay used, physical pubertal status (stage, scale, and by whom), results obtained 
with analysis type, and whether co-variables or confounders were assessed.  
4.3.3.3. Statistical analyses. 
Given the heterogeneity of both the measures and the outcomes, no further analyses 
could be performed and the results are presented as descriptive data.  
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4.4. Results  
4.4.1. Search results  
From the initial search, 8,731 citations were identified from the following databases: 
MEDLINE (2,151), Pre-MEDLINE (31), Education Resources Information Centre 
(45), PsycINFO (756), EMBASE (1,536), Scopus (3,352), and Web of Science 
(860). One reviewer (S.A.D.) scanned these references, and 7,981 were removed as 
being either not on topic, reviews, or duplicates. The abstracts (and full reference if 
abstract unavailable) were studied in detail of the remaining 750, with 117 citations 
identified as potentially relevant. Two reviewers (S.A.D. and K.S.S.) studied the full 
references of the 117 citations and 27 studies completely fulfilled the inclusion 
criteria. There was consensus between the two reviewers. All 27 final publications 
were in English (Figure 4.1).  
The main reasons for exclusion were age of participants, if the subjects were selected 
for a particular disease or disability, the time of testosterone collection not 
documented or standardized, the behaviour measured not contemporaneous with 
testosterone collection, testosterone was the dependent variable (the effect of 
behaviour on testosterone levels), or sexual behaviours only were studied (see 
Appendix E for more details).  
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Figure 4.1. PRISMA flow diagram for study selection (14). ERIC = Education 
Resources Information Centre. 
Records identified through database searching 
(n=8731) 
MEDLINE (2151)  
Pre-MEDLINE (31)  
ERIC (45)  
PsycINFO (756) 
EMBASE (1536)  
Scopus (3352)   
Web of Science (860) 
Exclude obviously irrelevant, duplicates, reviews (n=7981) 
Did not fulfil inclusion criteria (n=633) 
Full references of potentially relevant articles studied in detail by 2 reviewers (n=117) 
 
Finally excluded studies (n=90) 
Abstracts reviewed in detail and full references when necessary (n=750) 
Studies completely fulfilling inclusion criteria (n=27) 
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4.4.2. Included studies 
A total of 27 studies met the inclusion criteria. These are summarized in Tables 4.1 
and 4.2. There was one longitudinal study and 26 cross-sectional studies or 
longitudinal studies with cross-sectional analysis.  
The extraction data are reported in behavioural type subgroup for clarity. 
4.4.2.1. Aggressive and/or disruptive behaviour.  
Most of the studies focused on this behaviour type. There was only one longitudinal 
study that investigated the association between testosterone and aggressive 
behaviours (15). Halpern et al. reported data from a 3-year study of 100 boys in early 
adolescence with the aim of determining whether pubertal changes in testosterone 
predicted changes in aggressive behaviour. This was a random sample of white boys 
in grade 7 and 8 with a 50% participation rate. Analyses considered first whether 6-
month changes in testosterone predicted 6-month changes in aggression and second 
whether changes in testosterone over 1-year periods predicted changes in aggression 
over the concurrent 1-year periods. In this study, changes in testosterone were not 
significant over 6-month periods. Testosterone change over a 1-year period was 
significantly and positively associated with concurrent 1-year changes in one of the 
six measures of aggression (fights) and one of the two aggression scales (ACL). 
However, the direction of the relation- ship varied over time, and the authors 
concluded that change in testosterone showed little relationship with concurrent 
changes in aggression. There was no evidence of a systematic increase in aggression 
during the 3 years of the study.  
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The cross-sectional studies are detailed in Table 4.3 and can be summarized as 
follows: sample size varied from 20 to 478 with a mean of 143 and median 93.5. The 
ages of the subjects are given in Table 4.2 with a variation in age range between 
studies. The scale used to measure the behaviour differed greatly from study to 
study. There were at least 16 different scales used in the 18 studies. The separation of 
aggression, aggressive risk taking and risk taking or delinquency, and other nuances 
of aggressive behaviour did not allow for comparisons between studies.  
The most common scale, but only used in five studies, was the CBCL. The CBCL is 
completed by a parent or teacher and covers a number of different aspects of 
behaviour including aggression and delinquent behaviour. None of the five studies 
using CBCL found a significant relationship between testosterone and aggression, 
and only one of four studies (16) found a positive relationship between testosterone 
and delinquent behaviour which was moderated by family cohesion.  
The three largest studies (17, 25, 36) focused on delinquent or risk behaviour and 
each used a different scale. Aggression may have been a component but was not 
separated out in all. A study by Vermeersch et al. (36) used a Dutch self-report scale 
designed to measure both nonaggressive and aggressive risk taking. This study found 
a significant but modest relationship between testosterone and nonaggressive risk 
taking, moderated by peers and no relationship between testosterone and aggressive 
risk taking. Booth et al. (17) used the Risky Behaviour Scale which is a self-report 
questionnaire of 18 risky behaviours in the last year and found no relationship 
between testosterone and risk behaviour but found modification of behaviour by 
parent-child relationships. The study by Kirillova et al. (25) was the largest study in 
this group and did find a relationship between testosterone and the development of 
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conduct disorder in two of the three periods studied. However, their focus was on 
conduct disorder, the more extreme degree of aggressive behaviour, and a psychiatric 
diagnosis measured with the K-SADS-E (Kiddie-Schedule for Affective Disorders 
and Schizophrenia for School Age Children).  
4.4.2.2. Substance use, self-image or social interaction and competency, depression, 
and anxiety. 
There were very few studies looking at other behaviours, mood, or affect. These are 
summarized in Table 4.4: alcohol and other drug use (group B), self-image and self-
competency (group C), and depression and anxiety (group D), and all were cross 
sectional. Four investigated alcohol and other drug use, three considered aspects of 
self-image and social competency, and six included depression and anxiety in their 
analysis.  
In group B, only one study (21) found a positive association between testosterone 
and drug use, which increased as the family, peer, neighbor, and school context 
became more harmful. The other studies did not find associations between 
testosterone and drug use but did not consider any peer or family context or other 
potential modifiers of behaviour.  
The three studies in group C focused on different aspects of self-image and 
competency and included two from Vermeersch’s group that reported on the same 
study sample (37, 38). None found significant associations between testosterone and 
measures of self-image or competence.  
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Of the studies that looked at testosterone and depression or anxiety, sample size 
varied from 40 (23) to 315 (17). Granger (24) demonstrated an inverse association 
between testosterone level and anxiety or depression. The remaining five studies 
demonstrated no significant relationship between testosterone and anxiety or 
depression.  
4.5. Discussion 
To the best of the authors’ knowledge, this systematic review is the first to examine 
the effect of endogenous testosterone on behaviours, mood, or affect in male 
adolescents. Twenty-seven studies were included in the data extraction: only one was 
a longitudinal analyses with the other studies either cross sectional in their design or 
longitudinal cohorts with cross- sectional analyses. As a variety of measurement 
tools were used for the specified outcomes, no quantitative meta-analysis was 
possible.  
To summarize the findings of this review, there was only one longitudinal study that 
satisfied the inclusion criteria. This study by Halpern et al. (15) found a positive 
association between male testosterone and aggression but only in one of six measures 
of aggression and with variation of the direction of the relationship over time. The 
findings from 18 cross-sectional studies on the relationship between testosterone and 
aggression and risk taking were equivocal and conflicting. Significant relationships, 
when described, often related to only a subset of measures. Most of the 13 cross-
sectional studies focusing on other behaviours or mood demonstrated no relationship 
between testosterone and the behaviour measured.  
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Contextual modification was only analyzed in a minority of studies. However, there 
was significant modification of aggressive behaviour by parent-child relationship 
(17) and modification of substance use through peer, family, and school context (21).
Vermeersch et al. (36) found that peer association moderated the relationship 
between testosterone and risk taking. These moderating external influences are not 
surprising and should inform future studies which aim to describe the role of puberty 
hormones on adolescent behaviour and mood.  
Our findings are limited by the cross-sectional nature of most of the studies 
reviewed. Reported outcomes can only show associations between testosterone levels 
and the behaviour or affect of interest. As such, the conclusions of this review are 
simply indicative of potential relationships between testosterone and adolescent 
behaviour and affect. Accordingly, causality cannot be inferred, as an association 
could be a persistent relationship, short-term change, or mere coincidence. Likewise, 
the direction of the effect can only be postulated.  
There is also a limitation in the acceptance of all testosterone assays, when in fact 
these may be highly variable in their assessment of the true biological effect of 
testosterone.  
The Greater Smoky Mountains Study (3) of children and adolescents remains one of 
the largest cohort studies to date that has addressed the relationship between pubertal 
hormonal and psychological changes, as a part of this major study on the prevalence 
and causes of psychiatric illness. It was excluded on the criterion of sample timing as 
the study used only annual single-point measures of testosterone uncontrolled for the 
4. Testosterone and Male Adolescent Mood and Behaviour
125
  
time of day. The study showed an association between depression and testosterone 
over the pubertal transition.  
It is important to consider how the timing of the initial testosterone rise in puberty 
(onset) and the rate of testosterone change (tempo) might influence behaviour. 
Because many undesirable adolescent behaviours ameliorate over time, despite 
hormone levels remaining high, it is possible that the speed of hormone change may 
be more important than the absolute hormone levels. It is also likely, as suggested by 
cross-sectional studies, that any effect of testosterone is ameliorated or modified by 
exogenous factors. As an example, there is some evidence in males that delayed 
puberty is associated with increased anxiety, decreased self-esteem, and lower social 
competency (41). This might be affected by timing and tempo of testosterone rise. 
However, such a situation could also be affected by dissonance from peers in sexual 
maturation. The descriptors of male pubertal timing are less well characterized when 
compared with females because of the lack of a clearly defined and easy-to-
remember pubertal event like menarche and emphasize the importance of 
measurement of biological markers of puberty. The knowledge of neural change and 
cognitive development over adolescence has dramatically advanced over the last 
decade (42-45). None of the studies in the systematic review addressed 
neurocognitive change and its association with testosterone, a topic that is currently 
under investigation by a number of groups. Human studies cannot investigate central 
neurotransmitter changes (although the peripheral androgen receptor can be studied), 
which are the likely pathways for testosterone effects on mood and behaviour, either 
directly or via aromatization to oestradiol (46).  
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The strength of this study is the comprehensive search strategy and strict inclusion 
criteria. The weaknesses are the lack of quality longitudinal data and the validity of 
the testosterone assays used, particularly in older studies. Thus, the authors conclude 
that insufficient evidence exists to answer the original question about the 
nonphysical effects of endogenous testosterone on behaviour and mood in adolescent 
males. This is nevertheless an important outcome, given the assumptions about 
testosterone’s effect on male behaviour that are often made both by clinicians and the 
general population and appear in the lay press, including parenting self-help 
publications. These assumptions, which particularly relate to undesirable behaviours 
in both adolescent and younger male children, need to be challenged. This is both 
because of the lack of evidence currently and the fact that the etiology of such 
behaviours is likely multifactorial and with strong psychosocial interactions. These 
predictors are likely to be both significant and modifiable, unlike a normal pubertal 
testosterone rise, which could never be a target for intervention. The optimal 
approach to demonstrate a relationship between testosterone and any behavioural or 
mood/affective patterns would be a longitudinal study in a well-described, 
sufficiently powered cohort that accounted for possible confounders, and with 
concurrent, frequent, and accurate measurement of testosterone levels and contextual 
modifiers.  
Summary 
This systematic review has shown that there are insufficient longitudinal data of high 
methodological quality to currently confirm that the changing testosterone levels 
during puberty significantly affect male adolescent behaviours and mood.  
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5.1. Abstract 
Introduction: Longitudinal studies of adolescents must be ‘adolescent-friendly’, both 
to collect data and encourage maintenance in the study cohort. Text messaging may 
offer a feasible means to do both. 
Methods: Adolescents in the Adolescent Rural Cohort, Hormones and Health, 
Education, Environments and Relationships (ARCHER) study (n=342) are sent 
automated text messages every three months, prompting biological specimen 
collection.  
Results: A total of 99.2% of participants (or their parents) owned a mobile phone, of 
which 89.1% of participants responded to text messages and 97.3% of intended urine 
samples were collected. The average time to provide a urine sample after prompting 
correlated with time to reply to SMS.  
Conclusions: This study shows SMS can be used effectively in longitudinal research 
involving adolescents, and is both feasible and useful as a reminder tool for regular 
biological specimen collection.  
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5.2. Introduction 
Longitudinal studies in adolescents have their own particular challenges, especially 
when the collection of biological samples is included. (1) In this context, 
‘adolescent-friendly’ research tools are required both for the collection of 
longitudinal data and to encourage retention in the study cohort. One potential tool is 
text messaging via Short Message Service (SMS), (2) a ubiquitous communication 
means among adolescents. SMS has been shown to be effective in a variety of 
healthcare contexts, (3) though its usefulness in research involving adolescents is 
unclear. The aim of this study was to determine the usefulness of SMS as a reminder 
tool in a longitudinal study of adolescents.  
5.3. Methods 
The Adolescent Rural Cohort, Hormones and Health, Education, Environments and 
Relationships (ARCHER) study (2) is a three-year longitudinal cohort study of 
adolescents, which requires the regular collection of urine samples for puberty 
hormone assay. The principal aim of the ARCHER study is to explore how the onset 
and tempo of changes in gonadal hormones during puberty affect adolescent 
behavior, health and wellbeing.  
Participants are sent urine collection kits every three months. SMS messages are sent 
the morning of the scheduled urine collection day. Depending on family cellular 
phone ownership, participants (or parents) are instructed to reply when the urine 
collection is completed. Participants without cellular phones were provided with a 
sticker on which they wrote their mood score number (part of the broader study and 
data not presented here). The standard text was: “Hi <First Name><Last Name>. On 
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a scale from 0 to 9 (with 9 = best ever). What is your mood now? Thanks 
<Investigator Name>.” This reply is in a form of a linear analog self-assessment 
scale of mood (focusing on the adolescent). Prior research has shown that any 
request for action increased the chances of a response to a text message (4) and we 
hypothesized our request would increase the likelihood of specimen collection. If 
participants did not provide an SMS response or urine specimen within two weeks, 
they were followed up by telephone call. 
The ARCHER Study has full ethical approval from the Human Research Ethics 
Committee, University of Sydney (HREC 13094) within the Australian National 
Health and Medical Research Council Guidelines for Human Experimentation, 
which are consistent with the Declaration of Helsinki. All participants and their 
parents provided written informed consent prior to commencing the study. 
5.4. Results 
The total study recruitment was 342 adolescents (153 female). Three hundred and 
thirty-nine participants (151 female) in the ARCHER study had provided at least one 
SMS mood indicator response by June 30, 2013. The average age (SD) for 
adolescent participants at enrollment was 11.8 (0.99) years for males and 11.7 (0.98) 
years for females. Three hundred and thirty-seven (99.4%) of these participants or 
their parents owned a cellular phone and were able to provide responses by SMS. 
The two participants without a mobile phone provided their responses written on 
stickers provided with the urine collection kit. A total of 1555 SMS were sent to the 
339 participants between 1 June 2011 and 30 June 2013, with 1386 replies (89.1% 
response rate).  
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From 1555 intended urine collections, 42 were not provided (2.7%). Of these, 36 
(85.7%) did not provide an SMS response. Over two-thirds of SMS replies and urine 
samples were obtained within seven days of the scheduled date (see Table 5.1). 
Males and females did not differ in time to reply to SMS (mean difference = 1.75 
days; 95% CI = -0.431 – 3.933 days; p=0.116), though females took longer than 
males to provide a urine specimen (mean difference = 2.01 days; 95% CI 0.526 – 
3.50 days; p=0.008).  
Time of urine specimen collection was correlated with the time of SMS reply, as 
shown in Figure 1 (r = 0.606, p<0.001). Some SMS replies and urine collections 
occurred before scheduled dates if participants were unavailable then, giving 
negative times relative to scheduling (Figure 5.1).
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Table 5.1. Time to SMS reply and urine collection scheduled date by gender. 
 
Overall 
N (%) 
Male  
N (%) 
Female 
N (%) 
SMS Reply*    
Time to reply (days) (Median/IQR) 3 (0-10) 2 (0-8) 4 (0-12) 
    
Reply within 24 hours 599 (39) 333 (40) 266 (36) 
Reply between 2 to 7 days 365 (23) 208 (25) 157 (21) 
Reply between 8 to 28 days 332 (21) 159 (19) 173 (24) 
Reply between 29 to 90 days 90 (6) 38 (5) 52 (7) 
Did not reply (no reply after 90 days) 169 (11) 83 (10) 86 (12) 
    
Urine Collection*    
Time to collection (days) (Median/IQR) 3 (0-10) 3 (0-8) 4 (0-12) 
    
Collection within 24 hours 643 (41) 354 (43) 289 (39) 
Collection between 2 to 7 days 409 (26) 239 (29) 170 (23) 
Collection between 8 to 28 days 373 (24) 177 (21) 196 (27) 
Collection between 29 to 90 days 88 (6) 42 (5) 56 (8) 
Did not collect (no specimen after 90 days) 42 (3) 20 (2) 22 (3) 
* Time in days to SMS reply or urine collection from scheduled date 
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Figure 5.1. Plot of urine specimen collection time and SMS reply time. Line shows 
y=x. Dots on the line indicate SMS reply and urine sample conducted on same day, 
dots above line indicate urine sample occurred before SMS reply and dots below the 
line indicates urine sample conducted post SMS reply. 
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5.5. Discussion 
In this study, SMS reminders were used to increase compliance and retention. The 
high cellular phone ownership and high response rates to the text messages in this 
cohort indicate that contact via SMS is both feasible and acceptable in a longitudinal 
cohort study of adolescents.  
The time to reply to the SMS strongly correlated with the time to supply a urine 
sample, and less than 10% of collections were missed. While this does not imply 
SMS was the sole reason for remembering to collect a sample, the timing of the 
message with scheduled collection is likely to have an influence. The mean time 
from scheduled date to reply SMS receipt and the provision of a urine sample were 
both approximately one week. This is primarily due to scheduling and logistics 
between research staff and participants: dates had to be organized for specimen kit 
delivery, timing for follicular phase of menstrual cycle and participant preference. 
Menstrual cycle adjustments may explain the difference in urine specimen collection 
between sexes. The negative times seen in Figure 1 did not affect the correlation 
between SMS reply and collection time. 
There are several limitations to our study. There was no control group so we cannot 
be certain the SMS prompt contributed to compliance and may limit the conclusions 
which we can draw. Likewise, the SMS component was used once every three 
months so results could differ if contact occurred at different frequencies, though 
weekly SMS contact with children and adolescents has been shown to have similar 
response rates (5). We could not tell whether the parent or the adolescent was 
replying to the text message. As the SMS was one aspect of the reminder system 
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(along with the delivery of the specimen collection kit), it may not be the sole reason 
for collection reminder, though the strong correlation between reply time and 
collection rate shows participants were compliant in replying to the SMS as 
requested. The use of smartphone applications, such as “SnapChat” or “What’s App” 
may appeal more to adolescents and possibly increase reply rate, however SMS is a 
feature common to all cellular phones so avoids limitations imposed by operating 
systems, data access and application costs. 
In conclusion, SMS has been shown to be an acceptable and feasible tool for use as 
part of a reminder system in longitudinal research involving adolescents. The current 
analysis suggests that SMS may be used in research studies involving multiple home-
based data collection points and replies are in line with instructions (regarding timing 
and content). Young people readily reply to a simple and short SMS. Our findings 
suggest that SMS may be a potential data collection tool for other information, 
provided the question does not require a complex response. Clinically, SMS may be 
useful in monitoring and compliance with adolescent patients who require multiple 
specimen collections over a period of time.  
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6.1. Abstract 
Background/Aims: The longitudinal relationships of within-individual hormone and 
anthropometric changes during puberty have not ever been fully described. The 
objectives of this study were to demonstrate that 3 monthly urine collection was 
feasible in young adolescents and to utilise liquid chromatography-tandem mass 
spectrometry assay methods for serum and urine testosterone (T), oestradiol (E2) and 
luteinizing hormone (LH) in adolescents by relating temporal changes in urine and 
serum hormones over 12 months to standard measures of pubertal development. 
Methods: A community sample of 104 adolescents (57 female) was studied over 12 
months with annual anthropometric assessment, blood sampling and self-rated 
Tanner staging and urine collected every 3 months. Serum and urine sex steroids (T, 
E2) were measured by liquid chromatography-tandem mass spectrometry (LC-
MS/MS) and LH by immunoassay.  
Results: A high proportion (92%) of scheduled samples were obtained with low 
attrition rate of 6.7% over the 12 months. Urine hormone measurements correlated 
cross-sectionally and longitudinally with age, anthropometry and Tanner stage.  
Conclusion: We have developed a feasible and valid sampling methodology and 
measurements for puberty hormones in urine, which allows a sampling frequency by 
which individual pubertal progression in adolescents can be described in depth.  
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6.2. Introduction 
The circulating gonadotropin, testosterone (T), and oestradiol (E2) changes that drive 
the external manifestations of puberty are well described from cross-sectional studies 
according to chronological age or Tanner staging interpreted quasi-longitudinally (1, 
2). Such cross-sectional analysis artificially smooths longitudinal data due to a low 
resolution in temporal sampling, markedly underestimating the underlying within-
subject variability. Combined with this variation in individual hormones is the 
normal variability in both time of onset and tempo of completing puberty. Both 
timing and tempo of hormone change might be an important intermediate factor in 
the marked behavioural and psychological changes of adolescence, but presents 
challenges in its study. Previous studies that have considered how the individual 
variability in puberty hormone change might influence the dramatic psycho-bio-
behavioural changes in adolescence relied upon older methods of often direct 
(unextracted) sex steroid immunoassays. This is a less accurate technology especially 
at low circulating steroid levels concentrations (3-5), and is now being supplanted by 
more sensitive and specific liquid chromatography-tandem mass spectrometry (LC-
MS/MS)-based steroid assays (3). Similar more sensitive LC-MS/MS -based 
methods have been recently described for serum sex steroids in pre-pubertal children 
(6). 
In clinical settings the usual methods to appraise pubertal development and, by 
implication, its variability, comprise hormone measurements and anthropometry, 
with emphasis on timing of the height growth spurt, clinical inspection and rating of 
secondary sexual characteristics and bone age (7, 8). In epidemiological studies and 
community studies the definition of puberty has to be simplified to be based on 
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adolescent self-report or parental report against either Tanner stage line drawings (9, 
10) or Petersen’s Pubertal Development Scale (1). Self-rated Tanner staging is less 
intrusive and often the only Ethics Board approved method to assess puberty as 
defined by secondary sexual characteristics for epidemiological and community 
studies involving adolescents who remain legally minors. This has to sacrifice some 
reliability, especially in early puberty, and with the limited number of developmental 
stages available to select (11-14). Recent work has demonstrated self-rating is of 
insufficient accuracy to be of use in the clinical setting, however may be acceptable 
in research settings where clinician assessment is not possible (15). Menarche (a late 
pubertal event), spermarche (16, 17) which is difficult to evaluate (18),  and voice 
breakage have all  been described in relation to age and/or Tanner stage (19, 20). 
However, as singular time points these provide minimal information on either timing 
of onset or tempo of puberty. To date in the literature there have been no reports 
describing individual puberty hormone change with a sufficient measurement 
frequency to adequately capture individual variation.  Unless this is achieved, it is 
not possible to determine the true effects of puberty hormones on adolescent mood, 
wellbeing and behaviour. 
This study aims to examine the feasibility of frequent three-monthly urine collection 
in a large Australian adolescent cohort, as well as the utility of LC-MS/MS assays 
urine and serum sex hormones. Additionally, we will describe changes in E2, T (using 
these LC-MS/MS) assays and luteinizing hormone (LH) over 12 months in 
adolescents to compare results for urine and serum hormones. Finally, we aim to 
examine the association between the changes in anthropometry and self-reported 
Tanner stage with changes in hormones in both urine and serum.  
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6.3. Materials and Methods 
6.3.1. Setting and Participants 
The study was set in two regional towns in the state of New South Wales (NSW), 
Australia. Adolescents between the ages of 10 and 12 years were recruited from local 
schools. Fasting morning blood samples were collected at 0 and 12 months for the 
measurement of E2, T and LH and first morning (fasting) urine collected three-
monthly for the same measures. No participants had an endocrine disorder or were 
on any type of gonadal steroid hormone therapy. 
6.3.2. Anthropometry and pubertal staging  
Height was measured using a portable stadiometer (to 0.1 cm). Weight was measured 
in light clothing using a Tanita TBF-300 Pro Body Composition Analyzer (21). Body 
mass index (BMI) was calculated using these measures. The adolescents provided a 
self-rating of puberty using line drawings based on the Tanner stages (9, 10). 
Females provided self-rating of breast stage and males provided self-rating of 
genitalia stage. Self-report of Tanner stage (11-14) was the only feasible and 
ethically acceptable measure of pubertal staging available to the investigators. This 
situation is now a common limitation, as both Institutional Review Boards and 
parents are reluctant to permit direct physical examination of undressed healthy 
children for a research study of normal puberty.  
6.3.3. Hormone measurements  
Following a 12-hour fast urine was collected at home before blood samples were 
collected between 7:00 am and 8:30 am in order to minimise the effects of diurnal 
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hormone variation (1, 22). The urine sample was collected as a first morning void 
into a lidded container and immediately placed into an insulated carry bag on an ice 
brick. This was refrigerated in a freezer at -20 C within 3 hours. Blood and urine 
samples were then transported on dry ice to the research laboratory where these were 
kept at -80 C until analysed – approximately 12 months later. Post-menarcheal girls 
provided urine and blood specimens in the mid-follicular phase (Day 7-10) of their 
menstrual cycle in order to standardise collection time. Urine and serum steroids 
were measured by liquid chromatography, tandem mass spectrometry (LC-MS/MS) 
as modified from a previously described method for serum (23) and adapted for urine 
specimens following enzymatic deconjugation. The conjugated steroid underwent 
hydrolysis using β-glucuronidase enzyme from Escherichia coli K12 (Roche 
Diagnostic, Mannheim, Germany) that deconjugates the glucuronides moiety from 
steroids. The developed LC-MS/MS method measures unconjugated steroids (i.e. 
originally unconjugated plus deconjugated).  The details of the novel urine assays 
have been published (24). Briefly, urine and serum specimens were separated by 
liquid chromatrography using a Shimadzu Nexera UHPLC system (Shmadzu 
Scientific Instruments, Columbia, MD). Following this, tandem-mass spectrometry 
analysis was performed on samples using an API-5000 triple-quadrupole mass 
spectrometer (Applied Biosystem/MDS SCIEX, Ontario, Canada) (24). A thorough 
validation was carried out for the LC-MS/MS method to measure E2 and T according 
to standard FDA/EMEA analytical validity criteria.  
The calibration curves of the urinary steroid LC-MS/MS method ranged from 0.025 
and 32 ng/mL for T and 0.05 and 32 ng/mL for E2, and fitted quadratic functions 
with r of 0.999 or better. Within-day and between-day accuracies and precision at all 
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levels of quality control ranged from 95-105% and 2.6-9.7%, respectively. Using a 
500 µL urine sample the limits of detection (LOD) and limits of quantitation (LOQ), 
respectively, were 5 pg/mL and 25 pg/mL for T and 25 pg/mL and 50 pg/mL for E2. 
Matrix effects were negligible with no significant ion suppression or enhancement 
for either analyte with recovery values between 102-108%. Extraction recovery and 
process efficiency were between 93-103% for both the analytes at all levels of QC. 
The β-glucuronidase enzyme hydrolysis (deconjugation) efficiency was 100-102% 
after an overnight incubation at room temperature.  
Specificity of both the analytes was tested against structurally related compounds 
that potentially may interfere with the method, including oestrone, epitestosterone, 
androsterone, etiocholanolone, epietiocholanolone, 3-α androstanediol, 3-β 
androstanediol, and dehydroepiandrosterone. All the steroids listed did not interfere 
with the studied analytes. Blood and urine samples with values less than the lower 
limit of quantitation (LLOQ) for E2 and T were taken as half the LLOQ. Total of 27 
urine (E2: 16, T: 11) and 2 serum (T) samples were below the LLOQ. Serum and 
urine LH were measured by Immulite 1000 LH (Siemens) which detects intact LH 
and LHβ subunit and provided reproducible measurements in frozen stored 
urine(25). The within-assay coefficients of variation were <10%. Serum and urine 
LH values below the detection limit (0.1 IU/L) were set at zero (10 serum and 5 
urine samples). Urine FSH assays (Immulite, Delfia) did not pass validity tests 
(dilutional linearity, quantitative spike recovery) and were therefore not used in this 
study. All urine hormone concentrations were adjusted for urine specific gravity 
(SG) measured by reagent strip (ChoiceLine 10, Roche Diagnostics) to a standard 
SG of 1.020.  
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6.3.4. Statistical analyses  
Anthropometric measurements and hormones levels (blood and urine) were 
summarised by gender over time using means and standard deviations for continuous 
variables and frequencies and proportions for categorical variables. Linear mixed 
effects models were used to assess longitudinal changes in hormones, with gender 
and collection time as covariates. A random effect for child was included in these 
models. Interaction between gender and collection time was tested for each hormone. 
Linear regression was used to analyse the association between changes in 
anthropometry (height, weight, BMI) and self-rated Tanner stage and changes in 
urine and serum hormones. For these, the models were adjusted for the baseline 
anthropometric measurement and baseline hormone concentration. All p-values were 
calculated using Wald tests. Statistical analyses were conducted using Stata 12.1 
(StataCorp, Texas, USA). Statistical significance was set at 0.05.  
6.3.5. Ethical considerations  
The study has ethical approval from the Human Research Ethics Committee, 
University of Sydney (HREC 13094) within the National Health and Medical 
Research Council Guidelines for Human Experimentation, which is consistent with 
the Declaration of Helsinki. All participants assented, and a parent provided written 
informed consent prior to commencing the study.  
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6.4. Results 
6.4.1. Cohort Characteristics 
One hundred and four participants were recruited. The mean ages (SD) for the study 
participants at baseline were 12.5 (0.93) years for males and 11.8 (0.98) years for 
females. At follow-up, the ages were 13.5 (0.94) years for males and 12.9 (0.97) 
years for females. Anthropometric characteristics for this cohort are shown in Table 
6.1. For the females, 22 (39%) had menarche prior to the study and one additional 
girl experienced menarche during the follow-up year. Post-menarcheal girls were 
significantly older than their pre-menarcheal counterparts (12.9 years vs. 11.9 years, 
p<0.001). A high proportion of scheduled samples were collected for urine (484, 
92%) and serum (194, 93%). There was a low loss to follow-up (7, 6.7%). For those 
not lost to follow-up, 16 females and 12 males did not provide at least one urine 
specimen. There was no difference in age between those who provided a specimen 
and those who did not (mean difference 0.35 years; 95% CI -0.21-0.92; p=0.23), nor 
was there a difference in self-rated Tanner stage (p=0.53).  
Mean anthropometric measurements (Table 6.1) increased significantly over 12 
months whereas age- and gender-standardized z-scores did not change over the 12 
months follow-up. Pre-menarcheal girls significantly increased their age-
standardized weight (p<0.001) and height z-scores (p = 0.002), whereas these z-
scores did not change for post-menarcheal girls. Rate of change in anthropometric 
measurements were similar between genders (interaction p>0.05).  
Self-rated Tanner staging increased with fewer in stage 1 and more in stage 5 at 12-
month follow-up (Table 6.2). During the year, 14 participants (13.5%) progressed 
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two Tanner stages, 43 (41.3%) progressed one stage and 41 (39.4%) did not change 
in their self-rated Tanner stage. Six (5.8%) participants (three boys) provided a lower 
self-rated Tanner stage at follow-up than baseline. One participant (1%, 1 boy) did 
not provide baseline Tanner staging and seven (6.7%, 1 boy, 6 girls) did not provide 
follow-up Tanner staging. 
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Table 6.1. Baseline and 12-month follow-up anthropometry measurements. 
 Baseline 12 Months p-value 
Mean (SD) Male 
(n=47) 
Female 
(n=57) 
Male 
(n=47) 
Female 
(n=57) 
Gender* Time* Gender x 
Time 
Height (cm) 156.8 
(9.9) 
150.8 
(8.5) 
163.8 
(10.1) 
157.1 
(7.9) 
<0.001 <0.001 0.18 
Weight (kg) 49.3 
(12.0) 
44.1 
(10.9) 
55.2 
(13.2) 
50.1 
(11.4) 
0.026 <0.001 0.98 
BMI (kg/m2) 19.7 
(3.5) 
19.3 
(3.7) 
20.4 
(3.8) 
20.3 
(4.0) 
0.56 <0.001 0.16 
Self-rated 
Tanner stage 
3 (1.2) 2 (1.1) 4 (1.0) 3 (1.1) 0.001 <0.001 0.72 
* these p-values were calculated with both gender and time in the model, but with no 
interaction term 
 
Table 6.2. Self-Rated Tanner staging at baseline and 12-month follow-up. 
N Baseline 12 Months 
Tanner Male (%) 
Female 
(%) 
Male 
(%) 
Female 
(%) 
1 6 (13) 14 (25) 0 (0) 3 (6) 
2 8 (17) 17 (30) 7 (16) 13 (25) 
3 9 (20) 16 (28) 6 (13) 15 (29) 
4 18 (39) 7 (12) 18 (40) 12 (24) 
5 5 (11) 3 (5) 14 (31) 8 (16) 
Total 46 57 45 51 
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6.4.2. Hormone measurements 
6.4.2.1. Urine hormone levels versus time 
For the 484 urine collections, 14 (3%) E2, nine (2%) T and five (1%) LH assays were 
below the LLOQ. For LH, these participants were younger than the rest of the cohort 
(mean difference 1.35 years; 95% CI 0.41-2.30; p=0.005), but there was no age 
difference between those with urine E2 or T samples below or above the limits of 
detection. In five such cases (one urine E2, one urine E2 and T, one urine T, one urine 
and serum and one urine LH) the participant provided a Tanner stage 1 at baseline. 
Figure 6.1 shows within-person changes from baseline over the 12-month collection 
period and Table 6.3 shows the mean three monthly values for urinary E2, T and LH 
over 12 months. There is a significant increase and clear upward pattern for all 
subjects in mean urine T and E2 plotted over time from baseline to follow-up in E2, T 
and LH. The same pattern is seen in females when stratified by menarcheal status 
(data not shown).  Urine hormone levels were not strictly progressive and in some 
instances decreased over time, though there was an overall increase in mean levels 
for all three hormones for males and females. For example, there was a 22.2% 
decrease in mean male and a 40.0% decrease in mean female E2 between six and 
nine months, a 14.6% decrease in male T between baseline and three months, a 
24.6% decrease for male and 16.7% decrease for female T between six and nine 
months. For LH, there was a decrease for males between baseline and three months 
of 3.4% and between six and nine months a 14.3% decrease and a 23.3% decrease 
for males and females, respectively. At all other times there was an increase in urine 
hormones.  For serum hormones, a decline from baseline to follow-up was observed 
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22 adolescents (11 female) for E2, 19 (13 female) for T and in 26 adolescents (18 
female) for LH. Overall declines were observed in 23 (9 female) for urinary E2, 24 
(14 female) for urinary T and in 48 adolescents (30 female) for urinary LH.  
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Figure 6.1. Plots of mean and SD of urinary E2, T and LH concentrations derived 
from 3-, 6-, 9- and 12-months collection changes from baseline (0) for urine (top) 
and serum (bottom)
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6.4.2.2. Urine versus Serum 
Urinary E2, T and LH all correlated with their serum hormone measurements 
(p<0.001 for all; see Table 6.4), and increased in each Tanner stage.  
6.4.2.3. Serum hormone levels versus time 
Mean serum hormone levels at baseline and one year follow-up are shown in Table 
6.5. Of the 194 serum collections, two (1%) T and nine (5%) LH assays (all in 
separate individuals) were below the LLOQ. No E2 samples were below LLOQ. 
Those with LH samples below the limits of detection were significantly younger than 
their peers (mean difference = 1.47 years 95% CI 0.81-2.14 p<0.001). No difference 
in age was observed for those with serum E2 or T samples below limits of detection.  
Hormone values all significantly increased over the 12-month period and were 
significantly different between genders, but rate of change was not statistically 
significant between genders (interaction p>0.05), except for T. 
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Table 6.4. Pearson’s Correlation Coefficients for Serum and Urinary Hormones 
using 0- and 12-month data. 
 Urine  
Baseline 
Serum E2 0.7089 
Serum T –0.7864 
Serum LH –0.5513 
Follow-Up 
Serum E2 0.7245 
Serum T 0.7918 
Serum LH –0.4206 
Pooled 
Serum E2 0.7187 
Serum T 0.7746 
Serum LH –0.4735 
p<0.001 for all 
 
Table 6.5. Baseline and 12-month follow-up serum E2, T and LH. 
Mean (SD) Baseline 12 months p-value  
 Male  
(n=47) 
Female 
(n=57) 
Male 
(n=47) 
Female 
(n=57) 
Gender* Time* Gender 
x Time  
E2 (pg/mL) 19.1 (8.5) 43.4 (29) 24.9 (9) 54.7 (30) <0.001 <0.001 0.17 
T (ng/mL) 2.4 (2.3) 0.16 (0.10) 3.4 (2.55) 0.2 (0.12) <0.001 <0.001 0.03 
LH (IU/L) 1.7 (1.3) 2.3 (2.4) 2.5 (1.8) 3.6 (2.7) 0.23 0.001 0.82 
* these p-values were calculated with both gender and time in the model, but with no 
interaction term 
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6.4.3. Association between Anthropometry Measurements and Urine and Serum 
Hormones  
Urinary E2, T and LH all positively correlated with Tanner staging at baseline and 
12-month follow-up (p<0.001 for all). Table 6.6 shows the associations between 
anthropometry changes and changes in sex hormones. Change in height was 
associated with changes in serum T, and serum and urine LH in females and both 
serum and urine T in males. Change in weight was associated with changes in urine 
E2, serum T and serum LH in females. Serum T and LH was associated with self-
rated Tanner stage in males, but this was not statistically significant based on the 
urine samples. No other significant associations were observed between serum or 
urinary hormones and changes in anthropometry over 12 months. 
Figure 6.2 shows urine and serum E2, T and LH stratified by Tanner stages. Data 
stratified by chronological age were similar. Hormone concentrations increased 
through each Tanner stage and each year of age.  
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Table 6.6. Regression results for serum (left) and urine (right) hormones and 
anthropometric markers of puberty. 
Serum R2 β  p-
value 
Urine R2 β p-
value 
Change in Height 
Female 
E2 0.15 -0.001 0.94 E2 0.25 0.26 0.24 
T 0.22 10.19 0.035 T 0.22 0.13 0.24 
LH 0.32 0.52 0.001 LH 0.24 0.09 0.045 
Male 
E2 0.15 0.09 0.12 E2 0.16 0.61 0.22 
T 0.34 0.89 <0.001 T 0.15 0.04 0.019 
LH 0.02 -0.16 0.68 LH 0.08 0.04 0.44 
Change in Weight 
Female 
E2 0.03 -0.01 0.66 E2 0.15 0.55 0.034 
T 0.08 11.81 0.031 T 0.12 0.21 0.10 
LH 0.26 0.45 0.013 LH 0.07 0.08 0.14 
Male 
E2 0.03 0.07 0.58 E2 0.06 1.56 0.16 
T 0.04 0.21 0.69 T 0.06 0.05 0.13 
LH 0.01 -0.10 0.90 LH 0.003 -0.01 0.88 
Change in BMI 
Female 
E2 0.04 0.001 0.92 E2 0.07 0.12 0.20 
T 0.07 2.18 0.27 T 0.08 0.03 0.48 
LH 0.16 0.03 0.63 LH 0.03 0.01 0.69 
Male 
E2 0.04 -0.02 0.41 E2 0.02 0.05 0.82 
T 0.46 -0.01 0.96 T 0.01 0.003 0.63 
LH 0.02 -0.10 0.58 LH 0.22 0.02 0.11 
Change in Self-Rated Tanner Stage 
Female 
E2 0.19 0.005 0.40 E2 0.23 0.10 0.11 
T 0.23 2.18 0.15 T 0.19 0.03 0.31 
LH 0.26 0.10 0.06 LH 0.20 0.02 0.36 
Male 
E2 0.39 0.04 0.042 E2 0.31 0.20 0.22 
T 0.46 0.18 0.008 T 0.35 0.01 0.13 
LH 0.29 -0.06 0.62 LH 0.36 0.02 0.21 
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Figure 6.2. Plots of mean and SD E2 (left), T (centre) and LH (right) in urine (top) 
and serum (bottom) specimens, by Tanner stage. 
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6.5. Discussion 
There are two major findings of this study. First is the demonstration that it is 
feasible to collect urine samples from a community-based adolescent cohort at three-
monthly intervals, with high compliance (93% serum and 92% urine collections 
completed) and low follow-up attrition rate. Second is the finding that urine levels 
both correlate with serum testosterone and oestradiol and have the potential to 
provide a more subtle and nuanced description of individual puberty hormone 
progression. 
In order to demonstrate the specific effects of puberty hormones on any biological 
aspect of adolescent development and health, a methodology that allows more 
frequent biological sampling than has ever been previously reported for community-
based field studies is essential. A single reading of testosterone or oestradiol in 
whatever biological sample is of limited use. It is change that is relevant and hence 
the importance of longitudinal samples with frequent sampling. Urine samples have 
the advantage over blood samples that these are more acceptable to both research 
ethics and adolescents. Each overnight sample also provides a more time-integrated 
hormone measure. This is particularly true in early puberty when pubertal hormones 
commence pulsatile secretion nocturnally (1), so that a morning overnight urine 
sample may be more informative than a serum sample at any single time point. Urine 
collections also allow for more frequent collection than repeated venepuncture would 
be tolerated (26). Salivary samples are potentially easier to collect, but blood 
contamination and influence of flow-rate on measurements seriously limits validity 
and accuracy and these may be subject to non-compliance by children (27). 
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Urine steroid measurements have been dramatically improved upon by introduction 
of new LC-MS/MS technology.  Urine steroid LC-MS/MS measurements have been 
used exclusively as the basis of for anti-doping tests worldwide for the last few 
decades (3) and were required to have high level specificity. As a result this led to 
the recognition of the lower specificity of steroid immunoassays and resulted in 
major changes to clinical endocrinology research (3). Steroid mass spectrometry 
ensures the accuracy and specificity necessary for the measurement of low levels of 
E2 and T and the detection of subtle changes in these gonadal steroids over time. 
Anthropometric and serum hormone changes in our study revealed the anticipated 
increases over the course of one year in a cohort of young adolescents. The urine 
data also revealed anticipated hormone increases over the 12-months of observation. 
However, mean and individual urinary hormone changes were not strictly 
progressive, suggesting within-subject variability in early and mid-pubertal hormone 
levels, which may contain novel and hitherto unexploited information on 
determinants of biological aspects of pubertal progression. As these urine data are 
novel we are unable to compare with any previously published data, notably the 
degree of individual variability. Mouritsen and colleagues have shown that serum 
testosterone is variable in a longitudinal study of 20 adolescents (10 male) with 
sample collection biannually for five years (28). Individual hormone curves showed 
testosterone levels fluctuated during the study, though the overall pattern 
demonstrated an increase in serum hormones testosterone (as assayed by LC-MS/MS 
and immunoassay) from recruitment to the end of follow-up. Biro’s work in 252 
females followed every six months for six years similarly demonstrated 
androstenedione, oestrone, E2 and T by LC-MS, with changes which increased over 
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the transition from pre-puberty to six months after reaching Tanner stage 2 (29); 
however, neither provide inter-individual variability or mean inter-individual 
hormone levels. Both previous studies measured only serum steroids in a single 
gender. We also identify the need for studies of longer duration in order to comment 
on what implications this variability (or what could be interpreted as instability) of 
hormone change may have on more distal responses to gonadal hormone change 
patterns in puberty be these physical, neurobehavioural or mood. This finding also 
suggests that three monthly urine collections over an extended period have the 
capacity to provide new insights into the biology of puberty.  
We have shown considerable overlap between hormone levels at each age and self-
reported Tanner stage, which emphasises the need for better descriptors of individual 
puberty hormone changes. Such overlap is consistent with other data using LC-
MS/MS and clinician rating (30-32) and indicate the complexity and dynamic nature 
of puberty. Both Tanner stage and anthropometric change lag behind hormonal 
change. Using the former as surrogates for puberty hormone change will less 
accurately describe the relationship between hormone changes and the resultant 
physical changes, as well as any other adolescent health or developmental change of 
interest, such as mood or behaviour. More broadly still, this study has potential 
importance to the understanding of normal puberty because there is a paucity of 
frequently sampled longitudinal studies of the hormonal changes during puberty. 
This situation leads to over-interpretation of how adolescent mood, behaviour and 
wellbeing relate to puberty hormones, going well beyond available data (33, 34). Our 
study methodology with frequent sampling of an easily accessible biological fluid is 
likely provide new insights into the dynamics of pubertal hormonal changes, 
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especially in the tempo and stability of puberty change. These data in turn may allow 
an understanding of how puberty hormone change relates to the behavioural aspects 
of adolescence.  
Previous work has questioned the validity of self-rated Tanner staging (1, 11-14). In 
this study a high proportion of adolescents completed self-assessment with findings 
of stable or an advance in Tanner stage at 12 months follow-up in all but 6% of 
adolescents (who went backwards in a Stage) Self-rated Tanner staging also 
corresponded well with conventional anthropometric measures of puberty change.  
In conclusion, our work has established a feasible method for intensive urine 
sampling of community-dwelling adolescents and used a robust methodology of 
urine sex steroid hormone measurement, using liquid chromatography-tandem mass 
spectrometry measurements for urine sex steroids (3), which display the high 
sensitivity and specificity to detect lower levels of sex hormones, a particular 
challenge in the study of pubertal progression (6, 35). Based on previously recorded 
longitudinal growth data (36, 37), it is anticipated that frequently measured urine 
samples over the two to three year window of normal puberty might well provide a 
firmer biological basis for clinically observed patterns of puberty, such as rapid, slow 
or variable tempo, which may over the longer term support some of the observed 
differences in adolescent mood and behaviour.  
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7.1. Abstract 
Introduction: In large community-based studies of puberty, Tanner staging by a 
clinician is often not possible. We compared self-rated Tanner staging and other 
subjective ratings of pubertal development with serum hormone levels measured by 
liquid chromatography-tandem mass spectrometry (LC-MS/MS) to reassess the 
utility of self-rated pubertal stage using highly sensitive and specific hormone 
analysis.  
Methods: Adolescents and their parents enrolled in the Adolescent Rural Cohort study 
of Hormones and Health, Education, Environments and Relationships (ARCHER) 
answered annual survey questions on pubertal development. Annually, adolescents 
provided blood samples for serum testosterone and oestradiol measured by LC-
MS/MS.  
Results: Longitudinally, self-rated Tanner stage was positively associated with serum 
testosterone and oestradiol levels in both sexes. Confirmation by adolescent and 
parent that puberty had commenced was associated with higher gonadal hormone 
levels in both sexes. Parent and adolescent responses demonstrated ‘fair’ to 
‘moderate’ agreement.  
Conclusions: Over a three-year follow-up, self-rated Tanner staging and simple 
questions regarding pubertal onset and development are positively associated with 
adolescent gonadal hormone concentrations in serum measured by mass 
spectrometry. Thus, self-report of puberty stage still has a role in large community-
based studies where physical examination is not feasible.  
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7.2. Introduction 
Identifying the onset and progression of puberty is a significant developmental 
milestone of interest to clinicians, adolescents and parents. This also has important 
public health significance given the known associations between pubertal timing and 
long-term health outcomes (1, 2). Multiple markers of puberty onset and progress 
have been used, such as Tanner stage, peak height velocity and circulating sex 
steroid levels (3). Tanner staging or similar physical change assessment by the 
Pubertal Development Scale (PDS) are the most widely used pubertal assessment 
methods (4, 5) and describe a continuum of change. These represent an assessment 
of secondary sex characteristic changes induced primarily by gonadal steroids. While 
direct physical examination remains the gold standard for Tanner staging, it is 
applicable to patients but not feasible in large community-based research of healthy 
children due to ethical and privacy concerns (4).  Self-examination and/or 
comparison to images of Tanner stages offer a substitute method by which pubertal 
staging can be determined, removing the discomfort or concerns with physical 
examination clinical research involving healthy children.  
The validity of self-rated Tanner staging for research is debated (4). It appears to 
differentiate children prior to and during puberty as assessed by adolescents or their 
parents (6-10) but findings using this method vary. As examples, in one longitudinal 
study (8), maternal and adolescent rating of development was slightly less sensitive 
and specific compared to clinician rating. In another cross-sectional cohort, self-
assessment was inferior to clinician assessment, but still correlated with a composite 
hormone rating score derived from puberty hormone levels measured with 
radioimmunoassay (9). Two recent cross-sectional community-based studies from 
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one group have recently used clinician-based Tanner staging to deduce pubertal 
reference ranges for serum testosterone and oestradiol measured by liquid 
chromatography-tandem mass spectrometry (LC-MS/MS) (11, 12). The present 
study is the first to assess longitudinally self-rated Tanner stage and other pubertal 
rating by adolescents and parents against mass spectrometry-measured circulating 
puberty hormones.   
7.3. Methods 
Subjects were enrolled in the Adolescent Rural Cohort study of Hormones and 
health, Education, environments and Relationships (ARCHER), a three-year 
longitudinal study of adolescents living in regional New South Wales, Australia 
investigating the effects of puberty hormone changes on mood, well-being and 
behaviour (13). Adolescents provided self-rated Tanner staging by comparison to 
line drawings each year. Females matched breast and pubic hair, whereas males 
matched genitalia and pubic hair. At each assessment visit over three years (four in 
total) adolescents (and parent or guardians) nominated whether they thought their 
puberty had started and indicated whether they felt their pubertal progress was 
behind, equal to, or more advanced than their age- and sex-matched peers. Female 
adolescents were asked if and when they had reached menarche at each time point 
(13). Surveys were piloted before use in the study.  
Adolescents provided fasting, first-morning blood samples annually (around the time 
of questionnaire completion). Collection times were standardised only for the 
follicular phase of the menstrual cycle in post-menarcheal females. Serum 
testosterone and oestradiol were measured by LC-MS/MS (13), which is sensitive 
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and specific for low circulating sex steroids in early puberty (14). Adolescents were 
classified as pre-pubertal if serum testosterone was < 0.5 nmol/L (males) or serum 
oestradiol < 40 pmol/L (females).  
Means of pooled continuous data were compared by t-test or analysis of variance as 
appropriate. Where serum hormone levels were the outcome, the relationship with 
survey answers (Tanner stage, relative pubertal development compared to peers) was 
modelled using mixed-models linear regression with random intercepts for each 
individual. Where dichotomous outcomes were assessed (pubertal commencement), 
mixed-models logistic regression was used with random intercepts for each 
adolescent. For analysis of differing degrees of pubertal development, Tanner stage 
was dichotomised three ways: pre-pubertal (stage 1) vs early pubertal (stages 2-3); 
pre-pubertal (stage 1) vs late pubertal (stages 4-5) and pre-pubertal (stage 1) vs 
pubertal (stages 2-5). Hormone levels were logarithmically transformed due to 
skewed data so regression results are presented as odds ratios when back-
transformed. Odds ratios were relative to Tanner stage 1 (i.e. pre-puberty) or a rating 
of ‘same’ compared to ‘behind’ or ‘ahead’ for relative development questions.  
Cross-tabulations between survey questions and dichotomised Tanner stage 
outcomes or pubertal commencement (based upon serum hormones) were assessed 
using chi-squared (χ2) tests. Cochran’s Q test was used to assess if Tanner stage 
increased with time. Cohen’s weighted kappa (κ) was used to assess agreement 
between adolescent and parent questionnaire results and between these questionnaire 
results and dichotomised Tanner staging as well as pre-puberty vs puberty based on 
serum hormones. Interpretation of κ scores was based on Landis’ criteria: ‘poor’ (κ 
<0.20), ‘fair’ (κ 0.21-0.40), ‘moderate’ (κ 0.41-0.60), ‘substantial’ (κ 0.61-0.80), 
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‘almost perfect’ (κ 0.81-1.00) (15). Sensitivity and specificity of the questionnaire 
results was calculated using the pre-pubertal definition above as reference standard. 
Statistical analyses were conducted using Stata 12.1 (StataCorp, College Station, 
Texas, USA) with significance set at p<0.05. 
The ARCHER study had ethics approval from the Human Research Ethics 
Committee, University of Sydney (HREC 13094) consistent with the Declaration of 
Helsinki. Participants provided full informed written assent and their parents 
provided full written informed consent prior to commencing the study.  
7.4. Results 
There were 329 adolescents (185 male) who provided an initial survey response and 
1193 survey responses were provided over the course of the study. Mean (standard 
deviation) age at baseline was 11.3 (1.0) years for males and 11.2 (1.0) years for 
females (p=0.43). Table 7.1 shows a progression through pubertal stages from 
baseline to three years follow-up. Most adolescents commenced puberty and self-
rated higher pubertal stages over the duration of the study (p<0.001 for males and 
females). Based on the hormone cut off for pubertal onset, 57.0% (n=94/165) of 
males and 86.7% (n=111/128) females had commenced puberty at baseline and 
95.9% of males and 92.8% of females had commenced puberty by three years’ 
follow up (p<0.001). Self-rated Tanner stage increased through the study (p<0.001 
for males and females) and most adolescents (84.9% males and 75.9% females) self-
rated as Tanner stages 4 or 5 at the end of the study, as shown in Figure 7.1 and 
Table 7.1.  
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Figure 7.1. Box plots of Tanner stages at each year by sex. Median (bold line) and 
dots indicate outliers. 
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There were fifty-three occasions where adolescents rated their Tanner stage as lower 
than the previous year (of the 869 ratings performed after baseline – 6.1%). Thirty-
one males and 21 females provided a lower rating on one occasion, and one male and 
one female provided lower ratings on two occasions. The most common decrease in 
stage was from stage 3 to stage 2 and stage 4 to stage 3 in females (eight instances 
each) and from stages 3 to 2 and 5 to 4 in males (eight instances each). One male 
rated himself stage 5 at baseline and stage 1 at one year follow up. There was no 
significant difference in age between adolescents who rated their Tanner stage as 
lower (mean (SD) 12.8 (1.4) years) compared to those who reported either no change 
or an increased stage (12.7 (1.5) years), p=0.77. When pooled across the study, no 
difference between mean testosterone or oestradiol levels was observed for 
adolescents with a lower subsequent rating at any point compared to those who 
reported no change or an increased stage, p=0.65 for males, p=0.36 for females. 
Mean hormone levels with each Tanner stage, separated by gender, are shown in 
Figure 7.2. Overall, serum testosterone and oestradiol levels were strongly related to 
self-rated Tanner stage for both males and females (p<0.001). Table 7.2 provides the 
odds ratios of hormone level increase for each Tanner stage, relative to Tanner stage 
1. 
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Figure 7.2. Mean serum testosterone (left) and oestradiol (right) with 95% 
confidence interval (bars) by self-rated Tanner staging in males and females.
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Table 7.2. Odds ratio (95% confidence intervals) of hormone increase based on self-
rated Tanner stage, relative to Tanner stage 1. For each Tanner stage, the odds ratio 
refers to the multiplicative factor increase in hormone levels relative to stage 1. 
 Males Females 
Self-rated Tanner Stage   
Testosterone 
1 - - 
2 2.31 (1.34-3.99)* 1.73 (1.40-2.15)* 
3 4.47 (2.57-7.78)* 2.46 (1.97-3.07)* 
4 22.53 (12.94-39.24)* 2.50 (1.99-3.14)* 
5 30.47 (17.90-51.85)* 2.31 (1.80-2.96)* 
   
Oestradiol 
1 - - 
2 1.13 (0.85-1.51) 1.72 (1.29-2.28)* 
3 1.56 (1.16-2.08)* 2.48 (1.86-3.31)* 
4 2.19 (1.63-2.93)* 2.67 (1.99-3.59)* 
5 2.29 (1.74-3.03)* 2.18 (1.58-2.99)* 
*p<0.05 (compared to Tanner stage 1) 
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As shown in Table 7.1, the percentage of adolescents who answered that they 
commenced puberty increased over time for adolescent (males p<0.001; females 
p<0.001) and parent (males p<0.001; females p<0.001) surveys. The majority of 
adolescents (64.1% of females, 70.9% of males for all surveys) and their parents 
(65.7% female, 71.7% male for all surveys) felt that pubertal development was the 
same as their age- and sex-matched peers. There was no significant change in the 
proportions of adolescent or parent ratings of relative pubertal development 
(behind/same/ahead) over the three years’ follow-up (p>0.05 for both). However, 
males were more likely to rate their development as ahead of their peers and females 
more likely to rate as behind (p<0.001). There were no significant differences in age 
between the relative rating groups (p=0.42 for males, p=0.79 for females). Self-rated 
Tanner stage was higher in adolescents who rated their development as greater than 
their peers’ (mean stage (SD) males: 4.1 (1.1); females 3.9 (1.1); p<0.001), and the 
converse was seen for adolescents who rated their development as behind (males: 2.9 
(1.1); females: 2.7 (1.2); p<0.001).  
Table 7.3 provides the relative (odds ratio) hormone levels for adolescents who rated 
themselves ‘behind’ or ‘ahead’ of peers, relative to those who rated themselves as 
having ‘same’ pubertal development.
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Table 7.3. Odds ratio (95% confidence interval) of hormone levels based on 
adolescents who rated their pubertal development as ‘behind’ or ‘ahead’ of their 
peers, relative to those who had ‘same’ pubertal development. 
 Males Females 
Relative pubertal rating   
Testosterone 
Behind 0.55 (0.31-0.96)* 0.79 (0.66-0.95)* 
Same - - 
Ahead 1.63 (1.04-2.56)* 0.98 (0.80-1.19) 
   
Oestradiol 
Behind 0.95 (0.73-1.24) 0.88 (0.70-1.10) 
Same - - 
Ahead 1.21 (1.00-1.47) 1.05 (0.82-1.34) 
*p<0.05 (compared to ‘same’ rating) 
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There were 1170 parental survey responses over three years’ follow up, with 1040 
(88.9%) completed by a female parent/guardian. Where a sex discrepancy existed 
(such as female parent/guardian rating male adolescent), parents/guardians were less 
likely to rate their child as having started puberty (77.5% for sex discrepancy 
compared to 82.4% for like-sex pairs; p=0.03). Similarly, they were more likely to 
rate their child’s relative development as ‘same’ or ‘ahead’ (88.0% compared to 
80.8% for like-sex pairs; p=0.02).  
The accuracy, sensitivity and specificity of the subjective markers of puberty onset 
and progress compared to the objective assessment (testosterone >0.5 nmol/L for 
males; oestradiol >40 pmol/L for females) are provided in Table 7.4. The ratings 
ranged between κ 0.13-0.66 (Table 7.4). All subjective markers demonstrated high 
sensitivity and poor specificity for objective puberty onset. Adolescents in early 
puberty (Tanner 2-3) showed ‘poor’ to ‘fair’ agreement (κ 0.10-0.29) with objective 
assessment of puberty onset, whereas adolescents in later puberty (Tanner 4-5) had 
‘moderate’ to ‘substantial’ (κ 0.15-0.66) agreement based upon κ scores. Separating 
females by menarcheal status showed post-menarcheal females’ answers had greater 
sensitivity and specificity for survey responses compared to hormone levels, with 
better percent agreement compared to pre-menarcheal females. Agreement was 
‘poor’ for survey answers whether females were post-menarcheal or not. 
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Table 7.4. Percent agreement, κ score, sensitivity and specificity of subjective 
markers (survey) of puberty compared with objective markers (hormone levels, 
males <0.5nmol/L and females < 40pmol/L). 
 Males Females (all) Females (pre-menarche) Females (post-menarche) 
Commencement of Puberty (adolescent reported) 
Agreement (%) 81.4 74.3 63.6 86.0 
κ 0.45* 0.13* 0.05 0.13 
Sensitivity (%) 90.3 78.2 89.6 95.1 
Specificity (%) 52.3 41.4 14.6 15.4 
Commencement of Puberty (parent/guardian reported) 
Agreement (%) 80.9 79.3 74.4 89.0 
κ 0.52* 0.19* 0.11 0.19* 
Sensitivity (%) 82.8 83.9 90.1 95.0 
Specificity (%) 74.7 41.4 19.2 22.2 
Self-rated Tanner Stage: Pre-Puberty vs Early Pubertya  
Agreement (%) 60.4 80.0 77.9 90.5 
κ 0.13* 0.26* 0.10 0.29* 
Sensitivity (%) 60.0 91.0 88.8 97.4 
Specificity (%) 63.0 32.3 20.0 25.0 
Self-rated Tanner Stage: Pre-Puberty vs Late Pubertyb  
Agreement (%) 93.1 80.4 64.9 89.6 
κ 0.66* 0.32* 0.18 0.15 
Sensitivity (%) 97.4 94.4 95.5 93.2 
Specificity (%) 63.0 32.3 20.0 25.0 
Self-rated Tanner Stage: Pre-Puberty vs Pubertyc  
Agreement (%) 79.1 85.7 81.2 90.9 
κ 0.22* 0.26* 0.11 0.14 
Sensitivity (%) 96.6 91.4 90.2 94.6 
Specificity (%) 19.8 35.7 20.0 25.0 
*p<0.05 
a Self-rated Tanner stage 1 vs 2-3 
b Self-rated Tanner stage 1 vs 4-5 
c Self-rated Tanner stage 1 vs 2-5 
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7.5. Discussion 
Our investigation has firstly shown that mean serum gonadal hormone levels, 
measured by LC-MS/MS, are strongly associated with increasing Tanner stage self-
ratings by adolescent males and females. Secondly, serum gonadal hormone levels 
verify that both adolescents and their parents can identify puberty onset and 
progression with reasonable accuracy. Given that earlier and later puberty onset are 
both associated with impaired wellbeing in later adolescence and beyond (1, 2), 
simple subjective questions such as those used in this study may be useful to identify 
puberty onset. Certainly, in the context of large longitudinal community-based 
research studies of healthy children or where puberty may not be the main focus, 
these findings are reassuring. While we did not include text with Tanner line 
drawings (6,7) because of varying age-related literacy, our cohort (aged between 9 
and 14 years at baseline) demonstrated similar levels of agreement between objective 
(gonadal hormones) and subjective pubertal assessments to those statistics seen in an 
older cross-sectional cohorts with over 75% Tanner stage 4 using clinician compared 
to self-rated Tanner stage (10). This finding differs from a report that younger 
children are less accurate in self-rating their development compared to older peers 
(7).  
Our longitudinal study investigated subjective measures of pubertal development and 
their associations with gonadal hormone levels measured by sensitive and specific 
LC-MS/MS, in order to further define the utility of self-rating tools in longitudinal 
adolescent health research. We have combined these data with additional information 
on pubertal progression, such as whether an adolescent or their parent felt they had 
started puberty and relative pubertal progress compared to age- and sex-matched 
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peers. Longitudinal regression showed a significant positive relationship between 
both serum hormones and self-rated Tanner stage in both males and females, 
consistent with findings reported by a cross-sectional reference-range study using 
LC-MS/MS and clinician-based Tanner staging (11, 12). While a positive 
relationship was seen between testosterone levels and male and female subjective 
ratings of pubertal commencement and progress relative to peers, a relationship was 
seen with oestradiol for males only. It is unclear why oestradiol did not have a 
significant relationship with relative pubertal progress in females.  
Females generally had poorer agreement and lower κ scores between survey answers 
and hormone measures than males. In later puberty (Tanner stage 4 or 5) the 
sensitivity and specificity were increased in both sexes, indicating more accurate 
identification at later puberty. Nevertheless, agreement, sensitivity and specificity 
were largely unchanged for self-rated Tanner staging in earlier puberty, the exception 
being for males in early puberty who displayed lesser agreement and sensitivity. 
Collection in the early follicular stage, where oestradiol levels are relatively low, 
may explain the poorer agreement observed in females compared to males. Other 
explanations could be the variability in ovarian follicular activity even prior to 
menarche and menarche may be perceived by adolescents or parents as the ‘true’ 
marker of pubertal onset, rather than the late event it is. The latter explanation is 
supported by our analysis by menarcheal status; post-menarcheal females had better 
agreement with subjective pubertal questions than pre-menarcheal. In contrast, 
testosterone potentiates more obvious physical changes which act as clearer 
indicators of puberty in males.  
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The increasing demand for physical privacy in adolescence is the likely reason for 
the overall lack of agreement between parent and adolescent responses. This rather 
obvious explanation does however highlight the importance of who is asked 
questions about puberty development and using youth-friendly protocols and 
questions to engage adolescents in such research (16). Given the low number of 
fathers performing the annual surveys, we are unable to comment on the reporting 
effect of same sex versus opposite sex parent. We were however able to provide data 
on how uncommonly adolescents rate their Tanner stage as lower with follow-up, 
which is useful to refute criticism about the reliability of self-report. A similar 
number of males and females self-rated their pubertal development as lower than the 
preceding year, though no differences in age or hormone levels were observed to 
explain the lower ratings, which would be anticipated given adolescents cannot go 
‘backwards’ in pubertal development. This may reflect better familiarity with the 
survey questions and Tanner stage diagrams though they were only surveyed 
annually, making such a memory effect less likely. It may also reflect a more mature 
understanding of their bodies.  
Our study also found no difference in age between adolescents who rated their 
development as behind or ahead of their peers, though males were more likely to 
answer that they were ahead and females were more likely to describe themselves as 
behind their peers in development. This suggests that this type of subjective question 
may not be useful in the current format, or that numbers are too low to detect 
extremes of development. The reason for the discrepancy between males and 
females’ developmental ratings is unclear, though may be related to body image. 
Further, assumptions that menarche as the ‘true’ marker of puberty in females may 
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make pre-menarcheal females more likely to rate their development as behind their 
peers. Alternatively, differences in breast size (but not development) may be 
interpretation by females as indicative of their pubertal status and thus alter their 
perceptions. This discrepancy may also explain why the known difference in timing 
of puberty between boys and girls is less apparent than expected in the self-rating 
results. 
Our study’s strengths include the large cohort of adolescents with variable progress 
through puberty, inclusion of parental perspectives about puberty, and the use of 
sensitive LC-MS/MS gonadal hormone assays to detect the low circulating hormone 
levels of early puberty, something of importance to our understanding of this life 
phase. The lack of any clinician-performed staging which was not appropriate in a 
community study, or indeed allowable by our Ethics Committee for non-clinical 
populations is a limitation. More females (86.7%) were pubertal at baseline (based 
on hormone values) than males (57.0%), which means recruitment did not 
adequately capture early puberty in many, which may also explain the differential 
results between males and females. Recruiting females at a younger age than males 
would have enabled us to better capture their pubertal onset, however, the ARCHER 
study’s overall focus was not the onset of puberty, but rather how puberty hormone 
changes influence adolescent health, mood and behaviour (13).  
7.6. Conclusions 
Longitudinal changes in self-rated Tanner stage are strongly associated with changes 
in circulating serum testosterone and oestradiol concentrations measured by LC-
MS/MS. Adolescents and their parents can reasonably assess whether puberty has 
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commenced by using Tanner stage or simple yes/no questions. Our study is the first 
longitudinal study of self-rated Tanner stage against mass spectrometry-based 
measurement of puberty hormones. While self-rating is probably poor on an 
individual level, its utility at a population level has value in longitudinal research 
studies where clinician assessment and/or gonadal hormone measures are either not 
feasible or required, and especially where repeated measures are required.  
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8.1. Abstract 
Foot growth is part of overall pubertal growth but its relation to other anthropometric 
and hormonal changes is unclear. Our objective was to determine how foot length 
changes relate to changes in other growth parameters (height and weight), Tanner 
stage and serum hormones. Adolescents (n=342) were recruited to a three-year 
longitudinal cohort study, underwent annual anthropometric assessments (height, 
weight, foot length) and provided self-rated Tanner staging. They also provided 
blood samples that were analysed using liquid chromatography-tandem mass 
spectrometry for serum testosterone and oestradiol and classified as pre-pubertal or 
pubertal based on circulating hormone levels. Average annual percent increase in 
foot length was greater for pre-pubertal adolescents compared to pubertal. Increased 
foot length was associated with increases in height, weight and Tanner stage and 
serum hormones in males and pre-menarcheal females but not post-menarcheal 
females. Foot length offers a novel, non-invasive, cost-effective and easily 
demonstrable marker of early pubertal changes. 
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8.2. Introduction 
It is important to know when the pubertal transition is occurring because of the 
profound biological changes puberty brings (1). There are also known associations 
between the pubertal timing and adolescent psychosocial factors in both early- and 
late-maturing girls and boys compared to their on-time counterparts. These include 
emotional and behavioural problems (1) as well as poorer health outcomes in 
adulthood such as hypertension, type two diabetes mellitus, depression and anxiety 
(1-3). 
Commonly used indicators of puberty all have limitations that restrict their 
interpretation. Tanner stage, the gold standard clinical assessment of pubertal 
development, requires undressing and trained clinicians (though self-rating can be 
used with reduced accuracy) (4, 5). Physical inspection may not be acceptable in 
non-clinical environments. The accuracy of developmental self-rating by adolescents 
may be slanted according to subjective factors such as body image and 
understanding. Peak height velocity requires serial calibrated measurements with 
sufficient frequency to determine a clear peak. Sex steroid measurement directly 
samples the hormonal milieu that drives the observed physical changes of puberty, 
but is limited due to acceptability of repeat biological sampling with adequate 
frequency (6) and the assay cost making this approach less useful for population-
based assessment of puberty. Thus, a marker that is simple and easily measured, 
cost-effective, correlates with established markers of puberty (especially sex 
steroids) and which additionally may indicate the early stages of puberty is likely to 
be of significant research and clinical utility. Foot growth may be such a marker. 
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Current cross-sectional evidence suggests that change in foot length is an early 
pubertal event, preceding peak height growth (7, 8) and that peak change in foot 
length is related to the transition from Tanner stage 1 (pre-puberty) to Tanner stage 2 
(9). Limited longitudinal data in girls suggest foot length change precedes peak 
height velocity (7). One retrospective study in women with large feet showed a 
negative correlation between age at menarche and final foot size (10). While none of 
these studies comprehensively examine the relationship of foot growth to other 
markers of growth and development in adolescence, the current literature suggests it 
could be a novel objective marker of early pubertal development. Importantly, there 
are no data on relationships with hormonal drivers of pubertal growth (7-9).   
The aim of this study is to describe how longitudinal changes in foot length relate to 
changes in height, weight, Tanner stage and serum sex steroid levels (testosterone 
(T) and oestradiol (E2) in order to determine the utility of foot length change as a 
suitable marker of pubertal stage. This might offer a practical, novel and cost-
effective marker of puberty, something of interest to adolescents, parents, researchers 
and clinicians alike.  
8.3. Methods 
The Adolescent Rural Cohort, Health, Hormones, Environment, Education and 
Relationships (ARCHER) study enrolled 342 healthy community-dwelling 
adolescents (153 females) and their parents (n=272; 239 mothers) living in Central 
Western New South Wales, Australia, specifically around the towns of Dubbo and 
Orange (11). The primary aim of the ARCHER study was to determine the 
attributable impact of puberty hormones on adolescent mood, behaviour and 
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wellbeing. Recruitment occurred through schools and the local media. Adolescents 
provided informed assent and their parents informed written consent. The ARCHER 
study has full ethics approval through the University of Sydney (HREC 13094) 
within the National Health and Medical Research Council Guidelines for Human 
Experimentation, which are consistent with the Declaration of Helsinki. 
Participants were followed for three years, with annual clinic visits where 
adolescents underwent anthropometric assessment by trained staff and provided a 
self-rating of puberty using line drawings based on the Tanner stages (12, 13). 
Adolescents were contacted annually to arrange clinic follow-up (11). Females 
provided self-rating of breast stage and males provided self-rating of genital stage. 
Females were also asked if they had undergone menarche and, if so, when. 
Adolescents provided annual blood samples. Foot length (to 0.1 cm) was measured 
using a Ritz stick foot measure (Footer, Wisconsin, USA), modified with a 
millimetre-graduated measuring tape. The foot measure was placed under the sole of 
the foot and length measured from the heel to the end of the distal phalanx of the 
hallux. The right foot was measured unless this was inaccessible, in which case the 
left foot was used (3 of 1316 measurements, in three separate adolescents). Height 
(to 0.1 cm) was measured using a portable stadiometer (Seca GmBH, Hamburg, 
Germany). Weight (to 0.1 kg) was measured in light clothing using a Tanita TBF-
300 Pro Body Composition Analyzer (Tanita, Tokyo, Japan).  
8.3.1. Hormone Assays 
Blood samples collected by venepuncture at a study collection site were frozen at -80 
°C until assay in a single batch. Early morning serum E2 (collected in follicular phase 
8. Foot Length Growth as a Novel Marker of Early Puberty
192
  
for post- menarcheal participants) and T were measured by liquid chromatography-
tandem mass spectrometry (LC-MS/MS) using previously described methods (6, 14). 
Briefly, organic solvent extracts of serum were separated by liquid chromatography 
using a Shimadzu Nexera UHPLC system (Shimadzu Scientific Instruments, 
Maryland, USA). Following this, tandem-mass spectrometry analysis was performed 
using an API-5000 triple-quadrupole mass spectrometer (Applied Biosystem/MDS 
SCIEX, Ontario, Canada) (6, 14). This method can quantify low levels of circulating 
E2 and T in 99% of serum specimens from adolescents (6).  
8.3.2. Statistical Analysis 
Anthropometric and hormone outcomes by sex were summarised over time using 
means and standard deviations (SD). A t-test was used to assess the differences in 
age at baseline between the sexes. Adolescents were classified as being ‘pre-
pubertal’ if their baseline serum T was less than 14 ng/dL (0.5 nmol/L) for males or 
serum E2 less than 10 pg/mL (40 pmol/L) for females based on cross-sectional data 
using LC-MS/MS and clinician-rated Tanner stage (15, 16). Levels above these cut-
offs were defined as ‘pubertal’. Differences in the mean annual percent change in 
foot length, height and weight over the study between pre-pubertal and pubertal 
males and females were analysed using t-tests. Similarly, differences in the mean 
percent change in foot length, height and weight over the study between pre- and 
post-menarcheal females, were analysed using t-tests. Mixed-model linear regression 
was used to assess the relationship between longitudinal changes in the exposure 
variable foot length with changes in outcome variables height, weight and Tanner 
stage, by sex. Mixed-model linear regression was also used to assess the relationship 
between changes in the outcome variables height, weight, foot length and Tanner 
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stage, respectively, with changes in the exposure variables serum hormone levels, by 
sex and menarche status in females. Random intercepts for each subject were used in 
all mixed models to account for the repeated measures per subject. Analyses were 
conducted using Stata 12.1 (StataCorp, Texas, USA) and statistical significance was 
set at 0.05.  
8.4. Results 
8.4.1. Cohort Characteristics 
There was no difference in age between sexes: mean age (SD) was 11.7 (1.0) years 
for females and 11.8 (1.0) years for males (p=0.27) at baseline. Table 8.1 describes 
the basic demographics and anthropometric characteristics for each year of the study. 
Serum specimens were provided by 293 adolescents at recruitment, with 17 of 128 
(13.3%) females and 71 of 165 (43.0%) males classified as pre-pubertal at baseline 
by their serum E2 and T levels, respectively.    
8.4.2. Anthropometry 
Foot length, height, weight, and self-rated Tanner stage, all increased over the study 
period (Table 8.1) as did the prevalence of menarche. There were significant 
differences in mean percent annual change in foot length, height, and weight between 
adolescents who were pre-pubertal at baseline and those who were already pubertal 
(Table 8.2).  
Mean annual percent change in foot length over the course of the study was 
significantly greater if the adolescent was pre-pubertal at baseline (females: 2.7% vs 
1.5% p<0.001; males: 4.2% vs 2.9%, p<0.001; see Figure 8.1). Overall percent foot 
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growth (from baseline to final follow-up) was greater if the adolescent was pre-
pubertal at baseline (females 8.4% vs 5.0% p<0.001; males 12.5% vs 8.8% p<0.001). 
Pre-menarcheal females had greater mean percent foot length, height and weight 
change than girls who were post-menarcheal at baseline (foot length: 1.8% vs 0.9% 
p<0.01; height: 3.3% vs 2.1% p<0.001; weight: 12.1% vs 8.7% p<0.001).  
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Figure 8.1. Mean annual % change in foot length over three years’ follow up, 
separated by baseline pubertal status. 
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The longitudinal changes in foot length were associated with statistically significant 
increases in height, weight and Tanner stage. On average, a one-centimetre increase 
in foot length was associated with a 6.7 (95% confidence interval (CI) 6.5-6.9) cm 
increase in height and 6.2 kg (95% CI 5.9-6.5) weight gain in males, and the 
respective changes for females were 5.8 cm (95% CI 5.3-6.2) height growth and 6.6 
kg (95% CI 5.9-7.4) weight gain (p<0.001 for all analyses). 
8.4.3. Hormone Measures 
Mean serum hormone levels increased for both males and females over the study 
period. Serum T increased from mean (SD) 121.0 (175.8) ng/dL (4.2 (6.1) nmol/L) at 
baseline to 279.5 (129.7) ng/dL (9.7 (4.5) nmol/L) at three years in males. Serum E2 
was mean (SD) 39 (28.8) pg/mL (144 (105.8) pmol/L) at baseline and 37 (21.3) 
pg/mL (134 (78.1) pmol/L) at three years for females. Positive longitudinal 
relationships were seen for changes in foot length and changes in serum T and E2 for 
males and females (except post-menarcheal females) (p<0.001 for all). Self-rated 
Tanner stage progression was also positively associated with changes in serum T and 
E2 for both sexes (p<0.001). These results are shown in Table 8.3. In pre-menarcheal 
females, serum T and E2 were significantly positively associated with increasing foot 
length and increasing self-rated Tanner stage.   
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 8.5. Discussion 
This study demonstrates a positive longitudinal relationship between foot length 
change and pubertal hormone change which provides a biological basis for prior 
findings of a temporal relationship between foot length change and other pubertal 
anthropometric changes such as height velocity or Tanner stage (7-9). In earlier 
studies on foot growth (7-10), peak height velocity (PHV), Tanner staging and 
menarche timing have all been used as surrogates for pubertal hormone changes. In 
this study we further characterised this relationship, first, by showing that the 
longitudinal relationships between foot length change and other anthropometric 
changes are more marked in the adolescents who were younger at baseline. 
Secondly, a significant longitudinal relationship exists between gonadal hormone 
changes and foot length changes.  
Mean percent change in foot length was greater in pre-pubertal than pubertal 
adolescents in this study indicating this variable may be a useful indicator of early 
pubertal stage. Additionally, foot growth was consistently associated with serum 
hormones in pre-menarcheal but not post-menarcheal females. Both these 
observations combined with anthropometry and Tanner stage data support the 
concept that an increase in foot length velocity is an indicator of early puberty with 
increases in foot growth indicating that puberty has started. These findings likely 
come as no surprise to parents, as increasing frequency of changes in shoe size 
necessitates the more frequent purchase of larger and more costly shoes – concrete 
indicators more easily determined or recalled than the breast change or the 
appearance of body hair. The latter two features are visually subtle and often hidden 
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by adolescent privacy concerns. Foot length changes are both memorable and open 
(8). 
In our cohort, both male and female foot growth was greater in pre-pubertal 
compared to pubertal adolescents. In comparison, height and weight demonstrated 
different sex-based patterns. From an evolutionary viewpoint, humans as exclusively 
bipedal mammals need a stable platform to support the somatic growth spurt of 
puberty; foot growth preceding height growth would naturally facilitate this.  
Assessing foot length in the clinical setting is a low-cost, non-invasive measure, and 
as shoe sizes are directly proportionate to foot length, asking about shoe size changes 
is a readily accessible and non-intrusive measure. Like all measures the advantages 
and limitations of foot measurement need to be recognised. Shoe sizes are linearly 
related to foot length – there is an 8.47 mm (one third of an inch) increase in length 
for each full US shoe size. This utility is reflected in shoe sales data which show 
increases in the time preceding age at peak height velocity, based on population data 
(8). The practical applications of our results would be that serial increase in foot 
length or asking parents or adolescents about increasing shoe sizes may indicate the 
earliest phases of the pubertal transition and could offer a useful screening question. 
Further, in adolescents for whom accurate height assessment is not possible or 
population-based non-clinical studies using recalled development, serial foot 
measurements may be a convenient surrogate for other anthropometric assessment. 
While the Brannock device has been used in other studies (7, 9), it is only accurate to 
the nearest half shoe size (i.e. 4.3 mm or one sixth of an inch) so did not offer 
sufficient precision for our investigation. We were interested in how foot length 
changed, as opposed to shoe size. However, shoe size offers a practical correlate for 
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parents and adolescents. The translational implication is that regardless of 
manufacturers’ producing differing lengths for the same advertised size, a history of 
increasing shoe purchase frequency due to growing feet would sufficiently 
demonstrate increasing foot length and therefore suggest early pubertal changes. 
Additionally, foot length may be a useful measure in children for whom height 
measurement is not possible.   
The strengths of this study are its longitudinal design with a large cohort given the 
intensity of follow-up and the use of liquid chromatography-tandem mass 
spectrometry which is capable of measuring low levels of circulating sex steroids in 
early puberty (6). The annual anthropometry is a limitation, as more frequent 
measures would have provided further detail about foot growth velocity. Recent 
work has shown that, using the Super-Imposition by Translation And Rotation 
(SITAR) model, annual anthropometric measurements (such as those performed in 
our study) of sufficient duration are precise enough to estimate peak growth velocity 
during puberty (17). However, with only three years of sampling we did not have the 
requisite data to confirm that peak height velocity was preceded by peak foot growth 
velocity as described in Ford et al (2009) (7). As expected, due to the earlier puberty 
in females, more girls were pubertal at baseline compared to males. Some of these 
girls may have experienced epiphyseal fusion by the end of the study, with cessation 
of all bone growth, which may explain the decline in growth velocities being more 
than for males. As blood collection was in the early follicular phase for females, we 
observed consistent oestradiol levels over the course of the study.   
In conclusion, we provide longitudinal evidence that the pubertal increase in foot 
length is related to growth (height and weight) as well as secondary sex characteristic 
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changes (self-rated Tanner stage) and serum sex steroids. Foot growth is greatest in 
adolescents with the lowest gonadal hormone levels and is therefore a practical 
marker of other early pubertal changes. 
8.6. References 
1. Day FR, Elks CE, Murray A, Ong KK, Perry JRB. Puberty timing associated with diabetes,
cardiovascular disease and also diverse health outcomes in men and women: the UK
Biobank study. Sci Rep. 2015;5:11208.
2. Mendle J, Turkheimer E, Emery RE. Detrimental psychological outcomes associated with
early pubertal timing in adolescent girls. Dev Rev. 2007;27(2):151-71.
3. Lakshman R, Forouhi NG, Sharp SJ, Luben R, Bingham SA, Khaw KT, et al. Early age at
menarche associated with cardiovascular disease and mortality. J Clin Endocrinol Metab.
2009;94(12):4953-60.
4. Chavarro JE, Watkins DJ, Afeiche MC, Zhang Z, Sanchez BN, Cantonwine D, et al.
Validity of self-assessed sexual maturation against physician assessments and hormone
levels. J Pediatr. 2017;186:172-8 e3.
5. Terry MB, Goldberg M, Schechter S, Houghton LC, White ML, O'Toole K, et al.
Comparison of clinical, maternal, and self pubertal assessments: implications for health
studies. Pediatrics. 2016;138(1).
6. Singh GK, Balzer BW, Kelly PJ, Paxton K, Hawke CI, Handelsman DJ, et al. Urinary sex
steroids and anthropometric markers of puberty - a novel approach to characterising within-
person changes of puberty hormones. PLoS ONE. 2015;10(11):e0143555.
7. Ford KR, Khoury JC, Biro FM. Early markers of pubertal onset: height and foot size. J
Adolesc Health. 2009;44(5):500-1.
8. Busscher I, Kingma I, Wapstra FH, Bulstra SK, Verkerke GJ, Veldhuizen AG. The value of
shoe size for prediction of the timing of the pubertal growth spurt. Scoliosis. 2011;6(1):1.
9. Mitra S, Samanta M, Sarkar M, Chatterjee S. Foot length as a marker of pubertal onset.
Indian Pediatr. 2011;48(7):549-51.
10. Knudtzon J, Johannessen TM. Foreningen storfoten. Skostørrelse, høyde og alder ved
menarke. [The "Large Foot" association. The size of the foot, height and age at menarche].
Tidsskr Nor Laegeforen. 1991;111(30):3638-9.
11. Steinbeck K, Hazell P, Cumming RG, Skinner SR, Ivers R, Booy R, et al. The study design
and methodology for the ARCHER study - adolescent rural cohort study of hormones,
health, education, environments and relationships. BMC Pediatr. 2012;12:143.
12. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis
Child. 1969;44(235):291-303.
13. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis
Child. 1970;45(239):13-23.
14. Singh GK, Balzer BW, Desai R, Jimenez M, Steinbeck KS, Handelsman DJ. Requirement
for specific gravity and creatinine adjustments for urinary steroids and luteinizing hormone
concentrations in adolescents. Ann Clin Biochem. 2015;52(6):665-71.
15. Kushnir MM, Blamires T, Rockwood AL, Roberts WL, Yue B, Erdogan E, et al. Liquid
chromatography-tandem mass spectrometry assay for androstenedione,
dehydroepiandrosterone, and testosterone with pediatric and adult reference intervals. Clin
Chem. 2010;56(7):1138-47.
16. Kushnir MM, Rockwood AL, Bergquist J, Varshavsky M, Roberts WL, Yue B, et al. High-
sensitivity tandem mass spectrometry assay for serum estrone and estradiol. Am J Clin
Pathol. 2008;129(4):530-9.
17. Cole TJ. Optimal design for longitudinal studies to estimate pubertal height growth in
individuals. Ann Hum Biol. 2018;45(4):314-20.
8. Foot Length Growth as a Novel Marker of Early Puberty
203
9. THESIS DISCUSSION
9.1. Key Findings 
9.1.1. Introduction 
The primary aim of this thesis was to demonstrate novel ways of studying puberty 
using preliminary data from the longitudinal ARCHER study. Chapters 3 and 4 
reviewed the current evidence base for oestradiol’s effect on mood and behaviour in 
female adolescents and testosterone’s effect on male adolescent mood and behaviour 
respectively. The feasibility of the ARCHER study’s methodology with respect to 
specimen collection and analysis was considered (Chapters 5 and 6, respectively), 
with Chapter 6 also investigating the relationship between hormone changes and 
other anthropometric markers of puberty. Self-rated Tanner staging, a research tool 
for pubertal assessment, has been used in the ARCHER study, and its usefulness in 
this context was investigated in Chapter 7. The use of foot length growth as a novel 
marker of early puberty was demonstrated in Chapter 8. Each of these studies has 
demonstrated that it is both possible and necessary to perform intensive, complex 
longitudinal studies in adolescent research. There are important gaps in the evidence 
as to how the dynamic changes occurring during puberty over a relatively short 
timeframe affect adolescent health and well-being., although this latter question has 
not been examined in this thesis. This thesis’ studies have also identified ways we 
can identify early puberty and the means by which cost-, time- and labour-efficient 
research can be conducted in this important and under-researched population.  
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Here, the preceding chapters will be briefly summarised to provide an interpretation 
and discussion of their results in the greater context of the thesis. The limitations of 
the work will be discussed, and future research directions identified by this study will 
be considered.  
9.1.2. The Effects of Oestradiol on Mood and Behaviour in Human Female 
Adolescents and the Effects of Testosterone on Mood and Behaviour in 
Human Male Adolescents 
The systematic reviews presented in Chapters 3 and 4 summarised and synthesised 
the evidence base for the effects of oestradiol (Chapter 3) and testosterone (Chapter 
4) on female and male adolescents, respectively. We found that despite there being 
long-standing assumptions regarding sex hormone effects on female adolescents, the 
evidence to support these was not convincing. Nine studies on mood and affect in 
adolescent females were identified, with one longitudinal study showing an 
approximately linear relationship between oestradiol and depression (1), though 
cross-sectional data were less consistent. There was little consistency in studies 
regarding self-image and related behaviours with oestradiol, though a large Belgian 
study identified a positive correlation between oestradiol levels and risk taking (2). 
There were 27 studies focusing on testosterone’s effects on male adolescents. The 
majority of these were cross-sectional, and aggression was generally the outcome of 
interest. While one longitudinal study failed to demonstrate a clear relationship 
between testosterone levels and changes in aggression, several cross-sectional studies 
showed significant correlations between testosterone levels and conduct disorder, 
risk-taking and aggression. Similar to oestradiol, some of the reviewed studies 
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identified relationships between testosterone and anxiety or depression, though the 
relationship between testosterone and substance use was only demonstrated in one 
study. As with the oestradiol systematic review, issues with cross-sectional analyses 
and lack of consistency between studies limited the ability of this review to 
demonstrate a clear causal relationship between changes in testosterone and changes 
in mood and behaviour in male adolescents. Of note, most of these studies used the 
less reliable method of immunoassay to assess sex steroid levels, with our study 
moving to the much more reliable (especially at low levels) LC-MS/MS technique. 
As there are demonstrable effects of oestradiol on the adolescent brain (3) and in 
animal studies (4), one might anticipate these data to be translated in clinical 
research. We were surprised that there was little consistency in studies with positive 
results, though it is likely that confounding factors, failure to control for menstrual 
cycle, social factors, and the quality of oestradiol or testosterone assays played a role 
in this. For example, no studies used gold standard LC-MS/MS assays, which can 
detect the low levels of circulating oestradiol or testosterone in early puberty, as 
demonstrated later in Chapter 6.  
Our findings in these chapters will enable clinicians, policymakers, parents and 
adolescents alike, for whom the increasing awareness of mental health issues in the 
adolescent population indicates the need for greater research. Despite popular 
assumptions that mood and behaviour changes in puberty are a consequence of 
“raging hormones” or are simply “puberty blues”, we have demonstrated little 
systematic evidence for this conclusion. One of the main goals of the ARCHER 
study is to provide hormone data (using high quality LC-MS/MS assays) over three 
years of puberty. This, combined with several validated survey tools (Youth Self 
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Report/Child Behaviour Checklist and the Short Moods and Feelings Questionnaire), 
will provide longitudinal evidence for the true and attributable role of sex hormones 
in adolescent mood and behaviour. Surveys have also been designed to ask 
adolescents and their parents about a variety of other factors which may act as 
confounders or interaction factors, such as demographic data, education, socio-
economic status and sleep patterns (5). Accordingly, the ARCHER study data will 
provide more precise estimates than offered in the studies reviewed in Chapters 3 
and 4. We would anticipate that oestradiol and testosterone may contribute to a 
certain degree to mood and behavioural changes at adolescence, however it is likely 
that a variety of other environmental factors will play a larger role. For example, 
Brooks-Gunn identified 1% of variance in mood in their study was due to oestradiol 
level (6), highlighting the importance of other factors. Since the publication of these 
chapters, no work has been performed on a longitudinal cohort of sufficient size and 
intensity of hormone sampling to demonstrate whether a relationship truly exists 
between pubertal hormones and mood and behaviour in adolescence. The Avon 
Longitudinal Study of Parents and Children, a large longitudinal UK birth cohort 
(n=15656 children recruited), involves annual follow-up and will likely provide 
supportive data for future findings from the ARCHER study.  
9.1.3. Text Messaging is a Useful Research Tool 
Text messaging and mobile phones are nearly ubiquitous in Australia, particularly 
amongst adolescents (7). Indeed, it is now the most used communication tool 
globally (8, 9). Therefore, it is something to which adolescents are accustomed and 
can be effectively utilised by them and their parents. Text messaging has been used 
effectively in many clinical contexts, such as appointment reminders (10), and for 
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data collection (8, 11-15). Thus, our text message, requesting a self-rating of mood at 
the time a urine specimen was due for collection, was intended to utilise the benefits 
seen for researchers using text messaging for both goals. We were able to achieve a 
very high level of both specimen collection (primary aim; 97.3% of intended 
samples) and a high rate of text message response (89.1% response rate), with a 
strong correlation (r=0.606) and approximately linear relationship between these (see 
Figure 5.1).  
The Framingham Children’s Study (16), a longitudinal study in the United States 
(n=187), identified several aspects that benefitted their cohort’s retention and study 
compliance. These included flexibility in scheduling, reminders and minimal 
response burden (16). Our SMS reminder tool provides participants with a non-
intrusive reminder that also allows data collection and is cost-effective. This 
reminder tool has translated to a low level of attrition (2.6% per annum) compared to 
other longitudinal adolescent cohorts with intensive data collection (such as Koenis’ 
study of 224 adolescent twins, which had an attrition rate of 6.8% per annum (17)). 
Further, the SMS reminder tool was associated with a majority of specimens 
collected. This is especially important in the context of the ARCHER study, whose 
recruitment catchment is spread over 45000 km2, meaning effective, timely 
communication is important.  
The practical implication of this study is that text messaging can be feasibly 
employed to enhance compliance with a study protocol (18). While there was no 
control arm to demonstrate text messaging alone was the cause for this, our results 
show it is an economical and efficacious reminder and data collection tool. Further 
work by the ARCHER study group will identify how these SMS mood scores could 
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act as a marker for mood disorders such as depression or anxiety, which would then 
offer an adolescent-friendly, easily accessible and affordable tool for clinicians to 
detect these disorders. Future research could benefit from this finding by 
implementing text messaging for collection of other data from study participants 
through the prompting question.  
9.1.4. Urinary Sex Steroids and Anthropometric Markers of Puberty – A Novel 
Approach to Describing Puberty  
As in Chapter 5, this chapter demonstrated the feasibility of part of the ARCHER 
study’s methodology, namely whether LC-MS/MS could determine hormone levels 
in pre-pubertal fasting urine and serum samples and thus provide an earlier indication 
of pubertal progress than previous assay techniques have allowed. Further, we 
demonstrated the relationship between hormone measures and anthropometric 
markers of development such as height, weight and self-rated Tanner stage.  
Our methodology, which is more frequent and intensive than other recent work with 
a large study cohort, will provide the most comprehensive evidence for the effects of 
pubertal hormone changes on the adolescent than has been previously available. For 
example, the Copenhagen Puberty Study collected serum samples for  LC-MS/MS 
hormone assays from twenty adolescents every six months for five years (19), 
whereas ARCHER followed 342 adolescents every three months for three years (5). 
In so doing, the ARCHER study aims to identify the role hormones play 
longitudinally in modifying growth, mood, behaviour and other aspects of adolescent 
health.  
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Mouritsen’s work in the Copenhagen Puberty Study also used LC-MS/MS and 
showed it to be superior to immunoassay in measuring serum testosterone levels in 
early adolescence. Our LC-MS/MS serum assay was unable to quantify testosterone 
in only two (1%) of our first 104 participants and luteinising hormone levels could 
not be detected by immunoassay in eleven specimens (of 194 collected; 6%). 
Similarly, only 28 of 484 urine collections (6%) were below the limits of 
quantification for any hormone (23 were oestradiol or testosterone LC-MS/MS 
assays). Given an early-pubertal study cohort, our methodology has demonstrated, as 
with Mouritsen’s, that LC-MS/MS able to quantify most hormone levels at this life 
stage, which we could not previously determine with sufficient precision. Our data 
have added to this by including LC-MS/MS data on oestradiol and further 
demonstrated the utility of this assay methodology on urine assays for the same 
hormones. First-morning urine samples can be feasibly collected (Chapter 5) and are 
intuitively more acceptable than repeated venepuncture and blood collection for 
adolescents and their parents. Collection time is also important given the initially 
nocturnal pulsatile secretion of pubertal hormones in early puberty (20, 21). 
This work showed urine and serum hormone levels are correlated, and also identified 
that urine hormone changes were not strictly progressive, instead fluctuate, 
suggesting a greater level of complexity to the pubertal transition than previously 
known. The top panel of Figure 6.1 showed this, and it is not clear why hormone 
levels demonstrate this pattern. It should be noted that there were overall increases in 
urinary hormones over one year, however the apparent mid-year peak cannot be 
adequately interpreted until the final analyses of all ARCHER study urine samples. 
We could not demonstrate patterns for serum hormones as these are collected 
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annually and this Chapter only looked at one year of collection. Interestingly, Figure 
6.2 showed that there were increases in hormones at each self-rated Tanner stage, 
with the exception of urine and serum luteinising hormone that showed less clear 
progression and for females there was an apparent decrease in luteinising hormone 
between Tanner stage 4 and Tanner stage 5 which we cannot explain. Though both 
sexes showed increases in sex hormones over each Tanner stage, females 
demonstrated greater increases in oestradiol and males in testosterone, as anticipated 
physiologically. As these are preliminary data, one must bear in mind the significant 
limitation this poses upon the interpretation of these findings. Our data follow 
anticipated trends and identify new ones. However, these data are from 
approximately one-third of the cohort over one year (of three) for the ARCHER 
study. Therefore, it is not possible to say whether such trends will continue for the 
larger cohort or in their longer-term follow-up. However, we do demonstrate the 
feasibility of the methodology, which has implications for the larger study and 
provides promising data suggesting the success of the ARCHER study as a whole in 
achieving its aims.  
9.1.5. Adolescent and Parental Ratings of Puberty: Associations with Serum 
Hormones 
The use of clinician-rated Tanner staging may pose ethical issues in studies involving 
community (non-clinical) adolescents, as it requires exposing their genitalia. The 
logistical issues requiring trained examiners added further challenges given the wide 
catchment area of the ARCHER study, and subjecting adolescents to this 
examination may have further deterred them from participating in ongoing research. 
For this reason, the ARCHER study relied on self-rating of Tanner stage and other 
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more basic assessments (such as “Do you think you have started puberty?”). In this 
chapter, we compared adolescent self-rating and adolescent and parent reports with 
LC-MS/MS assays of serum testosterone and oestradiol. We found significant 
relationships between self-rated Tanner staging and serum hormones and that those 
who affirmed the onset of puberty (or parental report of same) had significantly 
higher hormone levels than those who said puberty had not commenced. To this end, 
we have shown what Rasmussen and colleagues identified in their work (22) – self-
rated Tanner staging is useful in a broad epidemiological context where clinician 
assessment and/or gonadal hormone measures are not feasible, though may not be 
useful in clinical situations requiring accurate assessment (where clinician 
assessment is the gold standard). We have demonstrated that adolescents and their 
parents are able to assess whether puberty has commenced to a reasonable degree. 
Asking parents and adolescents whether puberty has commenced may thus offer a 
useful screening tool in non-clinical situations.  However, it remains unclear whether 
an adolescent or parent can assess puberty progress relative to other age- and sex-
matched adolescents.  
We also identified that statistical agreement between adolescent and parent report is 
generally poor. One of the principal reasons for this is that adolescents may become 
more private about their bodies, and thus less likely to divulge changes or allow 
parental inspection. Despite this, both parental and adolescent reporting was 
associated with hormone changes. Additionally, more adolescent males said they had 
started puberty compared to their parents, and opposite trends were observed for 
females. This is an interesting finding, that may relate to the clinical manifestations 
of pubertal development. For males, events such as spermarche and penile 
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development may be seen as developmental milestones, but these are often kept 
private. In contrast, female breast development and menarche may be less so, due to 
the visibility of the former and salience of the latter, both necessitating purchases 
(bras or hygiene products). However, it is unclear why female adolescents are less 
likely to report the commencement of puberty than their parents given this. It is 
possible that parents base their observation on behavioural change and infer this 
change is hormone related. 
Without clinician assessment (gold standard of Tanner staging) we are unable 
determine the accuracy of self-rating in this cohort, so our work relies on previous 
findings that self-rating has an adequate accuracy to be used as a tool in 
epidemiological research (22). Confidence intervals for hormone levels at each self-
rated stage fall within clinician-rated Tanner stage reference ranges established for 
LC-MS/MS (23, 24). We did not provide adolescents or parents with any information 
about signs of puberty by which they could answer questions which creates inherent 
issues in the definition of “pubertal onset”, which would likely differ between 
individuals in this context. Additionally, we asked adolescents and parents whether 
they felt puberty has commenced and to rank their development as behind, same or 
ahead of their peers. As discussed in Chapter 1, the subjective assessment of puberty 
by an adolescent is an important piece of data, regardless of accuracy, as it reflects 
the individual’s self-perception (25). The perceived maturity may therefore lead to 
the adolescent behaving in ways they feel more congruous with their idealised 
development, as opposed to the clinician rating or neuro-endocrine drivers of these 
changes. Moore and colleagues found that perceived pubertal timing was important 
in predicting engagement in sexual and romantic behaviour whereas objective 
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pubertal timing (age at menarche) only predicted the onset of sexual behaviour (26). 
The adolescent’s (and their parent’s) perception is therefore critical to understanding 
some of the changes observed in pubertal behaviour. When using this frame of 
reference, future work in the ARCHER study could look at how self- or parental-
rating (Tanner stage or brief ranking questions) is associated with changes in 
behaviour, relationships (familial, friendships and romantic or sexual) and mood. For 
example, whether boys who rate their development as ‘ahead’ of their peers are more 
likely to engage in delinquent behaviour (27), could provide useful information about 
the intersection of puberty, self-image and mood and behavioural outcomes in this 
group and allow better targeted interventions.   
9.1.6. Foot Length Growth as a Novel Marker of Early Puberty 
In this chapter, foot growth was greatest over the three-year study follow-up period 
for adolescents whose hormone levels were pre-pubertal (at baseline) compared to 
those with pubertal hormone levels. There are four studies which have looked at foot 
length as a pubertal marker (28-31). Ford found foot growth preceded peak height 
velocity in a small longitudinal study of girls (29). In a large Indian cross-sectional 
study, Mitra demonstrated foot growth was greatest between clinician-rated Tanner 
stages 1 and 2 (30). Using population growth data and local shoe sale data, Busscher 
showed an increase in shoe sales in the time preceding peak height velocity (31). 
These studies showed foot length precedes other anthropometric changes in puberty, 
but our work is the first to demonstrate a relationship with hormone changes.  
In our work, foot length was longitudinally related to changes in serum testosterone 
and oestradiol, as well as height, weight and self-rated Tanner stage. Percent annual 
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foot growth was significantly greater in male and female adolescents with pre-
pubertal hormone levels. There are only three years’ follow-up data so further work 
could be focused at studying foot length from before puberty until completion of 
growth, in concert with height and weight growth velocities. Additionally, annual 
foot measurements may not provide sufficient detail to define adequate growth 
curves, though, using the Super-Imposition by Translation And Rotation (SITAR) 
model, recent work found that annual anthropometric measurements (such as those 
performed in our study) may estimate peak growth velocity during puberty (32). 
However, with only three years of sampling we could not determine if peak growth 
velocities were reached to delineate whether peak foot growth velocity preceded 
peak height velocity as it did in Ford’s work (29). Using longitudinal regression, we 
showed that foot growth was positively associated with self-rated Tanner stage, a 
further finding of utility.  
Foot length therefore offers a novel and cost-effective way of assessing early 
puberty. It can be used by adolescents, parents and clinicians to broadly determine if 
an adolescent is in the early stages of puberty. Formal pubertal assessment, whether 
using clinician-rated Tanner stage or hormone assessment, would of course be 
needed if there were clinical concerns about puberty. Foot length is an obvious and 
public change that may necessitate new shoe purchases, which is therefore 
memorable to parents and adolescents, whereas other growth may not be noticed as 
early, whether due to subtlety of changes (such as initial height or weight change) or 
due to adolescent privacy or body image concerns. Foot growth could thus be used as 
a screening question to identify the early stages of the pubertal transition.  
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9.2. Future Directions 
The data presented here have some important translational implications for 
adolescent research. We have shown the feasibility of our novel study methodology, 
particularly in terms of meeting the technical challenges of measuring lower 
hormone concentrations than previously achieved through novel LC-MS/MS 
techniques, and the logistical challenges of a longitudinal study in rural New South 
Wales, where the study’s catchment area (over 45000 km2) and frequent study 
specimen collection, require novel research tools for communication and ways to 
minimise study attrition. Our findings can be utilised by other researchers as we have 
shown how successful regular specimen collection is in adolescents using SMS 
reminders, alternative ways to obtain puberty staging data and most importantly that 
novel urine LC-MS/MS techniques are feasible in this setting to measure previously 
unquantifiable early pubertal hormone levels. Our simple tools for reminders and 
data collection in early puberty are relevant and useful for those considering 
adolescent research, particularly longitudinal work.  
Findings regarding the true effects of pubertal hormones will inform policy and 
public health decisions and enable better education of parents and adolescents about 
puberty. It may also allow early intervention for those at risk of mood or behavioural 
changes. Future research guided at understanding how longitudinal changes in sex 
hormones are associated with mood and behaviour will provide stronger evidence 
than that found in two systematic reviews on the topic (33, 34). We will also be able 
to identify the role sex hormones play in moderating growth and health during 
adolescence, with further scope to understand how these affect adolescents in later 
life with planned work to follow the ARCHER study through data linkage.  
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All of these findings will significantly advance our understanding of puberty and its 
role in adolescence, either by confirming previous work with longitudinal data 
consisting of more accurate hormone assays, or providing novel results that question 
previous hypotheses and form the basis for a deeper, more rigorous understanding of 
this crucial life phase. The second decade of life is under-researched and yet is a key 
time in understanding how long-term health trajectories are established. 
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1.1. Abstract 
1.1.1. Background 
Adolescence is characterized by marked psychosocial, behavioural and biological 
changes and represents a critical life transition through which adult health and well-
being are established. Substantial research confirms the role of psycho-social and 
environmental influences on this transition, but objective research examining the role 
of puberty hormones, testosterone in males and oestradiol in females (as biomarkers 
of puberty) on adolescent events is lacking. Neither has the tempo of puberty, the 
time from onset to completion of puberty within an individual been studied, nor the 
interaction between age of onset and tempo. This study has been designed to provide 
evidence on the relationship between reproductive hormones and the tempo of their 
rise to adult levels, and adolescent behaviour, health and wellbeing. 
1.1.2. Methods/Design 
The ARCHER study is a multidisciplinary, prospective, longitudinal cohort study in 
400 adolescents to be conducted in two centres in regional Australia in the State of 
New South Wales. The overall aim is to determine how changes over time in puberty 
hormones independently affect the study endpoints which describe universal and risk 
behaviours, mental health and physical status in adolescents. Recruitment will 
commence in school grades 5, 6 and 7 (10–12 years of age). Data collection includes 
participant and parent questionnaires, anthropometry, blood and urine collection and 
geocoding. Data analysis will include testing the reliability and validity of the chosen 
measures of puberty for subsequent statistical modeling to assess the impact over 
time of tempo and onset of puberty (and their interaction) and mean-level repeated 
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measures analyses to explore for significant upward and downward shifts on target 
outcomes as a function of main effects. 
1.1.3. Discussion 
The strengths of this study include enrollment starting in the earliest stages of 
puberty, the use of frequent urine samples in addition to annual blood samples to 
measure puberty hormones, and the simultaneous use of parental questionnaires. 
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1.2. Background 
Adolescence is a time when interventions have the capacity to make changes in 
individual health trajectories (1-3). The aim of this study is to understand the effects 
of longitudinal changes in puberty hormones, especially the onset and tempo of 
change, on adolescent health and well-being. The present paper presents the research 
protocol for the study, with an emphasis on the newer technologies which have made 
this type of study possible. 
The two prime hormones, or biological measures, of puberty are testosterone (in 
boys) and oestradiol (in girls) (4), Figure 1.1. The dramatic hormone changes of 
puberty are a universal and unforgettable experience. Inevitably such a phenomenon 
prompts many assumptions about the effects of puberty hormones on wellbeing and 
health. However, the authentic, longitudinal effects of the puberty hormones on 
human health and wellbeing in adolescence and in later adult life are not well 
understood, and remain under-researched. Previous research has relied on proxy 
measures of puberty hormonal changes including self-report of physical change and 
physical growth (5). 
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Figure 1.1. Puberty hormone change and tempo. Shows the pattern of testosterone 
and oestradiol change during puberty, the puberty milestones of menarche and 
Spermarche in relation to puberty stage and how the tempo of puberty may vary 
between individuals. 
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The major and rapid increases in puberty hormones mean that repeated hormone 
measurement is essential to appraise the relationships between biological variation in 
puberty hormones and the concomitant adolescent health problems and to allow 
exploration of the biological determinants of individual, social and physical 
environmental factors that are prominent in adolescence (6). This is the first 
challenge in research of this nature. The onset of puberty occurs when testosterone 
and oestradiol begin to rise above the levels of childhood. This event occurs 
anywhere between the ages of 8 and 13 years (7, 8) but chronological age is an 
unreliable indicator of pubertal stage. The tempo, or time, to complete the pubertal 
increase in reproductive hormones is comparatively rapid, between 18 months and 
four years, which is too rapid to be characterized by annual or less frequent blood 
sampling. Although the impact of variable tempo of puberty on health and wellbeing 
has not been well studied (or reported) (9), we propose that tempo is a key variable 
mediating the clinical effects of dynamically changing puberty hormones on 
adolescent health and behaviour (10). It is notable that hormonal events of puberty 
are as dramatic in scope and amplitude as more well-known examples of rapid 
hormonal change that cause defined physical, behavioural and mental effects such as 
the menstrual cycle, pregnancy, castration, anabolic steroid use and the menopause 
(11-13). 
The additional challenges to research on puberty hormones are to create a framework 
where factors can be repeatedly studied with minimum reporter burden, and to 
ensure that the interactions between factors are understood and accounted for in 
order to satisfactorily interpret outcomes. The factors that have been chosen for study 
are those that are objectively measurable as well as being clinically important and 
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modifiable, thus forming the basis of subsequent interventional studies. These factors 
are listed below and a brief review of the factors, how these are interrelated and their 
roles as possible aetiological factors, co-variates or predictors follows (Figure 1.2). 
The Study Variables are: 
• Universal aspects of adolescent health and wellbeing which include social 
and emotional wellbeing, educational engagement and motivation, and sleep. 
• Health risk behaviours which include unintentional injury, alcohol and other 
drugs, sexual activity and conduct disorder. 
• Mental health which includes depression, anxiety and self harm. 
• Physical health which includes chronic illness and disability and 
cardiovascular risk factors – overweight, physical inactivity and tobacco use. 
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Figure 1.2. Depicts how the hormonal environment of puberty as defined by blood 
and urine testosterone and oestradiol may be related to the events of adolescence. 
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1.2.1. Universal aspects of adolescent health and wellbeing 
Socially competent adolescents are more likely to do well in education and less 
likely to have mental health problems (14). Learning and engagement in education in 
adolescence is critical to social and emotional development and well-being, but the 
influence of the onset of and tempo of pubertal hormone rise on motivation and 
engagement in education, particularly when compared with the effects of socio-
economic status and mental health, is as yet unknown (15). Sleep disturbances in 
adolescents are common and may affect school performance and mood. The most 
common adolescent sleep disorder is delayed sleep phase syndrome (5-10%) (16). 
What is not known is how the onset and tempo of pubertal hormone changes relate to 
sleep alterations and disturbances (17). 
1.2.2. Health risk behaviours 
Unintentional injury is the most common cause of death in adolescents (18), mainly 
as a result of road traffic accidents (19), poisoning and drowning. Previous work has 
highlighted possible associations between pubertal stage as estimated by direct 
physical examination and physical injury incidence (20), but the onset of and the rate 
of the rise in pubertal hormones have yet to be studied in this context. Drug and 
alcohol use in adolescence increases the likelihood for reduced educational 
attainment, co-morbid mental health disorders, substance abuse and dependence, 
criminality, and psychiatric disorders in adulthood (20). We propose that puberty 
onset and tempo also play an important role in these associations (22). Sexual 
activity in teenagers is occurring at younger ages and teenagers are more likely to 
report multiple partners than in previous generations (23). The relative contribution 
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of changing pubertal hormone levels, specifically tempo, to sexual activity has not 
been confirmed and the mechanism of their influence and modifiers are completely 
unknown. Conduct disorders appear in pre-puberty or first emerge in puberty (24). 
There are conflicting data about these disorders and their relationship to early or late 
maturation as measured by self-report and single measurements of blood testosterone 
levels. 
1.2.3. Mental health 
Depression and anxiety are the most common mental health problems in young 
people. At any time point, up to five percent of adolescents experience depression 
severe enough to warrant treatment, and around 20% of adolescents will have 
experienced significant depressive symptoms by adulthood (25, 26). On self-reported 
Tanner Stages, depression occurs most commonly at Stage 3 in girls and before 
Stage 3 in boys. There is conflicting evidence about whether age of onset of puberty 
influences depression (27-29). Higher rates of self-harm are found among 
adolescents in self-reported late puberty compared to early puberty (30). The 
association is mediated by depressive symptoms, sexual activity and alcohol intake, 
and often attenuates with increasing age (31). 
1.2.4. Physical health 
Fifteen percent of adolescents have a chronic physical illness or disability (32). If 
serious this may retard the onset of puberty and potentially alter tempo (33). 
Overweight, physical inactivity and tobacco use, which are the top three contributors 
to the burden of disease in developed countries (34), all increase during adolescence 
(35). Twenty percent of adolescents smoke by the age of 17 years (36). There are no 
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longitudinal studies on how the age of onset and rate of change or tempo of puberty 
hormones influence the cardiovascular risk factors of overweight, physical inactivity 
and tobacco use. 
1.3. Methods/Design 
1.3.1. Introduction 
The ARCHER study is a multidisciplinary, three year, longitudinal cohort study, 
using a convenience sample. The research hypothesis of the study is that onset and/or 
tempo of the rise in puberty hormones play a significant role in adolescent health and 
wellbeing. The ARCHER study commenced recruitment in June 2011 and has 
enrolled 200 adolescent participants (with parent/guardian) as of March 2012. 
A feasibility study for all aspects of baseline data collection was completed in 28 
students in years 5&6 at a rural primary school. Sample collection, labeling, 
transport and storage were successful. The plasma testosterone and oestradiol levels 
demonstrated that the participants (except 2 -1 M, 1 F) had levels consistent with pre- 
or very early puberty. On-line questionnaires were revised and successfully re-
piloted in August 2009 in a rural primary school with 26 students and their parents. 
In 2010 focus group discussions (single and mixed gender with 10–12 year olds and 
13–15 year olds) were held with 58 participants. Topics included what would 
positively influence recruitment and retention, how peers might participate in the 
study and the collection of biological samples. The young people expressed strong 
preferences in relation to the collection process and the focus group outcomes are 
now published (37). The methodology was further tested in 2010 in a funded pilot 
study on puberty, sleep and depression, with included the use of the Actiwatch. This 
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is a digitally integrated recording of wrist activity which provides more detailed 
information on sleep wake/times (38). 
1.3.2. Setting and study sample 
The study is being conducted in Dubbo and Orange, two large towns in regional 
Australia in the State of New South Wales and surrounding areas. Enrollment is in 
school Grades 5, 6 and 7 (10–12 years of age) to ensure that both the transition into 
early puberty and the end of puberty are captured in adequate numbers. Each student 
will require a parent or guardian to also participate in the study. Lack of parental 
competence in English or adolescent intellectual disability are exclusion criteria. The 
least common primary outcome that we measure is depression, which we estimate 
will affect 5% of children in mid- to late-puberty (39). We estimate that 160 boys 
and 160 girls at Tanner Stage 3 (the pubertal stage where clinical onset of depression 
is most likely) are required to detect a one standard deviation (SD) difference in 
testosterone nmol/l (SD = 5) (40) or oestradiol pmol/l (SD = 250) (41) levels between 
those with and without depression. The anticipated loss to follow up is 5% per 
annum in this setting. Assuming a mean age of puberty onset of 11.4 years (42), 400 
subjects will ensure adequate numbers of adolescents at Tanner Stage 3 in the study, 
as a few younger subjects may not reach this Stage at the end of the study (age 
14 years) and some older children may have already entered Stage 3 at the beginning 
of the study (age 12 years). 
1.3.3. Recruitment procedures and follow up rates 
Recruitment is primarily through schools, as well as through the media (targeted at 
parents) and through established links with local community groups. We have 
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permission from the state Department of Education and Communities - Western 
Region and the Catholic Education Office – Bathurst Diocese to recruit through their 
schools. Data collection does not take place in the schools. Information sessions are 
held in the community and at consenting schools. Parents are asked to provide two 
additional adult contact names with the written consent, to reduce loss to follow up. 
Participants who agree are sent birthday cards, updates and study newsletters as 
reminders by their preferred mode of contact (email, letter or Short Message Service 
(SMS)). These practices have been shown to increase retention rates in school age 
children (43). The young people requested ‘get togethers’ in the focus groups to 
celebrate their involvement in the study and these will be held annually. 
1.3.4. Data collection 
Adolescents will complete questionnaires at baseline and annually for the following 
three years. We will use a computerized on-line questionnaire with branched 
algorithmic structure, to enhance confidentiality and accuracy of responses and to 
reduce exposure to sensitive questions (particularly related to sexual activity). This 
has been created and trialed. The total number of questions for adolescents is 256. 
These are completed in approximately one hour (shorter for the older participants 
and closer to 75 minutes for younger participants). Adolescents complete the 
questionnaire under supervision of research staff. Questionnaires will not be 
performed in the fasted state and, as with all other data and biological sample 
collection, are done outside school hours. Physical examination occurs at baseline 
and annually for three years. Blood is collected at baseline and annually for three 
years, in the fasting state. A first morning urine sample is collected at baseline and 
every three months for three years. A single indicator question providing information 
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on mood fluctuation is sent to all participants with access to mobiles phones every 
3 months and functions as a reminder to complete urine collection. 
A parent or guardian completes a questionnaire at baseline and annually for three 
years, and in the same month as their child. The questionnaires are available online 
or as hard copy and contain approximately 180 questions. This questionnaire reduces 
reporter burden on adolescents for demographic data, as well as providing other 
relevant family and environmental data. 
1.3.5. Ethics 
Ethical approval has been granted for the pilot questionnaires, anthropometry, 
biological sample collection (HREC 10612), the pilot SMS and sleep studies (HREC 
12502) and for the full study described in this protocol (HREC 13094) from the 
Human Research Ethics Committee, University of Sydney. 
1.3.6. Instruments 
1.3.6.1. Questionnaires - adolescent 
The Child Behaviour Check List (CBCL) in the version validated for ages 11–
18 years as the Youth Self Report (YSR) (44) is the main questionnaire measurement 
instrument. It contains 20 social competence items that measure participation in 
hobbies, games, sports, jobs, chores, friendship, and activities and 8 sub-scales, 
measuring internalizing and externalizing behaviour. In addition the subscales 
provide data on social competence, learning and engagement in education, sleep, 
unintentional injury, drug and alcohol use, conduct disorders, disruptive behaviour 
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disorders, depression and anxiety, and self harm. The YSR also identifies the 
presence of physical illness and disability. 
The YSR is supplemented by the following questionnaires. 
a) Selected measures of self competency taken from the Raine cohort (45), 
including Cowen’s Self Efficacy (46) and Adolescent Self Perception Profile (47). 
b) 12 selected items from Motivation and Engagement; Enjoyment of School, 
Academic Buoyancy and Class Participation scales (48, 49). These results can be 
linked to the Australian National Assessment Program Literacy and Numeracy scores 
(50). 
c) A questionnaire is used to document sleep/wake patterns, and sleep disorders 
in the adolescent’s natural sleeping environment (51). In addition, a convenience 
subset of adolescents will use the Actiwatch home monitor system annually. 
d) Direct questions on unintentional injury type in the preceding 12 months 
provided by RI, selected questions from The Australian School Students Drug & 
Alcohol Survey (52), branched age appropriate sexuality questions on romantic 
relationships, sexual feelings, history of STI and pregnancy (23) and the 40 item 
validated Australian self-reported delinquency scale by Mak (53) in those 
adolescents who score highly on the YSR subscale for externalizing problems. 
e) The Short Moods and Feeling Questionnaire (13 item) in all subjects (54). 
The short form has been validated as a self-reported unidimensional measure of 
symptom severity of childhood depression in community samples. 
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f) The 16 item Deliberate Self Harm inventory (55) for those who respond with 
a 1 or 2 for YSR item 18 or 91 (relating to self-harm or suicide). 
g) Selected questions from Health Behaviors in School-aged Children for 
physical inactivity, nutrition and tobacco (56). 
h) One SMS question which is a linear analogue self-assessment scale question 
on mood providing information on mood fluctuation (57). 
i) Tanner Stage of puberty by self report using standardized line drawings 
which allow determination of accuracy of this method of pubertal staging, which is 
the main method used in epidemiological and non-clinical studies. 
  
1.3.6.2. Questionnaires – parent/guardian 
a) Demographic data for family and adolescent. 
b) Child Behavior Checklist (CBCL) validated questionnaire for parents of 
children aged 6–18 years to corroborate the adolescent’s YSR (58). 
c) The validated Macmaster’s Family Assessment Device (59) to obtain 
information on family and local environmental factors, which are potential 
confounders. 
After the final 3-year questionnaire all adolescents will be asked whether they 
believed that the speed of their puberty was faster, the same as or slower than their 
age peers and whether the onset of their puberty was earlier, the same as or later 
compared to their age peers. Their parent/guardian will be asked the same questions 
in relation to their child. 
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1.3.6.3. Physical examination – adolescents only 
Weight and body composition is measured in light clothing using Tanita TBF-300 
Pro Body Composition Analyzer (60). Height, and foot length as an indicator of 
growth stage (61) are measured on a portable stadiometer (to 0.1 cm) and with a 
metal ruler (to 0.5 cm) respectively, and waist (62) with a tape (to 0.1 cm) using 
standard techniques. Body Mass Index, as a measure of overweight (kg/m2) and waist 
circumference are expressed as individual z-scores based upon age and sex related 
reference charts (63). Blood pressure (BP) and pulse rate are measured using an 
automated BP monitor, under standardised conditions. 
1.3.7. Laboratory – adolescents only 
Fasting bloods are collected using local anaesthetic cream and separated serum and 
spot urine samples frozen at −80°C, as well as buffy coat in one sample. Total blood 
draw is approximately 30 ml. Menstrual cycle stage will be recorded in post-
menarchal females, with the perimenstrual week avoided. 
1.3.7.1. Blood 
Testosterone and oestradiol will be measured using AP5000 LC Tandem MS in the 
Andrology laboratory, ANZAC Research Institute (64) (DHEA, DHT and oestrone 
will also be measured). There will be adequate blood collected to measure other 
potential biological variables of interest, which will form the basis of future studies 
but which are not integral to this study. These variables include LH, FSH, SHBG and 
IGF-1, inhibin, anti-Mullerian hormone, ACTH, cortisol, growth hormone, prolactin, 
oxytocin, TSH, thyroxine, triiodothyronine and Vitamin D (all of which are 
hormones relevant to puberty) (4), full blood count, ferritin, glucose, liver function, 
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urea, electrolytes, full lipid profile, creatinine, and insulin, fatty acid profile, leptin, 
adiponectin, resistin, TNF alpha, CRP and Interleukin 6 (as indicators of 
cardiovascular risk and also to derive eGFR) (65). There is the potential to be able to 
study genes relevant to puberty and sex steroid action; KiSS-1, KAL1, FGFR1, 
GnRHR, GRPR-54, TAC3, neurokininB, androgen and oestrogen receptor, 
steroidogenic enzymes such as CYP, StAR, P450scc, P450 (17alpha) and 17beta-
HSD (66), and genes relevant to body composition and insulin resistance, such as 
leptin gene and product, MC4R, FTO, IL-6, and UCP-2 (67). 
1.3.7.2. Urine 
A first morning, fasting urine sample will be collected at home. Urinary testosterone 
and oestradiol will be measured, also using AP5000 LC Tandem MS. Urinary 
hormones, although less well standardized than blood, are essential to define 
hormone trajectories which can never be accomplished by a single annual sample. 
Sperm (indicating spermarche) will be measured in male urine samples (68). There 
will be adequate urine to measure creatinine and microalbumin, but these measures 
are not integral to the current study. 
1.3.8. Geocoding 
Residential address will be geocoded (69) to obtain additional information such as 
neighbourhood socioeconomic status, access to services and amenities and other 
environmental exposures, which may be study confounders for which adjustment 
will be required. 
Appendix A: ARCHER Study Methodology
237
  
1.3.9. Statistical analysis 
The main independent variables are tempo of puberty and age of onset at puberty. 
Both will be measured by testosterone and oestradiol, in blood and urine. Data 
analysis will have three main components. 
1. The first component is testing the reliability and validity of measures under 
focus. These analyses will centre on: (a) descriptive, reliability and item functioning; 
(b) factor analysis to test factor structure and validity of measures; (c) ANOVAs for 
preliminary tests of main and interaction effects of background socio-demographics; 
and (d) tests of (in)variance in factor structure to ensure congruence in measurement 
properties across sub-groups to justify pooling sample data for subsequent modeling 
throughout the project (70). 
  
2. The second component is a correlational one and assesses the impact of 
tempo and onset of puberty over time. Specifically, for example, by assessing in the 
one analytic model (eg. in linear regression models for continuous variables such as 
YSR scores for sensation seeking and in logistic regression models for dichotomous 
outcomes such as depression or sexual debut) the effects of Time 1 onset and tempo 
of puberty on Time 2 outcomes after controlling for Time 1 outcomes, it is possible 
to get a sense of the relative salience of the onset, and tempo of puberty in one time 
period over factors in a following time period (71). Also in these longitudinal 
analyses, key socio-demographic (and other) factors such as gender, school grade 
and socioeconomic factors can be included to get a further sense of puberty by 
controlling for other potential influences. The three monthly urine samples for the 
biological markers of puberty can be used to regress time on time measures, with 
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tempo being defined by the residuals. Thus the larger and the more positive a 
residual over time, the more rapid the tempo of change. 
3. The third component is based on mean-level differences (e.g. repeated 
measures) and explores for significant upward and downward shifts in means on 
target outcomes as a function of main effects (e.g. early and late onset; rapid and 
slow tempo) and interactions (e.g. early onset/rapid tempo; late onset/rapid tempo; 
early onset/slow tempo and late onset/slow tempo) of puberty effects that also 
control for key socio-demographic (and other) factors as covariates (72). Taken 
together, these analyses (and adaptations of them) allow for integrative tests of the 
substantive and methodological issues at hand. 
  
Analyses will be conducted using SAS, Stata and WinBUGS (for repeated measures 
analyses). 
1.4. Discussion 
This study aims to extend previous puberty research which has sought to consider the 
relationship between the biological events of puberty and the complex, longer state 
of adolescence and its associated health issues. As a longitudinal study it commences 
at a younger age in order to capture the transition into puberty, as defined by the first 
elevations of testosterone and oestradiol in blood and urine. Thus puberty is defined 
using biological markers, which are of fundamental importance to the project. 
Previous studies have relied on self report of pubertal stage, which is a lagging and 
insensitive measure, that correlates only weakly with measured puberty hormones 
(5). This will be the first study to focus on the biological tempo of puberty and its 
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impact on adolescent health and wellbeing, with frequent biological sampling and the 
introduction of new, ultrasensitive state-of-the-art, mass spectrometric steroid assays. 
Previous studies have used immunoassay with unextracted serum, which has proven 
analytically inaccurate and unreliable (although faster) and which further places in 
doubt previously described relationships between the clinical features of puberty and 
its hormonal determinants. 
The utility of this new knowledge, by the translation of hormone data into real life, is 
to better direct interventions at a time when developmental trajectories remain plastic 
and capable of alteration and without the need for biological sample collection. It can 
be done because ‘puberty phenotypes’ such as early or late onset (out of step with 
peers) or rapid tempo (rapid physical change) and which deviate most from average 
age of onset/average tempo (similar to the majority) are already recognizable using 
simple observation by clinicians, parents, educators and adolescents. What is missing 
is an understanding of the direction and magnitude of influence of intrinsic tempo 
and timing of puberty on adolescent behaviour, wellbeing and health and how 
hormonal changes interact with external factors. The indirect, non-biological 
evidence is that the magnitude of intrinsic hormonal influence is significant. 
There is no suggestion that altering the onset or tempo of puberty is a realistic 
intervention (despite its feasibility using modern steroidal or gonadotrophin releasing 
hormone analogue therapy (73, 74)). It is however of great interest to determine 
whether the dynamic hormonal changes of puberty trigger behavioural or physical 
problems. If puberty hormones do have an effect, it would be possible to target 
established, evidence-based directed interventions to at-risk adolescents, presumably 
those whose puberty patterns are dissimilar to the majority. These could include 
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evidence-based interventions in sleep hygiene, unintentional injury, mental health, 
and cardiovascular risk. In schools, where year levels are defined by age, rather than 
pubertal stage, information will be provided to better assist school personnel to 
identify and deal with the wide developmental range in any given year group. 
Adolescents, their parents and families will benefit from understanding how 
hormones influence adolescent behaviours. The community will benefit if knowledge 
gained from this study is used to improve adolescents’ health and wellbeing. 
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1.1. Abstract 
Aims:  
To provide an overview of preliminary findings from the longitudinal ARCHER 
(Adolescent Rural Cohort study of Hormones, Health, Education, Environments and 
Relationships) study of rural adolescent health.  
Methods:  
The ARCHER study is a three-year multidisciplinary longitudinal rural study of 
adolescents (recruited at 9 to 14 years) from two regional centres in the Central West 
of NSW. The ARCHER study includes an extensive yearly survey of adolescents and 
their parent(s)/guardian using questionnaires, anthropometry, blood and urine 
collection. Measures include universal aspects of adolescent health and wellbeing, 
such as education, health risk behaviours, mental and physical health. Data analysis 
was performed to explore trends over time and by age. 
Results:  
342 young people were recruited to ARCHER with 82% retention across four Waves 
of data collection over 3 years. At baseline, the median age was 11 years, 45% were 
female and 11% were Aboriginal or Torres Strait Islander adolescents. Serum 
testosterone and oestradiol levels confirmed that the majority of the adolescents were 
in early puberty. The young people came from diverse socioeconomic backgrounds, 
although participating families were generally more affluent and better educated than 
the broader regional population. Across the four Waves, between 10 and 18% 
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experienced significant depressive symptoms and rates increased with age. 
According to parents/guardians, only approximately 1 in 10 young people met 
national guidelines for physical activity, and between 16 to 22% lived in a household 
with at least one smoker. Prevalence of overweight and obesity ranged from 26 to 
28% overall (females 29 to 32%; males 23 to 25%). Associations between gender, 
mental and physical health and stage of puberty were present. 
Relevance:  
Adolescence is a critical epoch laying durable foundations for lifelong health and 
wellbeing. Understanding and promoting rural adolescent health and wellbeing will 
contribute to addressing known rural health inequities.   
Conclusions:  
We have successfully recruited and maintained a cohort to answer novel research 
questions. Data generated will further our understanding of puberty and its effects as 
well as providing insight into the specific determinants of health for young people 
growing up in rural Australia. 
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1.2. Introduction 
Adolescence is a critical phase of life that involves complex biological, physical, 
cognitive and social changes for the young person. These changes combine and 
interact with environmental factors such as socioeconomic status, education and 
familial/peer relationships to potentially alter trajectories of future health and 
wellbeing (Sawyer et al., 2012; Viner et al., 2012). Puberty is the biological event 
defining early adolescence. Many assumptions and assertions are made about the 
authentic, underlying biological effects of the major puberty hormones – testosterone 
in males and oestradiol in females - on adolescent health, wellbeing and behaviour. 
To date, the definitive longitudinal studies with appropriately frequent measures of 
puberty hormones have yet to be reported. Most studies rely on physical staging of 
puberty, a late effect of puberty hormone action (Dorn et al., 2006). The effect of 
arguably the most dramatic hormone changes in life and their interactions with other 
determinants of health and changes in adolescence remain poorly understood. 
Additionally, the frequency of many characteristic behaviours and recognised 
morbidities of adolescents increase after the physical events of puberty are complete. 
These observations suggest that the individual patterns of puberty hormones – both 
timing and tempo – may be influential. This is the hypothesis of the ARCHER study 
(Adolescent Rural Cohort study of Hormones, Health, Education, Environment and 
Relationships) which aims to identify the genuine biological influence of puberty 
hormones on adolescent health, wellbeing and behaviour (Steinbeck et al., 2012).  
Although about one-third of 10 to 13 year olds live in regional or remote areas 
(32.8%; ABS, 2011), the health determinants of Australian rural and regional 
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adolescents are poorly documented and under-researched. Known inequalities of 
rural populations include lower incomes, poorer levels of education and employment 
and access to services. The further from metropolitan areas young people live the 
higher the burden of disease and mortality rates, accidents are more common, diet is 
poorer, there are greater levels of alcohol abuse and poorer access to health care 
(AIHW, 2011). These inequalities in social determinants of health and the specific 
health needs of young people in non-metropolitan areas are not well understood.   
This preliminary analysis of the ARCHER study focusses on several important 
aspects of adolescent health from the myriad studied, namely sleep, depression and 
overweight and obesity (O&O). It is well recognised that sleep patterns change 
during adolescence. Adolescents tend to have decreased total sleep duration and 
increased differences between weeknight and weekend sleep (Owens, 2014). The 
known consequences of their poor sleep are wide-ranging and include poorer 
academic achievement, increased risk-taking behaviours, obesity and poorer mental 
health (Chaput et al., 2016; Shochat et al., 2014). This time in life is also 
characterised by substantial cognitive, social-cognitive and social-organisational 
changes that have significant implications for academic wellbeing, including lower 
academic motivation and engagement (Martin, 2009; Martin et al., 2015). Depression 
is the leading cause of disability amongst young people worldwide (WHO, 2014).  
During adolescence, the prevalence of depression increases, which is commonly 
attributed to puberty, although empirical evidence is almost entirely lacking (Balzer 
et al., 2015; Duke et al., 2014). The impacts of depression in young people include 
poor functioning at school or work, poor relationships with family and friends, risk-
taking behaviour and suicide (Lawrence et al., 2015). The prevalence of O&O 
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increased substantially in young Australians during the latter part of the 20th century, 
similar to global trends (Hardy et al., 2011; Ng et al., 2014). Although this increase 
appears to have plateaued in Australia in the last decade (ABS, 2013a), adolescent 
O&O remains an important public health issue. Australia has one of the highest rates 
of youth obesity among developed countries (Ng et al., 2014). Reduced physical 
activity is also a well-known risk factor for O&O. The Australian National 
Guidelines for Physical Activity and Sedentary Behaviour recommend moderate to 
vigorous activity for at least 60 minutes every day of the week (Australian 
Department of Health, 2014).  
The known contribution of adolescent health and health-related behaviours to adult 
health and wellbeing, and the dearth of research particularly into rural youth, 
emphasise the importance of this unique ARCHER cohort. This paper provides an 
overview of this rural youth cohort including: i) hormones and pubertal status; (ii) 
physical health, health risk behaviours, sleep and environment; (iii) mental health; 
and (iv) overweight and obesity; and examines predictors of mental health and 
overweight and obesity in this rural sample. 
1.3. Methods 
The detailed methodology of the multidisciplinary ARCHER study has already been 
published (Steinbeck et al., 2012). Briefly, young people in school years 5 to 7, and 
their parents/guardians, were recruited from two regional centres, Dubbo and 
Orange, in the state of New South Wales, Australia and surrounding rural areas (see 
Figure 1). Recruitment was primarily through schools, with information sent home to 
parents/guardians. Other recruitment methods included flyers on community 
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noticeboards, through sporting clubs and through local digital and print media. The 
lower year 5 school limit was selected to ensure that participating adolescents were 
capable of self-report yet were captured before puberty was too advanced. Annual 
surveys of both adolescents and parents/guardians included demographics (individual 
and household), socioeconomic factors, sleep patterns, health risk behaviours, mental 
health and physical activity/lifestyle factors. Young people were asked to complete 
the Short Mood and Feelings Questionnaire (SMFQ; Angold et al., 1995) and high 
levels of depressive symptoms were defined by scores of 11 or higher. They self-
reported their Tanner stage and answered a question on perceived stage of pubertal 
development: “Compared to other kids your age and sex, what is your stage of 
puberty?” responding either ‘behind’, ‘the same’ or ‘in front’. 
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Figure 1. Australian remoteness areas (with detail for the Central West of NSW). 
Source: ABS Australian Standard Geographic Standard (ASGS) Digital Boundaries; 
ABS, 2013b. 
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In addition, data on anthropometry and puberty hormones in serum were collected 
annually from adolescents (only Wave 1 serum hormones are available at this stage). 
Serum testosterone and oestradiol were measured by liquid chromatography, mass 
spectrometry (PMID 19747904, 26090565). Weight was measured using Tanita 
TBF-300 Pro Body Composition Analyzer. Height was measured on a portable 
stadiometer (to 0.1 cm) using standard techniques. Body Mass Index (kg/m2) was 
converted to grades of thin, normal weight, overweight and obese using the 
International Obesity TaskForce cut-offs for age and sex (Cole and Lobstein, 2012). 
The study population all completed the baseline questionnaires and measurements 
between June 2011 and August 2013. Participation rates are shown in Table 1. While 
the overall retention rate was 82% (n=281/342), between adjacent Waves the 
retention ranged from 92% to 95%. Participants’ baseline characteristics were 
compared with data for local government areas (LGAs) containing over 5% of 
ARCHER households. These included Cabonne, Dubbo, Orange, and Wellington.  
From the 2011 Census, there were 5,754 adolescents aged 10 to 13 years resident in 
these four LGAs, 24,690 parents (aged 30 to 49 years) of adolescents aged 10 to 13 
years and 35,258 dwellings. 
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Table 1. Young ARCHER participants with complete survey data over four annual 
Waves of data collection 
 Enrolled Survey data 
available 
Wave 1 342 339 
 did not continue/moved out of area 27  
 skipped Wave 2 (rejoined Wave 3) 1  
Wave 2 314 (91.8%) 313 
 did not continue/moved out of area* 18  
 skipped Wave 3 (rejoined Wave 4) 1  
Wave 3 296 (94.3%) 295 
 did not continue/moved out of area 18  
Wave 4 281 (94.9%) 281 
* n=2 joined study at Wave 4 
N.B. % represents proportion retained from previous Wave. 
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1.3.1. Data analysis  
Measures of central tendency and dispersion are given as medians and interquartile 
ranges (IQR) due to skewed distributions for age, age at menarche and total sleep 
times. Associations between categorical data were estimated using the chi-squared 
test. Paired comparisons across the four Waves for typical hours slept on weekdays 
and on weekends were made using the non-parametric Friedman Test. Sleep 
compensation was defined as sleeping at least one hour longer on weekends than on 
school nights, and was based on self-reported total sleep time (TST). The 
relationship between age and sleep compensation was explored using a Spearman’s 
correlation (rs). Separate generalised estimating equation (GEE) models were used to 
predict depressive symptoms and O&O across the four Waves of data. Variables 
included in each of the regression models were age, socioeconomic status (highest 
household occupation), number of days of moderate to vigorous physical activity 
(MVPA, self-reported), self-reported TST during school nights and during the 
weekend, and either Tanner stage or perceived comparative stage of pubertal 
development (same, behind or in front). All analyses were carried out using IBM 
SPSS Statistics v24. Alpha was set at 0.05 for all comparisons. 
1.3.2. Ethics 
Approval for the ARCHER study was granted by The University of Sydney Human 
Research Ethics Committee (HREC 13094 approved 2010). Both parental (or 
guardian) consent and child assent to participate were obtained. 
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1.4. Results 
Median age of the 342 young participants at baseline was 11 years, 45% were female 
and 11% were Aboriginal or Torres Strait Islander adolescents. The sample was 
representative of the region in terms of gender (proportion in LGA 49% female), but 
slightly underrepresented youth of Aboriginal background (proportion in LGA 17%). 
The young people came from diverse socioeconomic backgrounds. Approximately a 
quarter (26%) of households included an adult with a managerial occupation, 
whereas for 17% the highest household occupation was sales, machinery operation, 
labouring or home duties. In comparison to the LGAs, participating families were 
generally more affluent (more likely to be employed: ARCHER 87% vs LGA 81%; 
and to own a house: ARCHER 80% vs LGA 68%) and better educated (ARCHER 
49% with tertiary education vs LGA 20%). Only one young person had left school at 
Wave 4. 
1.4.1. Puberty and hormones 
The majority of the adolescents were in early puberty according to testosterone and 
oestradiol levels in plasma at baseline (Wave 1) (see Figures 2a-b). Fifty six percent 
of females and 49% of males rated themselves as pre-pubertal or early-pubertal 
(Tanner stage 1 to 2; see Table 2). Just under one quarter of females (23.2%) and 
10.1% of males rated their stage of puberty as ‘behind’ compared to others their age 
and sex (see Table 2).
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Figure 2a. Serum testosterone (nmol/L) at baseline for males (n=166). 
 
 
Figure 2b. Serum oestradiol (pmol/L) at baseline for females (n=133). 
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Table 2. Pubertal stage at baseline, by age group and sex.  
 9 to 10  
years 
(n=88) 
11 to 12 
years 
(n=202) 
13 to 14 
years 
(n=49) 
Tanner Stage 1 or 2 77.3% 51.8% 8.2% 
 Females 84.6% 54.3% 5.6% 
 Males 71.4% 49.5% 9.7% 
    
Perceived comparative stage of puberty 
 Behind 23.9% 15.8% 2.0% 
 Same 60.2% 65.8% 77.6% 
 In Front 15.9% 18.3% 20.4% 
Females    
 Behind 33.3% 22.3% 5.6% 
 Same 51.3% 60.6% 72.2% 
 In Front 15.4% 17.0% 22.2% 
Males    
 Behind 16.3% 10.2% 0.0% 
 Same 67.3% 70.4% 80.6% 
 In Front 16.3% 19.4% 19.4% 
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1.4.2. Physical health, health risk behaviours and sleep  
According to parent/guardian reports, only approximately 1 in 10 young people met 
national guidelines for physical activity (i.e. at least 60 minutes every day of 
moderate to vigorous physical activity) (8.5 to 11.2% across the study Waves). In 
contrast, between 13.5 and 23.7% of young people reported at least 60 minutes of 
MVPA each day. Across the four time points, between 16.3 and 21.5% lived in a 
household with at least one smoker. The proportions of young people reporting 
smoking ‘even part of a cigarette’ (but more than ‘just a few puffs’) increased from 
1.5% (n=5/339) at Wave 1 to 7.5% (21/281) at Wave 4. The proportions reporting 
having had even part of an alcohol drink, beyond a few sips, was 2.1% (7/339) at 
Wave 1, and rose to a quarter of the sample (24.9%, 70/281) by Wave 4. Other drug 
use was minimal, with no reported amphetamine use at all, and marijuana use 
between 0.6% and 3.2% across the Waves. Approximately one in five (19.3%) young 
people reported having an illness, disability or handicap at least once during the 
study (point prevalence between 6.8% and 11.8%). Of these 66 young people, 42% 
(n=28) reported having asthma. 
Total sleep hours decreased across the four Waves: from a median for weekdays of 
10 hours down to 8.8 hours (p < 0.001) and on weekends from 9.3 hours down to 9 
hours (p < 0.01). Across the Waves, sleep compensation (sleeping at least one hour 
longer on weekends than on school nights) was reported by between 26.7% and 
40.9% of adolescents. The difference in weekend and school night total sleep hours 
was significantly positively correlated with age (rs = 0.15, p < 0.001), indicating 
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increased compensation with age. There was also increased weekend sleep 
compensation by Tanner stage for both females and males (see Figure 3).
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Figure 3. Weekend sleep compensation by sex and Tanner Stage.  
Data are regardless of Wave; N=1,195. 
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1.4.3. Mental health 
Just under a third (30.7%) of young people had experienced significant depressive 
symptoms over the four Waves, with point prevalence ranging from 10.5% (Wave 2) 
to 18.1% (Wave 4). Depression increased in prevalence with age: 12.0% of 9 to 11 
year olds, 13.9% of 12 to 14 year olds and 17.2% of 15 to 17 year olds. For females, 
depressive symptoms increased in prevalence with advancing Tanner stage (12% at 
stage 1 and 27% at stage 5; p < 0.01), whereas for males there was no clear pattern 
(see Figure 4a). Perceptions of comparative pubertal development were associated 
with depressive symptoms for males (p < 0.001). Among young males who 
perceived themselves as ‘behind’ the pubertal stage of their peers, 22% had 
depressive symptoms compared to 14% of those who thought they were ‘in front’ 
and 6% of those ‘the same’ as others (see Figure 4b). The association of perceived 
pubertal stage was not significant in females.
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Figure 4a. Significant depressive symptoms by sex and Tanner stage. 
Data are regardless of Wave; N=1,216. 
 
Figure 4b. Significant depressive symptoms by sex and perceived comparative stage 
of puberty. 
Data are regardless of Wave; N=1,225.  
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1.4.4. Overweight and obesity 
Prevalence of O&O ranged from 26.4 to 28.1% across the Waves (see Table 3). 
While prevalence of O&O was always higher in females (females: 29-32% vs males: 
23-25%), it was not significantly higher than males during any Wave. O&O was 
significantly associated with increasing Tanner stage in females (p < 0.05), but not 
males (see Figure 5a). For females who thought their pubertal stage was behind 
others their age and sex, 16% were O&O, compared to 31% of those ‘the same’ and 
52% of those ‘in front’ (p < 0.001). For males, the rates of O&O for those ‘behind’ 
were 22%, ‘the same’ 23% and ‘in front’ 31%, not a significant pattern (see Figure 
5b). 
Age at menarche was available for 84% of females, and the median age was 13 (IQR 
1.7). One-fifth (26/129) reached menarche before 12 years, 27.1% between 12 and < 
13 years and 52.7% from 13 years onwards. Considering data from all Waves, there 
was a significant relationship between age at menarche and O&O, 45.9% (n=45/98) 
of those having an earlier (before 12 years) menarche were O&O, compared with 
29.7% (35/118) in the average age menarche group and 26.1% (63/241) in the later 
(13 years onwards) menarche group (p < 0.01).
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Table 3. International Obesity Task Force BMI grades, across the four Waves. 
 Wave 1 
(n=341) 
Wave 2 
(n=313) 
Wave 3 
(n=293) 
Wave 4 
(n=274) 
Thin 6.5% 7.3% 5.8% 8.4% 
Normal 67.2% 66.5% 66.2% 63.5% 
Overweight 17.3% 18.2% 18.4% 17.9% 
Obese 9.1% 8.0% 9.6% 10.2% 
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Figure 5a. Overweight and obesity by sex and Tanner Stage. 
Data are regardless of Wave; N=1,203. 
 
 
Figure 5b. Overweight and obesity by sex and perceived comparative pubertal stage. 
Data are regardless of Wave; N=1,212. 
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1.4.5. Predictors of mental health 
Models were developed to predict mental health (SMFQ significant depressive 
symptoms) over the four Waves. Depressive symptoms in females was associated 
with greater age, lower SES and fewer hours sleep on weekdays. Depression in males 
was associated with perceived pubertal stage, with significantly lower odds of 
depressive symptoms if perceived stage was ‘the same’, compared to perceiving self 
to be ‘behind’ (OR 0.25, 95% CI 0.10-0.58) (see Table 4).
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Table 4. Odds of significant depressive symptoms (SMFQ) across the four Waves. 
SMFQ caseness Females Males 
 Odds ratio  
(95% confidence interval) 
Odds ratio  
(95% confidence interval) 
 Model 1 Model 2 Model 1 Model 2 
Age 1.24 (0.98-1.57) 1.23 (1.04-1.46)† 1.02 (0.74-1.41) 1.04 (0.79-1.37) 
SES 1.19 (1.03-1.37)† 1.19 (1.04-1.37)† 1.12 (0.97-1.29) 1.11 (0.96-1.29) 
MVPA (SR) 1.02 (0.90-1.17) 1.01 (0.89-1.16) 0.94 (0.80-1.10) 0.96 (0.81-1.13) 
School night TST 0.75 (0.62-0.91)‡ 0.75 (0.62-0.91)‡ 1.17 (0.85-1.60) 1.14 (0.84-1.55) 
Weekend TST 0.85 (0.72-1.01) 0.86 (0.73-1.02) 0.84 (0.69-1.03) 0.86 (0.70-1.07) 
Tanner Stage     
 Stage 1 1.00  1.00  
 Stage 2 1.10 (0.23-5.15)  0.51 (0.17-1.51)  
 Stage 3 0.81 (0.16-4.18)  0.37 (0.10-1.46)  
 Stage 4 1.11 (0.20-6.09)  0.68 (0.21-2.25)  
 Stage 5 0.81 (0.12-5.26)  0.59 (0.15-2.31)  
Comparative Stage     
 Behind  1.00  1.00 
 Same  0.63 (0.32-1.24)  0.25 (0.10-0.58)‡ 
 In Front  0.99 (0.46-2.12)  0.62 (0.25-1.57) 
Model 1 includes Tanner stage as a predictor; Model 2 includes Comparative stage of pubertal 
development as a predictor. 
MVPA (SR), moderate to vigorous physical activity, self-reported 
SES, Socioeconomic Status, higher ratings indicate poorer SES 
SMFQ, Short Mood and Feelings Questionnaire 
TST, total sleep time. 
† p < 0.05; ‡ p < 0.01 
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1.4.6. Predictors of O&O 
Tanner stage and perceived comparative pubertal stage were significant predictors 
for female O&O, but not males (see Table 5), with increased odds of O&O with 
higher Tanner stage or perceiving self as ‘same’ or ‘in front’ compared to being 
‘behind’ peers in pubertal development. Weekend total sleep time was a significant 
predictor for males but not females, with O&O males having shorter weekend TST 
(median 8 hours) than normal weight males (median 9 hours). Self-reported MVPA 
was a significant predictor for both sexes, with O&O associated with fewer days of 
sustained physical exercise.
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Table 5. Odds of Overweight and Obesity across the four Waves. 
O&O Females Males 
 Odds ratio  
(95% confidence interval) 
Odds ratio  
(95% confidence interval) 
 Model 1 Model 2 Model 1 Model 2 
Age 0.73 (0.56-0.95)† 0.89 (0.74-1.07) 1.04 (0.83-1.30) 1.08 (0.93-1.25) 
SES 1.10 (0.93-1.32) 1.12 (0.94-1.34) 0.96 (0.82-1.14) 0.97 (0.82-1.14) 
MVPA (SR) 0.82 (0.73-0.93)‡ 0.83 (0.74-0.93)‡ 0.88 (0.78-0.99)† 0.88 (0.77-0.99)† 
School night TST 0.89 (0.73-1.09) 0.86 (0.71-1.05) 1.11 (0.93-1.32) 1.11 (0.94-1.32) 
Weekend TST 0.92 (0.77-1.11) 0.95 (0.80-1.14) 0.85 (0.76-0.95)‡ 0.85 (0.76-0.95)‡ 
Tanner Stage     
 Stage 1 1.00  1.00  
 Stage 2 1.45 (0.55-3.83)  0.84 (0.30-2.39)  
 Stage 3 2.68 (0.86-8.35)  1.40 (0.45-4.37)  
 Stage 4 2.67 (0.71-10.1)†  1.16 (0.34-3.90)  
 Stage 5 5.95 (1.30-27.3)†  1.23 (0.30-5.00)  
Comparative stage     
 Behind  1.00  1.00 
 Same  2.37 (1.25-4.49)‡  1.31 (0.71-2.40) 
 In Front  5.48 (2.43-12.4)₽  2.00 (0.94-4.28) 
Model 1 includes Tanner stage as a predictor; Model 2 includes Comparative stage of pubertal 
development as a predictor. 
MVPA (SR), moderate to vigorous physical activity, self-reported 
SES, Socioeconomic Status, higher ratings indicate poorer SES 
SMFQ, Short Mood and Feelings Questionnaire 
TST, total sleep time. 
† p < 0.05; ‡ p < 0.01; ₽ < 0.001 
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1.5. Discussion 
Special features of the ARCHER study are its rural location and large sample size for 
a study which involves intense biological sampling and family data collection. Few 
other studies nationally or internationally have achieved this sample size or focussed 
on rural young people. Three local birth cohorts, Dunedin and Christchurch from 
New Zealand (Marie et al., 2008; Poulton et al., 2006), and Raine from Western 
Australia (McKnight et al., 2012) have less frequent review and/or limited biological 
data collection. The Copenhagen Puberty study includes 4,000 children, of which 
only 209 provided consent for six-monthly blood samples (Aksglaede et al., 2009).  
The strengths of the ARCHER study are the detailed description of biological 
puberty, the data collection from both adolescents and their parents and the high 
retention in the study. An additional strength of the ARCHER study is that the data 
are obtained from young people growing up in regional and rural NSW, Australia. 
This location allows the investigators to consider additional aspects of rural health. 
The local community, including young people, have been involved since the 
conception of the study through ARCHER Community Consultative Committees and 
focus groups (Cooper Robbins et al., 2012). Their input has guided the study 
questions, methods, recruitment and retention, an additional strength of this cohort 
study. The ARCHER cohort is not a representative population sample. As with all 
recruitment into adolescent longitudinal studies with an intensive biological 
sampling methodology (Jeffery et al., 2012; Sorensen et al., 2010) the makeup of the 
sample is largely dictated by those who volunteer, and may therefore have some 
selectivity which may create participation bias.   
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The present analysis demonstrates that there is sufficient power and variability in the 
ARCHER study to draw conclusions about the biological effects of puberty 
hormones while also providing a sample that is both diverse and has the capacity to 
report on a range of rural and regional adolescent determinants of health, health risk 
factors and outcomes. The collection of the detailed annual questionnaires and 
anthropometry with the biological data in the ARCHER study will allow for the first 
time, the future investigation of the interactions of puberty hormones with the social, 
environmental and cultural factors that impact on and determine adolescent physical 
and mental health. To provide a clear description of the individual tempo of puberty 
the ARCHER study will use mass spectrometry-based urinary steroid assays to 
monitor hormone change in participant’s urine at three monthly intervals. 
This cohort exhibits expected adolescent behaviours and outcomes including 
changing sleep patterns, increases in health risk behaviours (such as smoking and 
alcohol consumption), mental health symptoms and O&O. A substantial proportion 
of the cohort were captured in early puberty, as indicated by serum hormones and 
self-report. This is important in order to study the longitudinal relationship between 
puberty and health. We demonstrated known relationships between pubertal stage 
and obesity in females. Interestingly, recent reports indicate an association between 
higher androgens and obesity in adolescent females (Cree-Green et al., 2015). 
However, models in this paper only used self-reported pubertal staging and perceived 
comparative development. Once longitudinal serum hormone data are available, the 
ARCHER study will be able to investigate relationships between the timing and 
tempo of puberty and health outcomes.  
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The predictive models in this study demonstrate the complex inter-relationships 
between physical and social determinants of health, with household socioeconomic 
status an important factor for female mental health and sleep having a relationship 
with both mental health and O&O. Specifically, increased school night sleep was 
associated with lower odds of significant depressive symptoms in females and 
increased weekend sleep with lower odds of O&O in males. There is little known 
about sleep in rural adolescents, which may be affected by specific rural 
determinants or cultural values and attitudes towards health risk behaviours 
(Reichenberger et al., 2016). To the authors’ knowledge this is the first study in rural 
Australian adolescents.  
Approximately 30% of the young participants in the ARCHER study experienced 
significant depressive symptoms at some stage of the study. While data indicate that 
rates of high psychological distress in secondary students in NSW are no higher in 
rural-regional than in metropolitan Local Health Districts (LHDs) (13.2% versus 
13.4%), hospitalisations for intentional self-harm among 15 to 24 year olds are 
significantly higher (326.9 to 422.5 in regional and remote areas versus 280.9 per 
100,000 population in major cities) (HealthStats NSW), making prevention of 
depression in young people an important rural public health issue. We confirmed the 
known relationship, for females, with pubertal development and depressive 
symptoms. Interestingly it was only perceived comparative pubertal stage that was an 
important predictor for males. 
Another important public health issue for rural youth is O&O. Rates of O&O among 
secondary students aged 12 to 17 years in NSW in 2014 were higher in rural and 
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regional LHDs (23.0%) than in metropolitan LHDs (19.7%) (NSW HealthStats). 
Little is known about any specific factors that are associated with overweight and 
obesity in young people living in regional and rural Australia. Rural and regional 
areas are diverse and differ from urban areas not only from an environmental 
perspective but also socioeconomically and culturally. Lower population densities, 
fewer transport options, and reduced access to health services challenge health 
promotion activities that might be effective in urban areas. More information is 
needed about O&O in rural and regional young people to better inform interventions 
(Pucius, 2008). As puberty is a risk factor for obesity (Jasik and Lustig, 2008), a 
study that captures early adolescence has a major scientific advantage. In the current 
preliminary analysis, we confirmed the relationship between physical activity and 
O&O, and found that pubertal factors were relevant for females and that sleep, 
particularly on the weekend, was a significant factor for males. This cohort provides 
a valuable data source to determine further, unidentified factors associated with 
O&O in rural adolescents. 
1.5.1. Conclusion 
We have successfully recruited and maintained an adolescent cohort to answer novel 
research questions. The ARCHER study provides a unique opportunity to investigate 
young people as they transition through adolescence. It is already contributing to our 
knowledge of rural adolescent health, and will allow the future investigation of the 
interactions of puberty hormones with the social, environmental and cultural factors 
that impact on and determine adolescent physical and mental health. Data generated 
will further our understanding of puberty and its effects as well as providing insight 
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into the specific determinants of health for young people growing up in non-
metropolitan NSW and importantly will allow for the development of appropriate, 
targeted interventions in at risk groups. 
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1.1. Abstract 
1.1.1. Objectives 
Urinary hormone concentrations are often adjusted to correct for hydration status. 
We aimed to determine whether first morning void urine hormones in growing 
adolescents require adjustments and, if so, whether urinary creatinine or specific 
gravity are better adjustments. 
1.1.2. Design and methods 
The study population was adolescents aged 10.1 to 14.3 years initially who provided 
fasting morning blood samples at 0 and 12 months (n = 343) and first morning urine 
every three months (n = 644). Unadjusted, creatinine and specific gravity-adjusted 
hormonal concentrations were compared by Deming regression and Bland–Altman 
analysis and grouped according to self-rated Tanner stage or chronological age. F-
ratios for self-rated Tanner stages and age groups were used to compare unadjusted 
and adjusted hormonal changes in growing young adolescents. Correlations of paired 
serum and urinary hormonal concentration of unadjusted and creatinine and specific 
gravity-adjusted were also compared. 
1.1.3. Results 
Fasting first morning void hormone concentrations correlated well and were 
unbiased between unadjusted or adjusted by either creatinine or specific gravity. 
Urine creatinine concentration increases with Tanner stages, age and male gender 
whereas urine specific gravity was not influenced by Tanner stage, age or gender. 
Adjustment by creatinine or specific gravity of urinary luteinizing hormone, 
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estradiol, testosterone, dihydrotestosterone and dehydroepiandrosterone 
concentrations did not improve correlation with paired serum concentrations. 
1.1.4. Conclusions 
Urine steroid and luteinizing hormone concentrations in first morning void samples 
of adolescents are not significantly influenced by hydration status and may not 
require adjustments; however, if desired, both creatinine and specific gravity 
adjustments are equally suitable. 
1.2. Introduction 
Measurements of urinary gonadotropins and steroids in children and adolescents 
emerged as methods to estimate pubertal development and gonadal function early in 
the immunoassay era (1-3). Urine sampling provides an integrated measurement 
especially for hormones such as luteinizing hormone (LH) (4) secreted in pulsatile 
manner or diurnally like sex steroids in early puberty and is more acceptable to 
children and adolescents than venipuncture. The relatively high hormone 
concentrations in urine compared with blood or saliva, together with the ability to 
concentrate urine, is advantageous for assays with low sensitivity or analytes at low 
concentrations. However, an inherent problem of using urine is the wide and 
unregulated variation reflecting the individual’s fluid status. 
Urine dilution or concentration creates corresponding changes in urine solute 
concentrations so that adjustment of urine concentration may be required to avoid 
misinterpreting hormone excretion due to variation in hydration (5). Osmolality, 
specific gravity (SG) and creatinine measurements are used to adjust hydration 
Appendix C: Specific Gravity and Creatinine Adjustments for Urine Hormone Analysis
279
  
(6). Although measurement of osmolality by freezing point depression is considered 
the reference method (7), it is laborious, time consuming and expensive and so is 
usually replaced by SG and creatinine measurements particularly for large-scale field 
studies. Urinary SG is measured using a refractometer to compare light refraction of 
a urine sample against pure water standard or by reagent strips which measure the 
ionic strength of urine by colour changes. Urine SG of sample is normalized to a 
population reference value. While SG measurement has been largely superseded by 
urine creatinine adjustment in clinical laboratories, SG adjustment for urine dilution 
remains standard in antidoping laboratories and is used in some toxicology studies 
(8). Creatinine adjustment is based on the assumption that (a) this end-product 
formed endogenously from muscle creatine is released into the bloodstream and 
excreted in urine at a constant rate depending only on total muscle mass (9) and (b) 
endogenous hormones and creatinine undergo renal excretion at the same rate 
(6). Yet, creatinine excretion rate may be influenced by the growing muscle mass 
during puberty leading to potential systemic errors in using creatinine adjustments 
(10).  
Some (11, 12) but not other (13-17) studies suggest creatinine or SG adjustment for 
measurement of urinary substances although such adjustments may be either 
unnecessary or even introduce additional measurement errors. Furthermore, none has 
focused on situations where creatinine is changing systematically due to somatic 
growth. Thus, the present study aimed to determine whether the first morning void 
hormonal assessments carried out in growing young adolescents at various stages of 
pubertal progression require adjustments and, if so, to determine whether creatinine 
or SG adjustment was better. 
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1.3. Materials and Methods 
1.3.1. Samples 
Adolescents aged 10.1 to 14.3 years initially were recruited from local secondary 
schools in the state of New South Wales (NSW), Australia. Ethical approval was 
obtained from the Human Research Ethics Committee, University of Sydney (HREC 
13094). Fasting morning blood samples were collected at 0 and 12 months (n = 343), 
and first morning urine collected three monthly after 12 h fasting at home by the 
adolescents between 7:00 and 8:30 (n = 644). Postmenarcheal girls provided samples 
in the mid-follicular phase (days 7–10) with the assumption of 28 to 32-day cycle. 
Serum and urine samples were stored at −80℃ until analysis. The adolescents also 
provided a self-rating of puberty using line drawings based on the Tanner stages at 0 
and 12 months. 
1.3.2. Assays 
Urine SG was measured by immersing a reagent strip (ChoiceLine 10, Roche 
Diagnostics) in freshly voided urine samples. Dipstick colour changes were 
compared visually with the colour chart to estimate the SG. Urine samples were 
subsequently stored at −80℃ and subjected to three freeze–thaw cycles for LH, 
creatinine and steroid analysis. The urine samples were first thawed and assayed for 
LH measurements with the Immulite 1000 LH (Siemens) as described previously 
(18). The within-assay coefficients of variation were <10%. The samples underwent 
second freeze-thaw cycle for the creatinine measurements. Urine creatinine 
concentrations were determined by the colorimetric alkaline-picrate (Jaffé) method 
(CREJ2, Roche Diagnostics, Cat. No. 04810716 190) on a Cobas C501 analyzer 
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(Roche Diagnostics GmbH, Indianapolis, IN). Calibrators (Roche Diagnostics, Cat. 
No. 10759350 190) were used for this automated system to generate a linear curve 
ranging between 375 and 55,000 µmol/L and the limit of detection of 375 µmol/L. 
The final urine thaw was for urine steroid measurement. Urinary and serum estradiol 
(E2), testosterone (T), dihydrotestosterone (DHT) and dehydroepiandrosterone 
(DHEA) were measured by liquid chromatography tandem mass spectrometry (LC–
MS/MS) as modified from a previously described method for serum (19) and adapted 
for urine specimens following deconjugation, with details described in the 
Supplementary Materials. 
The LH and steroid concentrations were adjusted to standard SG of 1.020 according 
to the formula [hormone concentrationsample × (1.020−1)/(SGsample−1)] (20) and to 
standard CR measurement of the present study adolescent population (12.40 mmol/L 
[n = 644; F 331]) using the formula [hormone 
concentrationsample × (Creatininepopulation/Creatininesample)] where 
Creatininepopulation was defined as the mean of the urinary creatinine of the whole 
sample. 
1.3.3. Data Analysis 
The steroid and LH concentrations unadjusted and adjusted for SG or creatinine were 
compared by Deming (orthogonal) regression and deviance (Bland–Altman) analysis 
using MedCalc software. Based on using the same analyte with different 
adjustments, the variance ratio in the Deming regression was assumed to be unity. 
Non-independence according to variations in the number of samples provided by 
each individual was ignored in this analysis. Descriptive statistics including mean, 
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standard deviation (SD) and standard error of mean (SEM) were performed by SPSS 
version 21. The F-ratios of age and Tanner stage group comparison for each 
hormone were calculated by one-way ANOVA separately for each gender. 
1.4. Results 
In first morning urine void samples (n = 644), the mean (SD, range) creatinine 
concentration was 12.4 (4.5, 1.4–31.5) mmol/L with an overall gender difference 
being higher in men (P < 0.05). The SG was 1.020 (0.0054, 1.005–1.030) without 
significant gender difference (P = 0.054). Urine creatinine concentrations were 
progressively increased according to chronological age and to Tanner stage (Figure 
1) for both genders. Pooling genders, there were significant differences in urine 
creatinine concentrations by age and Tanner stage (P < 0.05, two-way ANOVA) but 
not for urine SG according to age (P = 0.29) or Tanner stages (P = 0.22) (data not 
shown). 
Urinary LH, E2, T, DHT and DHEA concentrations, adjusted for either SG or 
creatinine, are compared according to Deming regression line, and the deviance plots 
are shown in Figure 2. For each urinary hormone concentration, there was a good 
correlation between the SG and creatinine-adjusted concentrations (R2: 0.69–0.85) 
free from proportional bias between adjustment methods. 
Similarly, Deming regression and Bland–Altman comparison between the unadjusted 
and adjusted hormone concentrations with either SG or creatinine (Table 1) also 
demonstrate lack of bias whether adjusted or not by either creatinine or SG. 
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The mean, SD and F-ratios of the unadjusted, SG-adjusted and creatinine-adjusted 
hormones according to Tanner stages and age groups in women and men are shown 
in Supplementary Tables 3 and 4 and Supplementary Tables 5 and 6, respectively. 
The results show consistent estimates and progression according to age and Tanner 
stage of unadjusted, SG-adjusted and creatinine-adjusted urine LH and steroid 
concentrations. The mean, SD and F-ratios of serum hormones according to Tanner 
stage and age groups are shown in Supplementary Tables 7 and 8.  
The correlation coefficient of paired urinary and serum hormone concentrations is 
given in Table 2. The unadjusted and adjusted (creatinine and SG) urinary LH, E2, T, 
DHT and DHEA concentration showed similar correlation against serum. The 
samples were also grouped into three creatinine and SG percentile ranges (up to 25th 
percentile, between 25th to 75th percentile and above 75th percentile), and 
regression analysis was performed between unadjusted/adjusted urine hormone 
concentrations against serum hormone concentrations (data not shown). There were 
no improvements in the correlation coefficient values within the groups. Dividing the 
same percentiles according to gender also did not improve the correlations between 
the urine unadjusted/adjusted hormones against serum hormones concentrations (data 
not shown). 
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Figure 1. Plot of urinary creatinine measurements of adolescents groups according 
to age (left panel) and Tanner stage (right panel). Data represent the creatinine mean 
and SEM. For the age plot, samples were from 3-monthly intervals (n = 644) whereas 
for the Tanner stage plot, samples were from 0 and 12 months (n = 359). 
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Figure 2. Comparison of urinary LH, E2, T, DHT and DHEA concentrations 
adjusted by SG and creatinine. Comparison was made according to Deming 
regression analysis (left panels) and Bland–Altman plots (right panels). For the 
Deming plots, the slope is shown as a solid line and line of identity in fine dotted 
line. Insets are the regression formula and 95% confidence limits on the intercept and 
slope. The Bland–Altman plots represent the differences between creatinine and SG-
adjusted hormone concentrations against the averages of the hormone concentrations 
adjusted with the two correction method. The solid line and the dashed lines 
represent the observed average and the 95% limit of confidence (±1.96 SD), 
respectively. 
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1.5. Discussion 
Urinary measurement of reproductive hormones is a convenient means to evaluate 
pubertal status and gonadal function for field population studies. In clinical settings, 
adjustment based on the assumption of stable urine creatinine excretion is commonly 
used to adjust for variations in hydration although other techniques such as 
regression normalization or log transformation are proposed (10, 21). As an end 
metabolite of muscle creatine, urine creatinine is determined by total muscle mass in 
addition to other factors such as age, gender, diet (meat consumption), physical 
activity and body mass index, some of which exert their effects via changes in 
muscle mass (6, 17, 22, 23). Hence, one aim of the present study was to determine 
for the first time whether creatinine adjustment was valid or required for longitudinal 
studies of growing adolescents. 
Our findings confirm that the first morning urine creatinine concentration increases 
with age and Tanner stages and was higher among men. However, adjustment for 
urine creatinine was no better or worse than adjustment for SG or even no 
adjustment. This may reflect the fact that we studied first morning void urine 
samples which control hydration, whereas similar interpretation may not apply to 
urine sampled at random when hydration state may vary more. Our findings are 
consistent with previous studies showing prominent intra- and interindividual 
variability in creatinine excretion of second morning and 24 h urine samples in adults 
due to variable fluid intake (17). Significantly higher creatinine concentrations in 
morning versus afternoon (24), in evening spot samples (6) and creatinine loss due to 
multiple freeze–thaw cycles have also been reported (25, 26) all of which introduce 
systematic errors in use of urine creatinine for dilution adjustments. Thus, although 
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studies have suggested alternative adjustment based on SG in adult humans and 
primates (27, 28), none has focused on the need for SG adjustments in first morning 
voids of growing adolescents. 
SG is readily measured by reagent strip for field studies without needing a 
laboratory. Previous studies demonstrate good agreement between SG measurements 
by reagent strip versus refractometer (29, 30) or osmolality (30-32). SG 
measurement by reagent strip is widely used in clinical applications (32, 
33). Although refractometer urine SG may be influenced by disease states leading to 
high serum protein or glycosuria (7, 34), reagent strip SG is not affected by glucose, 
only minimally by urea and albumin, but may be affected by the rare instances of 
alkaline urine (31). Urine SG reading may also be influenced by diet, environment 
and the renal reabsorption capacity (35). Among adolescents, we find that urine SG 
measured with reagent strips is systematically not influenced by age or gender 
consistent with previous reports (22, 36).  
Limits of acceptable creatinine and SG measurements vary between studies. 
Generally, urine is considered too dilute when the SG and creatinine concentrations 
are lower than 1.010 and 0.5 g/L (4.4 mmol/L), respectively, and too concentrated 
where SG and creatinine concentrations higher than 1.030 (or 1.035) and 3 g/L 
(26.5 mmol/L), respectively (17, 35). However, due to the standardized method of 
collection and hydration (first morning void), the present study did not discard any 
samples as too dilute or too concentrated. 
The present study demonstrated that the fasting first morning void urine hormone 
concentrations adjusted by creatinine correlated well with those adjusted by SG in 
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this adolescent population. This is consistent with previous reports that used 
randomly collected or timed urine collection from children and adults showing good 
correlations when creatinine and SG adjustments were compared directly (5, 12, 21, 
23, 35, 37) or with adjustment according to both (5, 27, 28) including a reduced 
variation using these adjustments in some studies (10, 12). However, the present 
study shows that neither of the adjustment methods for first morning void urine 
sample of adolescents were significantly improved compared with unadjusted 
hormone concentrations. These observations are consistent with previous reports for 
creatinine adjustment of urine steroid measurements in adult women (38, 39).  
In studies where the urinary hormone concentrations were correlated with paired 
circulating serum concentrations, the urinary unadjusted concentration or 
concentration expressed by volume of urine correlates better than the adjustment 
based on analyte to creatinine ratios (11, 13, 40), although some studies have shown 
improved correlation with creatinine adjustments (41, 42). The present study 
demonstrated that the urinary hormone concentrations adjusted with creatinine, and 
SG did not improve the correlation with paired serum concentrations. These samples 
were also grouped into three creatinine and SG percentile ranges (25th, 25–75th and 
75th) to replicate non-fasting conditions with wider variation in hydration status. 
However, no improvement was observed in terms of correlation between the 
unadjusted or adjusted urine hormone and paired serum concentrations. These 
findings further support that the adjustments may not be necessary for first morning 
void urine samples. 
In conclusion, the present study shows that adjustment of urinary steroid and LH 
concentration for hydration state may not be required for first morning void 
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specimens of even growing adolescents. If adjustments are required, then either 
creatinine or SG is equally suitable and provides comparable results. Reagent strip 
SG measurements are simple and sufficiently reliable, economical and time-saving 
for large numbers of urine sampling in long-term field studies. 
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APPENDIX D: SUPPLEMENTARY MATERIAL 
FOR CHAPTER 3 
Supplement A: Search Strategy 
MEDLINE 
1. Adolescent/
2. schools/ or students/
3. exp Puberty/
4. (adol* or teen* or juvenile* or youth* or student*).tw.
5. pubert*.tw.
6. 1 or 2 or 3 or 4 or 5
7. Adolescent Psychology/ or Adolescent Psychiatry/
8. behav*.tw.
9. adolescent behaviour/ or Behaviour/ or behavioural symptoms/ or affective
symptoms/ or aggression/ or agonistic behaviour/ or bullying/ or depression/ or self-
injurious behaviour/ or self mutilation/ or stress, psychological/ or drinking
behaviour/ or alcohol drinking/ or drug-seeking behaviour/ or impulsive behaviour/
or risk reduction behaviour/ or risk-taking/ or social behaviour/ or Risk-Taking/ or
Accidents/ or accidents, home/ or accidents, traffic/ or Dangerous Behaviour/ or
impulsive behaviour/ or compulsive behaviour/ or behaviour, addictive/
10. (Social* adj3 (behav* or conform* or adjustment or dominan*)).tw.
11. (Behav* adj3 (competitive or cooperative)).tw.
12. (Risk adj3 (taking or behav*)).tw.
13. (impulsiv* or dangerous* or dangerous behav* or hazardous or delinqu* or
antisocial behav* or conduct disorder* or oppositional defian*).tw.
14. exp Substance-Related Disorders/
15. (drug taking or drug abuse or smok* or tobacco or alcohol or addiction* or
substance abuse or drug dependenc*).tw.
16. (accident* or crash* or traffic accident*).tw.
17. exp Self Concept/
18. Body Image/ or personal autonomy/
19. (Self adj3 (concept* or image* or esteem or perception*)).tw.
20. exp aggression/ or bullying/
21. Violence/ or Juvenile Delinquency/ or Student Dropouts/ or Social Behaviour
Disorders/
22. (aggress* or violen* or bully* or bullies).tw.
23. mental disorders diagnosed in childhood/ or "attention deficit and disruptive
behaviour disorders"/ or child behaviour disorders/ or "feeding and eating disorders
of childhood"/ or Antisocial Personality Disorder/ or Conduct Disorder/
24. social behaviour/ or aggression/ or competitive behaviour/ or cooperative
behaviour/ or helping behaviour/ or shyness/ or social dominance/ or social
identification/ or social isolation/ or social stigma/
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25. exp Self-injurious behaviour/  
26. exp Suicide/ 
27. emotions/ or affect/ or irritable mood/ or anger/ or rage/ or anxiety/ or apathy/ or 
boredom/ or happiness/ or hate/ or hostility/ 
28. (emotion* or mood* or bored* or hostil* or apath* or frustrat*).tw. 
29. exp mood disorders/ 
30. mental disorders/ or Depression/ or anxiety disorders/ or eating disorders/ or 
mood disorders/ or sleep disorders/ or substance-related disorders/ 
31. (depress* or suicid* or parasuicid* or self harm* or self injur* or self destruct* 
or self mutilat*).tw. 
32. (anxiet* or nervous* or anxious).tw. 
33. motivation/ or achievement/ or "conflict (psychology)"/ or drive/ or goals/ or 
"power (psychology)"/ 
34. (motivat* or ambition*).tw. 
35. exp Sleep Disorders/ 
36. sleep/ or sleep disorders/ or dyssomnias/ or sleep deprivation/ or sleep disorders, 
circadian rhythm/ or sleep disorders, intrinsic/ 
37. (sleep* or insomnia or sleep disorder or late waking).tw. 
38. or/7-37 
39. exp Estrogens/ 
40. exp Oestradiol/ 
41. (estrogen or oestradiol or ?oestradiol or ?estrogen*).mp. 
42. 39 or 40 or 41 
43. 6 and 38 and 42 
65. limit 64 to humans 
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Supplement B: Table of Excluded Studies 
Author Year Reason for Exclusion 
Attie et al. 1989 No oestradiol measurement 
Avgoustinaki et al. 2012 Subjects outside of age range; no methodology for hormone measurement 
provided 
Baker et al.  2007 Oestradiol was combined with other markers of pubertal development 
meaning no analysis of oestradiol’s effects in isolation were given 
Balada et al. 1993 Outside age range 
Barrack et al. 2010 Subjects were a small number of elite runners and thus not a representative 
community sample 
Benjet et al. 2001 No oestradiol measurement 
Benjet et al. 2002 No oestradiol measurement 
Blyth et al. 1985 No oestradiol measurement 
Boettinger et al.  2010 Outside age range 
Brambilla et al.  2001  Outside age range 
Brooker et al.  2012 No oestradiol measurement 
Bruinsma et al.  2006 No oestradiol measurement 
Chandrashekhar et al.  2001 No oestradiol measurement 
Colzato et al.  2012 Outside age range; assessed cognitive, not behavioural outcomes 
Cotrufo et al.  2000 Outside age range 
Culbert et al.  2011 Review article 
Daitzman et al.  1980 Male only 
de Water et al.  2013 Females on oral contraceptive pill included (continuous contraception e.g. 
Mirena excluded) 
DeBruine et al.  2005 No oestradiol measurement 
Deng et al.  2011 Outside age range; looking at menstrual cycle changes 
DeRose et al.  2011 No oestradiol measurement 
Dick et al.  2001 No oestradiol measurement 
Dorgan et al.  2003 Oestradiol was a dependent variable 
Drapela et al.  2006 No oestradiol measurement 
Dubas et al.  1991 No oestradiol measurement 
Duncan et al.  1985 No oestradiol measurement 
Durante et al.  2009 Assertive mating is not a relevant behaviour 
Edelstein et al.  2012 Oestradiol was a dependent variable 
Edelstein et al.  2010 One third of females on oral contraceptive pill; behaviour is sexual 
Edwards et al.  2011 No oestradiol measurement 
Ehrhardt et al.  1981 No oestradiol measurement 
Finkelstein et al.  1997 Exogenous oestradiol used 
Fujisawa et al.  2012 Outcome of interest, loneliness, was not considered a behaviour or mood 
Ge et al.  2002 No oestradiol measurement 
Ge et al.  2001 No oestradiol measurement 
Ge et al.  2001 No oestradiol measurement 
Gearing et al.  2009 No oestradiol measurement 
Goddings et al.  2012 Neuroimaging study without validated behavioural or affective measure 
Hayward et al.  2002 No oestradiol measurement 
Inoff-Germain et al.  1988 Subjective assessment of behaviour 
Joinson et al.  2012 No oestradiol measurement 
Klump et al.  2006 Outside age range 
Klump et al.  2008 Outside age range 
Lazaro et al.  1996 Eating disorder cohort with no controls (oestradiol is affected by 
malnutrition) 
Llewellyn et al.  2012 No oestradiol measurement 
Mendle et al.  2012 No oestradiol measurement 
Pahlen et al.  2005 Review 
Paikoff et al.  1991 Oestradiol and behaviour not contemporaneous 
Pajer et al.  2006 Some subjects on oral contraceptive pill 
Reynolds et al.  2011 No oestradiol measurement 
Reynolds et al.  2012 No oestradiol measurement 
Riecher-Rössler et al.  1994 Outside age range 
Schelleman-
Offermans et al.  
2011 No oestradiol measurement 
Schiefelbein et al.  2005 No oestradiol measurement 
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Schiller et al.  2012 Outside age range 
Schwartz et al.  2012 Outside age range 
Smiarowska et al. 2002 No control group 
Soldin et al.  2011 Outside age range 
Susman et al. 1996 Oestradiol was a dependent variable 
Swarr et al.  1996 No oestradiol measurement 
Vermeersch et al.  2008 Male only 
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APPENDIX E: SUPPLEMENTARY MATERIAL 
FOR CHAPTER 4 
Supplement A: Search Strategy for MEDLINE 
1. exp adolescent/
2. exp schools/
3. exp students/
4. exp puberty/
5. (adol* or teen* or juvenile* or youth*).tw.
6. pubert*.tw.
7. (student* or school-student* or high-school student*).tw.
8. (school* or high-school*).tw.
9. or/1-8
10. exp "behavior and behavior mechanisms"/ or exp "psychological phenomena and
processes"/ or exp "behavioral disciplines and activities"/
11. exp Substance-Related Disorders/
12. exp Sleep Disorders/
13. exp Accidents, Traffic/ or exp Accidents/ or exp Accidents, Home/
14. behav*.tw.
15. (self concept* or self image* or self esteem or self perception* or body image or
personal autonomy).tw.
16. (risk taking or risk behav*).tw.
17. (aggress* or violen* or bully* or bullies or cyber bull*).tw.
18. depress*.tw.
19. (suicid* or parasuicid* or self harm* or self injur* or self destruct* or self mutilation).tw.
20. (anxiet* or nervous*).tw.
21. (dangerous* or dangerous behav* or hazardous).tw.
22. (impulsiv* or impulsive behav*).tw.
23. (emotion* or moodiness or boredom or hostilit* or apath* or frustrat*).tw.
24. (drug taking or drug abuse or smok* or tobacco or alcohol or addiction* or substance
abuse or drug dependenc*).tw.
25. (motivat* or ambition*).tw.
26. (self concept* or self discrepanc*).tw.
27. (delinqu* or antisocial behav* or conduct disorder* or oppositional defian*).tw.
28. (social behav* or social conformity or social adjustment or social dominance or
competitive behav* or cooperative behav*).tw.
29. (sleep* or insomnia or sleep disorder or late waking).tw.
30. (accident* or crash* or traffic accident*).tw.
31. or/10-30
32. exp Testosterone/
33. exp androgens/
34. testosterone.tw.
35. androgen*.tw.
36. or/32-35
37. 9 and 31 and 36
38. limit 37 to humans
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Supplement B: Characteristics of excluded studies 
Author Year Reason for exclusion 
Angold, A, et al. 1999 Time of testosterone collection not documented 
Banks, T, et al. 1996 Outside age range 
Bauman, KE, et al. 1992 Time of testosterone collection not documented 
Bauman, KE, et al. 1989 Time of testosterone collection not documented 
Biro, FM, et al. 2006 Review article 
Book, AS, et al. 2005 Reanalysis of meta-analysis  
Book, AS, et al. 2001 Meta-analysis; all age groups 
Brambilla, F, et al. 2001 Outside age range 
Bricker, J 2011 Focus on sexual behavior  
Bricker, JB, et al. 2006 Focus on sexual behavior  
Brooks, JH, et al. 1996 Young offenders: no normal controls 
Buchanan, CM 1989 No specific moods reported 
Cafri, G, et al. 2006 No measurement of testosterone 
Campbell, A, et al. 1997 Outside age range 
Christiansen, K 2001 Review  
Cota-Robles, S, et al. 2002 No measurement of testosterone 
Dabbs, JM, et al. 1991 Young offenders: no normal controls 
Daitzman, RJ, et al. 1978 Outside age range 
Dmitrieva, TN, et al. 2001 No data for relationship in control group 
Dorn, LD, et al. 2003 No measures of behavior  
Dorn, LD, et al. 1999 No measurement of testosterone 
Dorn, LD, et al. 2009 No data for relationship in control group; outside age range 
Drigotas, SM, et al. 1993 Testosterone level and behavior not contemporaneous 
Felson, RB, et al. 2002 No measurement of testosterone 
Field, T 2002 Review  
Forbes, EE, et al. 2010 No direct data between testosterone and behavior, (testosterone and fMRI) 
Fujisawa, TX, et al. 2011 No measurement of testosterone 
Gallup, AC, et al. 2010 No measurement of testosterone 
Gallup, AC, et al. 2007 Outside age range 
Granger, DA, et al. 1994 Letter which did not present original data 
Halpern, CT, et al. 1992 Study of testosterone  
Halpern, CT, et al. 1994 Focus on sexual behavior  
Halpern, CT, et al. 1993 Focus on sexual behavior  
Halpern, CT, et al. 1997 Focus on sexual behavior  
Halpern, CT, et al. 1998 Focus on sexual behavior  
Hassler, M 1991 Cognitive rather than behavioral outcomes 
Hassler, M 1991 Cognitive rather than behavioral outcomes 
Hassler, M 1992 Cognitive rather than behavioral outcomes 
Hassler, M 1992 Cognitive rather than behavioral outcomes 
Hassler, M, et al. 1993 Cognitive rather than behavioral outcomes 
Hassler, M, et al. 1992 Cognitive rather than behavioral outcomes 
Hassler, M, et al. 1991 Cognitive rather than behavioral outcomes 
Hines, M 2011 Review  
Inoff-Germain, G, et al. 1988 Behavior measurement subjective  
Kaiser, H, et al. 2006 Outside age range 
Kerschbaum, HH, et al. 2006 Time of testosterone collection not documented; outside age range 
Kreuz, LE, et al. 1972 Outside age range 
Kulin, HE, et al. 2000 Induction of puberty with exogenous androgen therapy 
Laznibatova, J 2004 Cognitive rather than behavioral outcomes 
Laznibatová, J 2001 Cognitive rather than behavioral outcomes 
Li, C, et al. 1993 Outside age range 
Liben, LS, et al. 2002 Cognitive rather than behavioral outcomes  
Maras, A, et al. 2003 Not a community sample  
Maras, A, et al. 2003 Not a community sample 
Martin, CA, et al. 2006 ADHD, no normal controls 
Martin, CA, et al. 1999 No data on testosterone alone  
Mattsson, A, et al. 1980 Young offenders only: no normal controls 
McBurnett, K, et al. 1994 Review article 
McHale, SM, et al. 2009 Cognitive not behavioral outcomes: personality and gender specific 
interests  
McHale, SM, et al. 2004 Cognitive not behavioral outcomes: personality and gender specific 
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interests  
Nerozzi, D 1984 Psychologically disturbed adolescents: no normal controls 
Newman, ML 2004 PhD dissertation, outside age range 
Nottelmann, ED, et al. 1990 Review 
Ostatnikova, D, et al. 2000 Cognitive rather than behavioral outcomes  
Paikoff, RL, et al. 1991 Testosterone level and behavior not contemporaneous, 
Popma, A, et al. 2007 Delinquent boys: no normal control group 
Post, JM 2010 Comment 
Reynolds, MD, et al. 2007 Testosterone level and behavior not contemporaneous 
Rowe, R, et al. 2004 Time of testosterone collection not documented 
Scerbo, AS, et al. 1994 Disruptive children only: no normal controls 
Scerbo, AS, et al. 1995 Letter 
Schaal, B, et al. 1996 Testosterone as dependent variable; low socioeconomic group 
Sinkkonen, J, et al. 1998 Time of testosterone collection not documented 
Smith, EA, et al. 1985 Focus on sexual behavior  
Strong, RK, et al. 2000 Male and female data pooled for correlation between testosterone and 
behavior 
Susman, EJ, et al. 1996 Effect of aggression and impulse control on testosterone 
Susman, EJ, et al. 1988 Review 
Tremblay, RE, et al. 1997 Book 
Udry, J 1991 Time of testosterone collection not documented 
Udry, J, et al. 1988 Cognitive not behavioral outcomes: personality 
Udry, JR, et al. 1985 Focus on sexual behavior  
Updegraff  KA et al 2006 Focus on romantic relationships 
van Bokhoven, I, et al. 2006 Behaviors averaged across ages 
van Goozen, SH, et al. 2000 No measurement of testosterone 
Vermeersch, H, et al. 2010 Data of testosterone and behavior previously reported in Vermeersch 2008 
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